<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 14 CANCER CONTROL | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.14/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.14/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|14|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|14" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.14"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 14 CANCER CONTROL | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.14/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.14/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|14" data-search-heading="">
                  <span title="Subtitle 14 CANCER CONTROL">Subtitle 14 CANCER CONTROL</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|14">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.14">Subtitle 14 CANCER CONTROL</h1>
                <h2 id="/us/md/exec/comar/10.14.01" data-order="|10|14|01|" data-ref-path="10|14|01" class="h__chapter">Chapter 01 Cancer Registry</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: September 28, 1992 (19:19 Md. R. 1707)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.01" title=".01 Scope.">Regulation .01</a> amended effective April 21, 1997 (24:8 Md. R. 616)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02#B" title="">Regulation .02B</a> amended effective April 26, 1993 (20:8 Md. R. 723); April 21, 1997 (24:8 Md. R. 616); June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.04" title=".04 Cancer Control Goals of the State.">Regulation .04</a> amended effective April 21, 1997 (24:8 Md. R. 616)</p>
                  <p>Regulation .04C amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.05#B" title="">Regulation .05B</a> amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.06#B" title="">Regulation .06B</a>, D amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p>——————</p>
                  <p>Chapter revised effective March 22, 2010 (37:6 Md. R. 478)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.01" title=".01 Scope.">Regulation .01</a> amended effective January 13, 2011 (38:1 Md. R. 11); April 15, 2013 (40:7 Md. R. 611); February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02#B" title="">Regulation .02B</a> amended effective January 13, 2011 (38:1 Md. R. 11); April 15, 2013 (40:7 Md. R. 611); February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02" title=".02 Definitions.">Regulation .02</a>-1 adopted effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02" title=".02 Definitions.">Regulation .02</a>-1 amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.05#C" title="">Regulation .05C</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.06#B" title="">Regulation .06B</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.07#G" title="">Regulation .07G</a> adopted effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.07#G" title="">Regulation .07G</a> amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.08#A" title="">Regulation .08A</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §§2-104, 18-104, 18-203 and 18-204, Annotated Code of Maryland; 42 U.S.C. §280(e)</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.01.01" data-order="|10|14|01|.01|" data-ref-path="10|14|01|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes a cancer registry within the Department, defines key terms, details the information to be contained in a cancer report, and specifies requirements of reporting facilities, nursing facilities, assisted living programs, and general hospice care programs. In addition, this chapter identifies requestors authorized to receive confidential data, allows a fee to be charged for data reports, and incorporates by reference the Maryland Cancer Registry Data Use Manual and Procedures (July 2016).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.02" data-order="|10|14|01|.02|" data-ref-path="10|14|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(1)">(1)</span> "Assisted living program" has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.14.02#B" title="">COMAR 10.07.14.02B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(2)">(2)</span> "Cancer registry" means a computerized system to register all cases of reportable human cancer or reportable human central nervous system (CNS) tumors of Maryland residents and nonresidents diagnosed or treated in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)">(3)</span> "Cancer report" means a one-time abstract from one or more of the following documents maintained by a reporting facility, nursing facility, assisted living program, or general hospice care program of each new case of reportable human cancer or CNS tumor diagnosed or treated, and any other case of reportable human cancer or CNS tumor initially diagnosed or treated for time periods as designated by the Secretary:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(a)">(a)</span> Medical record;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(b)">(b)</span> Pathology report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(c)">(c)</span> Radiological report.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)">(4)</span> Case of a Reportable Human CNS Tumor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)">(a)</span> "Case of a reportable human CNS tumor" means an identified human tumor, irrespective of histologic type or behavior, occurring as a primary tumor in any of the following sites or subsites with International Classification of Diseases for Oncology, Third Edition (ICD-O-3) topography codes C70.0 — C72.9 and C75.1 — C75.3:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(i)">(i)</span> The brain;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(ii)">(ii)</span> The meninges;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(iii)">(iii)</span> The spinal cord;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(iv)">(iv)</span> The cauda equina;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(v)">(v)</span> A cranial nerve;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(vi)">(vi)</span> The pituitary gland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(vii)">(vii)</span> The pineal gland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(viii)">(viii)</span> The craniopharyngeal duct.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)">(b)</span> “Case of a reportable human CNS tumor” includes all benign and uncertain behavior tumors of the CNS (ICD-10-CM Codes D18.02, D32.0 — D33.9, D35.2 — D35.4, D42.0 — D43.9, D44.3 — D44.5, Q85.00 — Q85.09 and D49.6, and all tumors of the CNS of benign and uncertain behavior with ICD-O-3 codes of “0” or “1”), which includes codes from:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)(i)">(i)</span> The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)(ii)">(ii)</span> The International Classification of Diseases for Oncology, Third Edition (ICD-O-3).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)">(5)</span> “Case of reportable human cancer” means the identification of a human cancer from the following list, which includes codes from the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) and the International Classification of Diseases for Oncology, Third Edition (ICD-O-3):</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)">(a)</span> All malignant neoplasms with ICD-10-CM Codes C00 — C43.9, C44.00, C44.09, C44.10_, C44.19_, C44.20_, C44.29_, C44.30_, C44.39_, C44.40, C44.49, C44.50_, C44.59_, C44.60_, C44.69_, C44.70_, C44.79_, C44.80, C44.89, C44.90, C44.99, C45._ — C96._, or with ICD-O-3 behavior code of “3”, including genital skin cancer of the vagina, clitoris, vulva, prepuce, penis, and scrotum and excluding other sites of skin cancer with ICD-O-3 topography codes C44.0 — C44.9 with one of the following ICD-O-3 histologies:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(i)">(i)</span> M-8000 — 8005 Neoplasms, malignant, not otherwise specified of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(ii)">(ii)</span> M-8010 — 8046 Epithelial carcinomas of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(iii)">(iii)</span> M-8050 — 8084 Papillary and squamous cell carcinomas of skin (C44.02, C44.12_, C44.22_, C44.32_, C44.42, C44.52_, C44.62_, C44.72_, C44.82, C44.92); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(iv)">(iv)</span> M-8090 — 8110 Basal cell carcinomas (C44.01, C44.11_, C44.21_, C44.31_, C44.41, C44.51_, C44.61_, C44.71_, C44.81, C44.91);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)">(b)</span> All malignant neoplasms with the following ICD-10-CM codes where ICD-O-3 behavior is “3” and ICD-O-3 histologies are reported except as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(i)">(i)</span> If there is evidence of multiple foci, lymph node involvement, or metastasis, C37 — Thymoma (M-8580);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(ii)">(ii)</span> C7A.020 — Malignant carcinoid tumor of the appendix (M-8240);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(iii)">(iii)</span> C54.1 — Endometrial stroma, low grade (M-8931);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(iv)">(iv)</span> If there is evidence of multiple foci, lymph node involvement, or metastasis, D48.1 — Stromal Tumor of the digestive system (GIST 8639);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(v)">(v)</span> D48.60 — Phylloides tumor (M-9020);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(vi)">(vi)</span> D45 — Polycythema (M-9950);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(vii)">(vii)</span> D47.Z9 — Plasmacytoma (M-9731, M-9734);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(viii)">(viii)</span> D47.3 — Essential thrombocythemia (M-9962), D46.0, D46.1, D46.20, D46.21, D46A, D46B — Low grade myelodysplastic syndrome lesions (M-9980), D46.22 — High grade myelodysplastic syndrome lesions (M-9983), D46.C — Myelodysplastic syndrome with 5q deletion (M-9986), D469 — Myelodysplastic syndrome, unspecified (M-9975), D47.1 — Myelofibrosis with myeloid metaplasia (primary myelofibrosis) (M-9961), D47.Z1 — post-transplant lymphoproliferative disorder (M-9989), C94.40, C94.41, C94.42, D47.9, D47.Z9 — lympho and myeloproliferative disease (M-9960, M-9970);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(ix)">(ix)</span> C88.2 — Alpha and gamma heavy chain disease (M-9762) or Franklin disease (M-9763);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(x)">(x)</span> C88.0 — Waldenstrom macroglobulinemia (M-9761);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(xi)">(xi)</span> D46.4 — Refractory anemia (M-9980); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(xii)">(xii)</span> D46.1 — Refractory anemia with ringed sideroblasts (M-9982), refractory anemia with excess blasts (M-9983), or refractory anemia with excess blasts in transformation (M-9984);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)">(c)</span> All cases of carcinoma in situ with ICD-10-CM Codes D00._ — D09.9, D47.Z2, D49.511 — D49.519, D49.59, D78.31 — D78.34, and D89.40 — D89.49, or with ICD-O-3 behavior code of “2”, including genital skin cancers of the vagina, clitoris, vulva, prepuce, penis, and scrotum and excluding other skin cancers with ICD-O-3 topography codes C44.0_ — C44.9_ with one of the following ICD-O-3 histologies:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(i)">(i)</span> M-8000 — 8005 Neoplasms, malignant, not otherwise specified of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(ii)">(ii)</span> M-8010 — 8046 Epithelial carcinomas of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(iii)">(iii)</span> M-8050 — 8084 Papillary and squamous cell carcinomas of skin; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(iv)">(iv)</span> M-8090 — 8110 Basal cell carcinomas; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)">(d)</span> All cases of intraepithelial neoplasia with ICD-O-3 histology code of M-8077/2:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)(i)">(i)</span> Including squamous intraepithelial neoplasia of the larynx (LIN), vagina (VAIN), vulva (VIN), and anus (AIN) (ICD-10-CM codes D02.0, D07.2, D07.1, and D01.3; and ICD-O-3 topography codes C52, C51, and C21._); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)(ii)">(ii)</span> Excluding squamous intraepithelial neoplasia of the cervix (CIN III) and glandular intraepithelial neoplasia of the prostate (PIN) (ICD-10-CM codes D06._ and D07.5; and ICD-O-3 topography codes C53 and C61.9).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(6)">(6)</span> "Computerized file" means an electronic data file using software approved for use by the Secretary, containing complete cancer report information transferable to a master electronic database system maintained by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(7)">(7)</span> "Department" means the Maryland Department of Health or a designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(8)">(8)</span> "Freestanding ambulatory care facility" has the meaning stated in Health-General Article, §19-3B-01, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)">(9)</span> "Freestanding laboratory" means a facility, place, establishment, or institution which performs a laboratory examination for a person, authorized by law to request the examination, in connection with the diagnosis of a reportable human cancer or CNS tumor, and is licensed by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03" title="Chapter 03 Medical Laboratories — Licenses">COMAR 10.10.03</a>, and:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)(a)">(a)</span> Not under the administrative control of a hospital; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)(b)">(b)</span> Under the administrative control of a hospital for a diagnosis of reportable human cancer or CNS tumor of a nonhospitalized patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(10)">(10)</span> “General hospice care program” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.21.02" title=".02 Definitions.">COMAR 10.07.21.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(11)">(11)</span> "Hospital" means a facility which is licensed by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(11-1)">(11-1)</span> “Maryland Cancer Registry Data Use Manual and Procedures” means the document that describes the Maryland cancer registry procedures for release of cancer data and that outlines the procedures to obtain both non-confidential aggregate data and confidential individual-level data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(12)">(12)</span> "Nursing facility" has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.02.01#B" title="">COMAR 10.07.02.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)">(13)</span> "Physician" means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)(a)">(a)</span> Practices medicine, as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=14-101" title="">Health Occupations Article, §14-101, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)(b)">(b)</span> Diagnoses or treats a case of reportable human cancer or a reportable human CNS tumor at a practice located in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)">(14)</span> "Reporting facility" means any of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)(a)">(a)</span> A hospital, freestanding laboratory, freestanding ambulatory care facility, or therapeutic radiological center; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)(b)">(b)</span> A physician who has care of or has diagnosed a case of reportable human cancer or reportable human CNS tumor for a nonhospitalized patient not otherwise reported.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(15)">(15)</span> "Secretary" means the Secretary of Health or a designee of the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)">(16)</span> "Therapeutic radiological center" means a facility or institution:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)(a)">(a)</span> Performing radiological treatment for a person authorized by law to request the treatment in connection with a reportable human cancer or a reportable human CNS tumor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)(b)">(b)</span> Licensed or registered by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.05.03" title="Chapter 03 Freestanding Major Medical Equipment Facilities">COMAR 10.05.03</a> and not under the administrative control of a hospital.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.02-1" data-order="|10|14|01|.02-1|" data-ref-path="10|14|01|.02-1" class="h__section">.02-1 Incorporation by Reference.</h3>
                <p>The Maryland Cancer Registry Data Use Manual and Procedures (Maryland Department of Health, July 2016) is incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.03" data-order="|10|14|01|.03|" data-ref-path="10|14|01|.03" class="h__section">.03 Establishment of a Cancer Registry.</h3>
                <p>There is a cancer registry established within the Department, whose purpose is to collect reportable human cancer data and reportable human CNS tumor data to further the cancer control goals of the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.04" data-order="|10|14|01|.04|" data-ref-path="10|14|01|.04" class="h__section">.04 Cancer Control Goals of the State.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A">A.</span> The cancer control goals of the State are to reduce the incidence and mortality of reportable human cancer and reportable human CNS tumors and racial, ethnic, gender, age, and geographic disparities in reportable human cancer and CNS tumor incidence and mortality in Maryland, by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(1)">(1)</span> Advancing the understanding of reportable human cancer and reportable human CNS tumor demographics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(2)">(2)</span> Describing reportable human cancer and reportable human CNS tumor sources, causes, risk factors, preventive measures, diagnostic tests, screening tests, treatment, and survival; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(3)">(3)</span> Evaluating the cost, quality, efficacy, and appropriateness of diagnostic, therapeutic, rehabilitative, and preventive services and programs related to reportable human cancer and reportable human CNS tumors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B">B.</span> Research that will further the cancer control goals of the State is research whose protocols have been reviewed by Department staff who have found that the research will:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(1)">(1)</span> Advance scientific knowledge or advance knowledge of clinical practice related to cancer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(2)">(2)</span> Have approaches, aims, and methods that will allow the researcher to perform descriptive analyses or test hypotheses;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(3)">(3)</span> Have one or more investigators who have training and experience with the approaches and methods; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(4)">(4)</span> Be conducted in a scientific environment likely to contribute to the success of the research.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.05" data-order="|10|14|01|.05|" data-ref-path="10|14|01|.05" class="h__section">.05 Content of a Cancer Report.</h3>
                <p>A cancer report shall contain the following information, using the standard nomenclature contained in the North American Association of Central Cancer Registries' Standards for Cancer Registries, Volume II, Data Standards and Data Dictionary:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#A">A.</span> Reasonably obtained patient demographic information, including risk factors;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#B">B.</span> Information on the industrial or occupational history of an individual with cancer, to the extent such information is available;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C">C.</span> Relevant information on the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(1)">(1)</span> Initial diagnosis, including the date of the diagnosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(2)">(2)</span> Initial treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(3)">(3)</span> Extent of the disease by the end of the first hospitalization; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(4)">(4)</span> Extent of the disease within 2 months of diagnosis, if the information is available to the reporting facility, nursing facility, assisted living program, or general hospice care program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#D">D.</span> Facility and other provider identification information; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#E">E.</span> Other requirements as considered necessary by the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.06" data-order="|10|14|01|.06|" data-ref-path="10|14|01|.06" class="h__section">.06 Reporting Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A">A.</span> A reporting facility shall submit a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(1)">(1)</span> Cancer report to the Secretary in a computerized file containing standard information required by the Secretary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(2)">(2)</span> Computerized file not less than quarterly; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(3)">(3)</span> Completed report of any new individual case of a reportable human cancer or reportable human CNS tumor not later than 6 months after diagnosis or treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#B">B.</span> A nursing facility, an assisted living program, or a general hospice care program shall submit a cancer report containing information that is under the control of the facility to the Secretary if the Secretary requests a cancer report on a patient who has been a resident of the nursing facility, assisted living program, or general hospice care program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.07" data-order="|10|14|01|.07|" data-ref-path="10|14|01|.07" class="h__section">.07 Confidentiality of Cancer Reports.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#A">A.</span> Information obtained under this chapter is not a medical record under Health-General Article, §4-301, Annotated Code of Maryland, but is subject to the confidentiality requirements of Health-General Article, §§4-101 — 4-103, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B">B.</span> The Secretary may release confidential data to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(1)">(1)</span> An institution or individual researcher for medical, epidemiological, health care, or other cancer-related or CNS tumor-related research approved by the Secretary and the Department's Institutional Review Board (IRB) in order to further the cancer control goals of the State set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.01.04" title=".04 Cancer Control Goals of the State.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)">(2)</span> A reporting facility which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(a)">(a)</span> Routinely submits information on cases of reportable human cancer or reportable human CNS tumors to the cancer registry;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(b)">(b)</span> Has been formally accepted as a participant in the cancer registry system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(c)">(c)</span> Requests data relating to patients reported by the facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)">(3)</span> An out-of-State cancer registry or cancer control agency which requests routine data if the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)(a)">(a)</span> Patient is a resident of the other state; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)(b)">(b)</span> Other state has authority to provide equivalent information on Maryland residents to this State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(4)">(4)</span> Each county health officer and the Baltimore City Commissioner of Health; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(5)">(5)</span> Another governmental agency performing its lawful duties pursuant to State or federal law.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C">C.</span> The Secretary may release confidential information, subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C(1)">(1)</span> A determination by the Secretary that a recipient of the information disclosed will maintain the confidentiality of the disclosed information; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C(2)">(2)</span> An agreement signed by the Secretary and by the recipient of the confidential information that the recipient of the information will maintain the confidentiality of the disclosed information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#D">D.</span> The Secretary shall release confidential data to a requestor in response to a written request only, in accordance with Health-General Article, §§4-101 and 4-102, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#E">E.</span> A reporting facility that in good faith submits a cancer report to the Secretary is not liable in any cause of action arising from the submission of the cancer report to the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#F">F.</span> The use or publication of any statistics, information, or other material that summarizes or refers to confidential records in the aggregate, without disclosing the identity of any person who is the subject of the confidential record is not subject to the provisions of Health-General Article, §4-102, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#G">G.</span> The Secretary shall release cancer data in accordance with the procedures outlined in the Maryland Cancer Registry Data Use Manual and Procedures.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.01.08" data-order="|10|14|01|.08|" data-ref-path="10|14|01|.08" class="h__section">.08 Authority and Requirements of the Secretary.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#A">A.</span> To assure compliance by a reporting facility, nursing facility, assisted living program, or general hospice care program with <a class="internal-link " href="/us/md/exec/comar/10.14.01.05" title=".05 Content of a Cancer Report.">Regulation .05 of this chapter</a>, the Secretary may, upon advance notice, inspect a representative sample of medical records, pathology reports, or radiological reports maintained by the facility of cases of reportable human cancer and reportable human CNS tumors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#B">B.</span> The Secretary may charge a reasonable fee to cover the cost of providing data reports to appropriate requestors, as allowed by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.08.04" title=".04 Fees.">COMAR 10.01.08.04</a>. All applicable fees shall be paid in full in advance of filling the request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C">C.</span> After receiving all necessary information to support a request to release cancer registry data, the Secretary shall act in a timely manner and decide on the request with one of the following outcomes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(1)">(1)</span> Final approval;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(2)">(2)</span> Interim approval, if the request has been accepted with one or more conditions which shall be met before final approval is granted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(3)">(3)</span> Disapproval.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#D">D.</span> The Secretary, in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=2-1246" title="">State Government Article, §2-1246, Annotated Code of Maryland</a>, shall submit an annual report to the Governor and General Assembly on the activities of the cancer registry, including use of cancer registry data.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#E">E.</span> Nothing in this chapter is intended to limit or otherwise restrict the Secretary from obtaining cancer report information on Maryland residents from sources located either inside or outside the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.02" data-order="|10|14|02|" data-ref-path="10|14|02" class="h__chapter">Chapter 02 Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12" title=".12 Medical Laboratory Services.">.12</a> under new Chapter, Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment, adopted as an emergency provision effective March 31, 1993 (20:8 Md. R. 715); Regulations .03 and .10 amended as an emergency provision effective May 24, 1993 (20:12 Md. R. 995); amendments to Regulation .10 expired June 30, 1993; adopted permanently effective September 13, 1993 (20:18 Md. R. 1430)</p>
                  <p>——————</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12" title=".12 Medical Laboratory Services.">.12</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.20" title=".20 Appeal Procedures.">.20</a> adopted effective December 5, 1994 (21:24 Md. R. 1988)</p>
                  <p>Chapter revised effective October 14, 2002 (29:20 Md. R. 1588)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.02#B" title="">Regulation .02B</a> amended as an emergency provision effective August 1, 2006 (33:21 Md. R. 1672); emergency status extended at 34:4 Md. R. 396; emergency status expired May 1, 2007; amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03" title=".03 Patient Eligibility.">Regulation .03</a> amended effective April 21, 2008 (35:8 Md. R. 805)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03#A" title="">Regulation .03A</a> amended as an emergency provision effective August 1, 2006 (33:21 Md. R. 1672); emergency status extended at 34:4 Md. R. 396; emergency status expired May 1, 2007; amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03#A" title="">Regulation .03A</a> amended effective January 26, 2009 (36:2 Md. R. 100)</p>
                  <p>——————</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08#H" title="">Regulation .08H</a>, I adopted as an emergency provision effective August 1, 2006 (33:21 Md. R. 1672); emergency status extended at 34:4 Md. R. 396; emergency status expired May 1, 2007; adopted permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08#J" title="">Regulation .08J</a> adopted effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Chapter revised as an emergency provision effective January 1, 2010 (37:6 Md. R. 474); revised permanently effective April 19, 2010 (37:8 Md. R. 616)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.01#B" title="">Regulation .01B</a> amended effective April 13, 2015 (42:7 Md. R. 569); May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.02#B" title="">Regulation .02B</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.02#B" title="">Regulation .02B</a> amended effective April 13, 2015 (42:7 Md. R. 569); May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03#A" title="">Regulation .03A</a>, G amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03#B" title="">Regulation .03B</a>, E amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03#C" title="">Regulation .03C</a>, G amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04" title=".04 Physician Services.">Regulation .04</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04#A" title="">Regulation .04A</a> amended effective July 2, 2018 (45:13 Md. R. 666)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04#A" title="">Regulation .04A</a>, E amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521); May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04" title=".04 Physician Services.">Regulation .04</a>-1 adopted effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04" title=".04 Physician Services.">Regulation .04</a>-2 adopted effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#A" title="">Regulation .05A</a> amended effective August 20, 2012 (39:16 Md. R. 1080); July 2, 2018 (45:13 Md. R. 666)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#A" title="">Regulation .05A</a>, B amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#A" title="">Regulation .05A</a>, D amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#A" title="">Regulation .06A</a> amended effective July 2, 2018 (45:13 Md. R. 666)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#A" title="">Regulation .06A</a>, B amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#A" title="">Regulation .06A</a>, D amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07" title=".07 Physical Therapy Services.">Regulation .07</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07#A" title="">Regulation .07A</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07#F" title="">Regulation .07F</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08" title=".08 Pharmacy Services.">Regulation .08</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08" title=".08 Pharmacy Services.">Regulation .08</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09" title=".09 Hospital Services.">Regulation .09</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09#C" title="">Regulation .09C</a>, G amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09#E" title="">Regulation .09E</a>, G amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10" title=".10 Disposable Medical Supplies and Durable Medical Equipment.">Regulation .10</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10#B" title="">Regulation .10B</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10#E" title="">Regulation .10E</a>, F amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.11" title=".11 Home Health Services.">Regulation .11</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.11#E" title="">Regulation .11E</a>, F amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12" title=".12 Medical Laboratory Services.">Regulation .12</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12#C" title="">Regulation .12C</a>, D amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12#D" title="">Regulation .12D</a>, E amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.13#A" title="">Regulation .13A</a>, E amended effective April 13, 2015 (42:7 Md. R. 569); May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.13#D" title="">Regulation .13D</a>, E amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.14" title=".14 Occupational Therapy Services.">Regulation .14</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.14#A" title="">Regulation .14A</a>, B amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.14#E" title="">Regulation .14E</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.15#A" title="">Regulation .15A</a>, B amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.15#B" title="">Regulation .15B</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.16" title=".16 Department, Local Health Department, Hospital, and Health Care Provider Responsibilities.">Regulation .16</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.17" title=".17 Reimbursement.">Regulation .17</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.17#D" title="">Regulation .17D</a> amended effective April 13, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.18" title=".18 Liability.">Regulation .18</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.19#A" title="">Regulation .19A</a>, B amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.20#A" title="">Regulation .20A</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21</a> amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.22" title=".22 Maryland Health Insurance Plan Coverage.">Regulation .22</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.22#A" title="">Regulation .22A</a>, D amended effective May 18, 2020 (47:10 Md. R. 517)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §§2-102, 2-104, and 2-105, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.02.01" data-order="|10|14|02|.01|" data-ref-path="10|14|02|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#A">A.</span> This chapter defines the reimbursed services for the diagnosis and treatment of breast cancer, cervical cancer, or precancerous cervical lesions, outlines the requirements for patient eligibility, and outlines the reimbursement and billing procedures for the reimbursed services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B">B.</span> This chapter also defines the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)">(1)</span> Responsibilities and duties of the Department, the participating local health department, the hospital-coordinated breast and cervical cancer screening program, the health care provider who determines patient eligibility and refers patients to the Program, and the following participating providers:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(a)">(a)</span> Physician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(b)">(b)</span> Physician assistant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(c)">(c)</span> Certified nurse midwife;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(d)">(d)</span> Nurse practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(e)">(e)</span> Nurse anesthetist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(f)">(f)</span> Physical therapist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(g)">(g)</span> Pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(h)">(h)</span> Hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(i)">(i)</span> Medical supply company;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(j)">(j)</span> Home health services provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(k)">(k)</span> Medical laboratory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(l)">(l)</span> Freestanding ambulatory surgical center; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(1)(m)">(m)</span> Occupational therapist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.01#B(2)">(2)</span> Process for termination from the Program and the procedure for appealing termination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.02" data-order="|10|14|02|.02|" data-ref-path="10|14|02|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(1)">(1)</span> “Admission” means the formal acceptance by a hospital of a patient who is to be provided with room, board, and medically necessary services in an area of the hospital where the patient stays at least overnight.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(2)">(2)</span> “Ambulatory surgical center” means a distinct, Medicare-certified entity that operates exclusively for the purpose of providing surgical services to patients not requiring hospitalization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(3)">(3)</span> “Annual gross income” means the total amount received per year from all sources before taxes are withheld.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(4)">(4)</span> “Applicant” means an individual who has applied to be eligible to have certain health care costs associated with the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion paid for by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(5)">(5)</span> “Biopsy” means the removal and microscopic examination of tissue from the living human body, performed to establish a precise diagnosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(6)">(6)</span> “Breast reconstruction” means surgery performed after the removal of a breast as a result of breast cancer to reestablish symmetry between the two breasts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(7)">(7)</span> “Certified nurse anesthetist” means a registered nurse who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(7)(a)">(a)</span> By reason of certification under COMAR 10.27.06, may practice in Maryland under the terms of those regulations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(7)(b)">(b)</span> Meets the certification requirements in the jurisdiction in which the service is provided, if the service is provided out-of-State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(8)">(8)</span> “Certified nurse midwife” means a registered nurse who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(8)(a)">(a)</span> By reason of certification under COMAR 10.27.05, may practice in Maryland under the terms of those regulations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(8)(b)">(b)</span> Meets the certification requirements in the jurisdiction in which the service is provided, if the service is provided out-of-State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(9)">(9)</span> “Certified nurse practitioner” means a registered nurse who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(9)(a)">(a)</span> By reason of certification under COMAR 10.27.07, may practice in Maryland under the terms of those regulations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(9)(b)">(b)</span> Meets the certification requirements in the jurisdiction in which the service is provided, if the service is provided out-of-State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(10)">(10)</span> “Cervical carcinoma in-situ” means cancer that involves only the intraepithelial layer of the cervix.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(11)">(11)</span> “Clinical breast examination” is a physical examination of the breast performed by a qualified health professional for the purpose of detecting breast cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(12)">(12)</span> “Clinically significant mass” means the presence of a discrete, dominant, palpable lump that raises the level of concern by either a patient or a provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)">(13)</span> “Controlled clinical trial” means a research study that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)(a)">(a)</span> Is conducted with cancer patients to evaluate the safety and effectiveness of a new treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)(b)">(b)</span> Is conducted after basic research in laboratory and animal studies have been well tested, and researchers have reason to believe that the new treatment will be as good as, or better than, current standard treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)(c)">(c)</span> Is reviewed for medical ethics, patient safety, and scientific merit by a research institution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)(d)">(d)</span> Includes an informed consent in which the patient is given information about the study and the potential benefits and risks; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(13)(e)">(e)</span> Involves review of the protocol and progress of the study and provides for monitoring the data and the safety of the patient during and after the study by researchers at places other than the institution at which the study is conducted.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(14)">(14)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(15)">(15)</span> “Diagnosis” means a histopathologic finding of breast cancer, cervical cancer, or a precancerous cervical lesion in a biopsy specimen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(16)">(16)</span> “Direct supervision” means that the physical therapist employer is physically present in the same area of the facility as the physical therapy assistant who provides service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(17)">(17)</span> “Disposable medical supplies” means consumable medical items with minimal or no potential for reuse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(18)">(18)</span> “Durable medical equipment” means equipment which satisfies all of the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(18)(a)">(a)</span> Can withstand repeated use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(18)(b)">(b)</span> Is used to serve a medical purpose; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(18)(c)">(c)</span> Is appropriate for use in the home.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(19)">(19)</span> "Eligible patient" means an applicant who has been determined to meet certain general, medical, health insurance, and financial criteria.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(20)">(20)</span> "Excisional biopsy" means the removal of the entire tumor mass for cytologic examination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)">(21)</span> “Experimental drug” means a drug or biological not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(a)">(a)</span> Approved by the Food and Drug Administration for the treatment of breast cancer or cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(b)">(b)</span> Used under the protocol of a peer-reviewed, Phase-III controlled clinical trial approved by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(b)(i)">(i)</span> The National Institutes of Health (NIH) or one of the NIH’s centers or cooperative groups;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(b)(ii)">(ii)</span> The Food and Drug Administration through an investigational new drug exemption;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(b)(iii)">(iii)</span> The Department of Veterans Affairs; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(21)(b)(iv)">(iv)</span> A qualified nongovernmental research entity as identified in guidelines issued by the NIH.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22)">(22)</span> "Experimental treatment" means a medical procedure or service for breast cancer, cervical cancer, or a precancerous cervical lesion that is not performed under the protocol of a peer-reviewed, Phase-III controlled clinical trial approved by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22)(a)">(a)</span> The National Institutes of Health (NIH) or one of the NIH's centers or cooperative groups;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22)(b)">(b)</span> The Food and Drug Administration through an investigational new drug exemption;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22)(c)">(c)</span> The Department of Veterans Affairs; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22)(d)">(d)</span> A qualified nongovernmental research entity as identified in guidelines issued by the NIH.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22-1)">(22-1)</span> "Explanation of benefits" means the statement sent to a patient or provider, or both, in a health plan that lists:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22-1)(a)">(a)</span> The health care services provided;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22-1)(b)">(b)</span> The amounts paid by the plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(22-1)(c)">(c)</span> The total amount billed to the patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(23)">(23)</span> “Family” means the unit comprised of the applicant or the applicant and one or more of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(23)(a)">(a)</span> Spouse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(23)(b)">(b)</span> A financially dependent child; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(23)(c)">(c)</span> A financially dependent relative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(24)">(24)</span> “Freestanding ambulatory surgical center” means a unit capable of providing ambulatory surgical services which is not located in a hospital setting and which is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(24)(a)">(a)</span> Certified by Medicare through the Health Care Finance Administration (HCFA) regional office to furnish ambulatory surgical services directly to patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(24)(b)">(b)</span> Licensed by the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(25)">(25)</span> “Homebound” means the status of a patient who is confined to the home due to a medical condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)">(26)</span> “Home health services provider” means a public or private agency or organization, or part of any agency or organization, that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(a)">(a)</span> Meets one of the following licensure requirements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(a)(i)">(i)</span> Is licensed pursuant to Health-General Article, §§19-401—19-408, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(a)(ii)">(ii)</span> If the entity is part of a hospital or related institution located in Maryland, is licensed pursuant to Health-General Article, §§19-301—19-359, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(a)(iii)">(iii)</span> If the entity is located outside of Maryland, is legally authorized to provide home health services in the jurisdiction in which the service is provided; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(a)(iv)">(iv)</span> Is a registered nurse licensed pursuant to Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-101" title="">8-101</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-301" title="">8-301</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-315" title="">8-315</a>, Annotated Code of Maryland, with a contractual agreement with the Department to provide skilled nursing care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(b)">(b)</span> Provides nursing or physical therapy services in the home; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(26)(c)">(c)</span> Meets the requirements for participation in Medicare.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(27)">(27)</span> “Hospital” means an institution which falls within the jurisdiction of Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland, and is licensed pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a> or other applicable standards established by the jurisdiction in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(28)">(28)</span> “Initial physical therapy evaluation” means the determination of the condition of the patient by a physical therapist through the administration of appropriate tests and a written case history on the first visit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(29)">(29)</span> “Innovator multiple source drug” has the meaning set forth at 42 U.S.C. §1396r-8(k)(7), as amended, which is incorporated by reference.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(30)">(30)</span> “Insurer” means a private carrier, nonprofit health service plan, or health maintenance organization that administers or provides reimbursement for health care benefits on an expense-incurred basis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(31)">(31)</span> “Intermittent basis” means a service which is furnished on or at medically predictable and recurring intervals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(32)">(32)</span> “Invasive cervical cancer” means cancer which has spread beyond the intraepithelial layer of the cervix or beyond to other body tissues and organs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(33)">(33)</span> “Invoice” means a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(33)(a)">(a)</span> Form issued or approved by the Department for use by a provider in submitting bills for payment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(33)(b)">(b)</span> Bill issued by a manufacturer or wholesaler to the provider which indicates proof of purchase and the price paid by the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(34)">(34)</span> “Legend drug” means a substance used as a medicine which is prescribed by a licensed health care provider in accordance with federal or State law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(35)">(35)</span> “Local health department” means the Baltimore City or a county-wide organization providing health services operated by the local health officer and under the supervision of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(36)">(36)</span> “Mammogram” means an X-ray of the breast that is performed to detect breast cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(37)">(37)</span> “Maryland Health Insurance Plan (MHIP)” means the nonprofit entity established under Insurance Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=14-501" title="">14-501</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=14-509" title="">14-509</a>, Annotated Code of Maryland, to provide affordable, comprehensive health coverage for medically uninsurable Maryland residents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(38)">(38)</span> “Medical Assistance” means the program administered by the State under Title XIX of the Social Security Act which provides comprehensive medical and other health-related care for eligible and medically needy low income individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(39)">(39)</span> “Medical case manager” means the participating physician or participating nurse practitioner who is responsible for making the medical decisions about the course of diagnosis and treatment for an eligible patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(40)">(40)</span> “Medical laboratory” means a licensed or certified facility operated for the examination of material derived from the human body, by one or more scientific disciplines, for the purpose of obtaining information that may be used to aid in the diagnosis, treatment, and management of breast and cervical cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(41)">(41)</span> “Medicare” means the medical insurance program administered by the federal government under Title XVIII of the Social Security Act, 42 U.S.C. §1395 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(42)">(42)</span> “Needle biopsy” means the removal of tissue from a solid mass with a needle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(43)">(43)</span> “Needle localization” means the application of radiologically guided needles to isolate breast lesions preoperatively.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(44)">(44)</span> “Negative mammogram” means the X-ray revealed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(44)(a)">(a)</span> Nothing of medical significance to comment on;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(44)(b)">(b)</span> A finding which is non-significant, but which may need to be described; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(44)(c)">(c)</span> A finding which is probably non-significant, but which may need to be described and which suggests the need for short interval follow-up.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(45)">(45)</span> “Occupational therapist” means an individual licensed by the Maryland Board of Occupational Therapy Practice or similarly licensed in the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(46)">(46)</span> “Oncologist” means a physician who specializes in the treatment of cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(47)">(47)</span> “Over-the-counter drug” means a substance used as a medicine that does not require a prescription under federal or State law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)">(48)</span> “Participating health care provider” means a local health department, hospital, or a participating:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(a)">(a)</span> Certified nurse midwife;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(b)">(b)</span> Freestanding ambulatory surgical center;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(c)">(c)</span> Home health services provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(d)">(d)</span> Hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(e)">(e)</span> Medical laboratory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(f)">(f)</span> Medical supply company;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(g)">(g)</span> Nurse anesthetist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(h)">(h)</span> Nurse practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(i)">(i)</span> Pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(j)">(j)</span> Physical therapist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(k)">(k)</span> Physician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(l)">(l)</span> Physician assistant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(m)">(m)</span> Occupational therapist; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(48)(n)">(n)</span> Other appropriate health care providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(49)">(49)</span> “Part-time basis” means services usually furnished during several visits per week, but not exceeding one visit per discipline per day, unless unusual circumstances are documented by the physician, which are reasonable and necessary to the treatment of breast and cervical cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(50)">(50)</span> “Patient contribution amount” means the amount of money required by an individual's health insurance policy to be paid by the individual for a given medical service received, excluding the deductible.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(51)">(51)</span> “Pharmacist” means an individual licensed to practice pharmacy in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(52)">(52)</span> “Pharmacy” means an establishment or institution requiring a permit in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(53)">(53)</span> “Phase-III controlled clinical trial” means a research study using an experimental drug or treatment which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(53)(a)">(a)</span> Has been shown to be effective in the treatment of breast or cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(53)(b)">(b)</span> May be compared with current standard treatment to evaluate which is more effective.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(54)">(54)</span> “Physical therapist” means an individual licensed or registered by the Maryland Board of Physical Therapy Examiners or similarly licensed or registered in the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(55)">(55)</span> “Physical therapist assistant” means an individual licensed as a physical therapy assistant, working under the direct supervision of a physical therapist, and performing those physical therapy procedures that are assigned by a physical therapist within the scope of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 13, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(56)">(56)</span> “Physical therapy aide” means a non-licensed individual in the employ of a physical therapist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(57)">(57)</span> “Physician” means an individual who is licensed to practice medicine in the jurisdiction in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(58)">(58)</span> “Physician assistant” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(58)(a)">(a)</span> Is licensed to practice medicine under the supervision of a physician under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 15, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(58)(b)">(b)</span> Meets the licensure requirements in the jurisdiction in which the service is provided, if the service is provided out-of-State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(59)">(59)</span> “Prescriber” means a participating health care provider licensed to prescribe legend drugs in the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(60)">(60)</span> “Prescription” means a written order for medication, medical supplies, or equipment signed by the prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(61)">(61)</span> “Program” means the Breast and Cervical Cancer Diagnosis and Treatment Program within the Department established to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(61)(a)">(a)</span> Reimburse for breast and cervical cancer diagnostic and treatment services provided by participating health care providers to eligible patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(61)(b)">(b)</span> Pay for MHIP coverage, if available, for eligible patients in lieu of providing direct reimbursement to participating health care providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(62)">(62)</span> “Progress note” means a dated, written notation which summarizes facts about the patient care given and the patient response during a given period of time that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(62)(a)">(a)</span> Specifically addresses the established goals of treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(62)(b)">(b)</span> Is consistent with the patient plan of care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(62)(c)">(c)</span> Is written immediately following each visit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(62)(d)">(d)</span> Is part of the permanent patient record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(63)">(63)</span> “Radiological examination of a breast surgical specimen” means an X-ray of the surgically removed tissue to ensure that the specimen contains the area of suspicion.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(64)">(64)</span> “Release of patient information” means a Departmental consent form signed by the patient granting permission to certain individuals to allow the release of certain medical and demographic information for the purpose of follow-up, reimbursement, and medical case management.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(65)">(65)</span> “Resident” means an individual who is currently living in, and intends to remain living within, Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(66)">(66)</span> “Single source drug” means a drug that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(66)(a)">(a)</span> Available from only one producer or distributor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(66)(b)">(b)</span> Produced or distributed under an original new drug application approved by the Food and Drug Administration, including a drug marketed by a producer or distributor operating under the new drug application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(67)">(67)</span> “Stage I breast cancer” means a tumor 2 centimeters or less in greatest dimension without regional lymph node or distant metastasis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(68)">(68)</span> “Staging” means the categorization of a cancer according to tumor size, regional lymph node involvement, and metastasis to distant areas in the body.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(69)">(69)</span> “Treatment” means the medical management and care of a patient for breast cancer, cervical cancer, or a precancerous cervical lesion.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.02#B(70)">(70)</span> “Utilization control agent” means the organization responsible for reviewing the use of hospital services to determine medical necessity and lengths of stay according to applicable professional standards.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.03" data-order="|10|14|02|.03|" data-ref-path="10|14|02|.03" class="h__section">.03 Patient Eligibility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A">A.</span> To be eligible to have a covered service reimbursed under the Program, an applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(1)">(1)</span> Be a resident;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(2)">(2)</span> Be screened for breast cancer or cervical cancer, or both, by a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(2)(a)">(a)</span> Hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(2)(b)">(b)</span> Local health department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(2)(c)">(c)</span> Health care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(3)">(3)</span> Be found to have an eligible medical condition as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(4)">(4)</span> Meet the health insurance criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(5)">(5)</span> Meet the financial eligibility criteria of an annual gross income that is not more than 250 percent of the federal poverty guidelines, as amended, which are incorporated by reference and updated periodically in the Federal Register by the U.S. Department of Health and Human Services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#A(6)">(6)</span> Receive a medical service only from participating health care providers for breast cancer diagnosis, breast cancer treatment, cervical cancer diagnosis, or cervical cancer or precancer treatment, or any combination of these services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B">B.</span> A medical condition which may render an applicant medically eligible includes the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B(1)">(1)</span> A mammogram, or breast ultrasound, or other diagnostic breast imaging requiring further diagnosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B(2)">(2)</span> A clinical breast examination requiring further diagnosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B(3)">(3)</span> A Pap test, or human papilloma virus test, or other approved cervical cancer screening test requiring further diagnosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B(4)">(4)</span> A breast biopsy which indicates the need for further diagnosis or treatment; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#B(5)">(5)</span> A cervical biopsy which indicates the need for further diagnosis or treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C">C.</span> Health insurance statuses which may render an applicant eligible include the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(1)">(1)</span> The applicant is not currently covered by health insurance, including Medical Assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(2)">(2)</span> The applicant is covered by Medicare which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(2)(a)">(a)</span> Does not provide reimbursement for the covered medical procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(2)(b)">(b)</span> Has a deductible for the year that has not been met; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(2)(c)">(c)</span> Has a patient contribution amount for the reimbursed medical procedure or service that the applicant is required to pay; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(3)">(3)</span> The applicant has health insurance other than Medical Assistance or Medicare which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(3)(a)">(a)</span> Does not provide reimbursement for the covered medical procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(3)(b)">(b)</span> Requires that a deductible be paid by the applicant for the covered medical procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(3)(c)">(c)</span> Reimburses at a rate lower than the Medical Assistance approved rate in the State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(3)(d)">(d)</span> Has a patient contribution amount for the reimbursed medical procedure or service that the applicant is required to pay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(4)">(4)</span> The applicant is enrolled in one of the following Medical Assistance programs:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(4)(a)">(a)</span> Family Planning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(4)(b)">(b)</span> Primary Adult Care (PAC);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(4)(c)">(c)</span> Specified Low Income Medicare Beneficiary (SLMB); or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#C(4)(d)">(d)</span> Qualified Medicare Beneficiary (QMB).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#D">D.</span> An applicant is not eligible if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#D(1)">(1)</span> The applicant is enrolled in a Medical Assistance program other than those listed in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03#C(4)" title="">§C(4) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#D(2)">(2)</span> During diagnosis or treatment of breast or cervical cancer, the applicant becomes enrolled in a Medical Assistance program other than those cited in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03#C(4)" title="">§C(4) of this regulation</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#D(3)">(3)</span> Any of the criteria established in §§A—D of this regulation are not met.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E">E.</span> An applicant is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(1)">(1)</span> Furnishing factual information regarding the applicant’s eligibility, including but not limited to verifying documents regarding financial eligibility and the applicability of health insurance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(2)">(2)</span> Completing, which may include the applicant providing the applicant's social security number, and signing the application form, provided that the Program informs the applicant that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(2)(a)">(a)</span> The applicant's disclosure of the applicant's social security number on the application is voluntary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(2)(b)">(b)</span> The Program's request for the applicant's social security number is authorized by federal law under the Social Security Act (42 U.S.C. 405(c), as amended); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(2)(c)">(c)</span> The applicant's social security number will be used only for the Program's administrative purposes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#E(3)">(3)</span> Completing and submitting a Medical Assistance application when notified by the Program that the applicant is considered potentially eligible.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F">F.</span> Social Security Number Collection.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F(1)">(1)</span> An applicant is not required to have or disclose a social security number to be eligible for Program benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F(2)">(2)</span> An applicant's disclosure of the applicant's social security number on the application form is voluntary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F(3)">(3)</span> The Program's request for the applicant's social security number is authorized by federal law under the Social Security Act at 42 U.S.C. §405(c)(2)(C)(i) and (vi), as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F(4)">(4)</span> The Program may only use the social security number provided by an applicant to establish the identity of the applicant for administrative purposes.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#F(5)">(5)</span> The Program may request a copy of an applicant's social security card for administrative purposes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#G">G.</span> An eligible patient is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#G(1)">(1)</span> Keeping the Program, local health department, hospital, or health care provider who determines the patient’s eligibility for the Program informed of any change in health insurance status;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#G(2)">(2)</span> Selecting and using only a participating health care provider; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.03#G(3)">(3)</span> Signing the release of patient information form for the Program developed and approved by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.04" data-order="|10|14|02|.04|" data-ref-path="10|14|02|.04" class="h__section">.04 Physician Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A">A.</span> To be considered a participating physician in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(1)">(1)</span> Provide a medical procedure or service related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(2)">(2)</span> Have a current license to practice medicine in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(3)">(3)</span> Agree to accept, for each covered medical procedure performed or service provided, the following reimbursement including, if applicable, a medical management fee as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(3)(a)">(a)</span> The current Medical Assistance approved rate in the State for an eligible patient who is uninsured or who has insurance that does not provide coverage for a reimbursed procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(3)(b)">(b)</span> The reimbursement rate approved by the insurer plus the payment of the outstanding deductible and patient contribution amount by the Department for an eligible patient who has insurance, other than Medicare, that provides coverage for a reimbursed procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(3)(c)">(c)</span> The reimbursement rate approved by Medicare plus the payment of the outstanding deductible and the patient contribution amount by the Department for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(3)(d)">(d)</span> For an eligible patient who has insurance that provides reimbursement for a covered procedure or service that is less than the current Medical Assistance approved rate, the reimbursement rate approved by the insurer plus the difference between the reimbursement rate approved by the insurer and the current Medical Assistance approved rate in the State plus the payment of the outstanding deductible by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(4)">(4)</span> Agree to abide by the provisions set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.04#A" title="">§A of this regulation</a> by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(5)">(5)</span> Agree not to bill an eligible patient, who is uninsured or is covered by Medicare or other insurance, for an additional charge for the reimbursed medical procedure performed or service provided;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(6)">(6)</span> Agree to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(6)(a)">(a)</span> Be the medical case manager for an eligible patient; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(6)(b)">(b)</span> Coordinate the reimbursed medical procedure or service with the designated medical case manager and submit the result of the procedure to the medical case manager;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)">(7)</span> Agree to the following medical guidelines:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(a)">(a)</span> That a negative mammogram alone is not sufficient to evaluate a clinically significant mass, and to perform or arrange for further diagnostic evaluation of the mass;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(b)">(b)</span> That a surgeon shall examine the patient and make the final determination of further diagnostic and treatment procedures needed when a needle biopsy performed by a non-surgeon is negative for cancer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(c)">(c)</span> To perform or arrange for needle localization of the mass before excisional biopsy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(d)">(d)</span> To perform or arrange for radiological examination of the breast surgical specimen after biopsy to accurately identify the mass;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(e)">(e)</span> To refer an eligible patient with a mammography assessment recommending biopsy to a surgeon for evaluation and a decision regarding the ultimate course of action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(f)">(f)</span> To implement the diagnostic tests or procedures required for cancer staging determination in keeping with the best interests of the patient and to determine staging on the cancer found;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(g)">(g)</span> To consult an oncologist before any treatment is initiated for Stage I or greater breast cancer or invasive cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(7)(h)">(h)</span> To consult with a radiation oncologist if radiation treatment is a medical option;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(8)">(8)</span> Agree to maintain the results of the reimbursed medical procedures performed as set forth in §E(6)—(9) of this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(9)">(9)</span> Agree to maintain administrative and health records, including medical records, to document compliance with this chapter for a minimum of 6 years and, upon request, allow the Department access to the records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#A(10)">(10)</span> Place no restriction on the eligible patient's right to choose a provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B">B.</span> An eligible medical provider may be, but is not limited to, one of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(1)">(1)</span> Anesthesiologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(2)">(2)</span> Clinical-anatomical or cytopathological pathologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(3)">(3)</span> Diagnostic, therapeutic, or nuclear radiologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(4)">(4)</span> Family practitioner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(5)">(5)</span> Medical internist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(6)">(6)</span> Medical or gynecological oncologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(7)">(7)</span> Obstetrician-gynecologist; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#B(8)">(8)</span> Surgeon.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C">C.</span> Reimbursed medical procedures include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)">(1)</span> Breast cancer diagnostic procedures including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)(a)">(a)</span> Cyst aspiration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)(b)">(b)</span> Diagnostic ultrasound;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)(c)">(c)</span> Incisional, excisional, or other breast biopsy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)(d)">(d)</span> Needle biopsy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(1)(e)">(e)</span> Needle localization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)">(2)</span> Breast cancer treatment procedures including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(a)">(a)</span> Adjuvant hormonal therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(b)">(b)</span> Adjuvant or sole chemotherapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(c)">(c)</span> Adjuvant or sole radiation therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(d)">(d)</span> Lumpectomy with radiation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(e)">(e)</span> Lymph node dissection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(f)">(f)</span> Modified radical mastectomy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(g)">(g)</span> Radical mastectomy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(2)(h)">(h)</span> Simple mastectomy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(3)">(3)</span> Contingent upon available funds, breast reconstruction procedures including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(3)(a)">(a)</span> Construction of breast mound;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(3)(b)">(b)</span> Augmentation mammoplasty;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(3)(c)">(c)</span> Reduction mammoplasty; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(3)(d)">(d)</span> Mastopexy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(4)">(4)</span> Cervical cancer or precancerous cervical lesion diagnostic procedures including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(4)(a)">(a)</span> Colposcopically directed cervical or vaginal biopsy, or both;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(4)(b)">(b)</span> Colposcopy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(4)(c)">(c)</span> Endocervical curettage; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(4)(d)">(d)</span> Endometrial biopsy if the patient has taken Tamoxifen for the treatment of breast cancer or has had cervical cancer documented;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)">(5)</span> Cervical cancer or precancerous cervical lesion treatment procedures including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(a)">(a)</span> Conization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(b)">(b)</span> Cryosurgery;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(c)">(c)</span> Dilation and curettage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(d)">(d)</span> Electric loop resection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(e)">(e)</span> Hysterectomy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(5)(f)">(f)</span> Laser treatment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(6)">(6)</span> Follow-up to treatment for breast cancer, cervical cancer, or a precancerous cervical lesion including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(6)(a)">(a)</span> Follow-up office visits with the medical case manager; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#C(6)(b)">(b)</span> Medical and laboratory tests ordered by the medical case manager.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D">D.</span> Non-reimbursed medical procedures and services include but are not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(1)">(1)</span> A screening mammogram;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(2)">(2)</span> A Pap or human papilloma virus test;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(3)">(3)</span> An experimental treatment other than a Phase-III controlled clinical trial for breast or cervical cancer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(4)">(4)</span> A procedure or service not related to the diagnosis and treatment of breast and cervical cancer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(5)">(5)</span> Organ transplants; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#D(6)">(6)</span> Nipple reconstruction or tattooing, or both.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E">E.</span> The participating physician is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(1)">(1)</span> Medical liability for the medical procedure performed on a referred, eligible patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(2)">(2)</span> Accepting a referral of an eligible patient from a local health department, hospital, or other health care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(3)">(3)</span> Performing a medical test needed by the eligible patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(4)">(4)</span> Charging the patient for a non-reimbursed medical procedure performed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(5)">(5)</span> Submitting a bill for the reimbursed medical procedure performed or service provided on the designated Departmental form within 12 months of the date of service as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(5)(a)">(a)</span> If an eligible patient is uninsured or is insured, but the insurance does not provide coverage for the reimbursed medical procedure or service, the participating physician shall send to the Department the bill for the procedure or service, with a denial from the applicable insurance carrier, on the form designated by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(5)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating physician shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(5)(b)(i)">(i)</span> Medicare or the other insurance for the procedure or service in accordance with Medicare or the other insurance billing specifications; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(5)(b)(ii)">(ii)</span> The Department for the outstanding deductible and patient contribution amount.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)">(6)</span> Maintaining reports of the results of the following diagnostic tests and sending to the Department upon request:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(a)">(a)</span> Sonogram or other breast cancer test which identifies an area as suspicious;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(b)">(b)</span> Breast biopsy in which cancer is present; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(c)">(c)</span> Cervical biopsy which identifies a change associated with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(c)(i)">(i)</span> Cervical carcinoma in situ;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(c)(ii)">(ii)</span> Cervical intraepithelial neoplasia;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(c)(iii)">(iii)</span> Invasive cervical cancer; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(6)(c)(iv)">(iv)</span> The human papilloma virus;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(7)">(7)</span> Maintaining reports of the results of the following diagnostic tests and sending to the Department upon request:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(7)(a)">(a)</span> Sonogram or other breast cancer test that is negative or shows a benign finding;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(7)(b)">(b)</span> Breast biopsy in which cancer is not present; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(7)(c)">(c)</span> Cervical biopsy which is negative or shows a benign finding;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(8)">(8)</span> Maintaining and sending to the Department upon request, reports pertaining to the staging of the cancer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#E(9)">(9)</span> Maintaining and sending to the Department, upon request, the result of a treatment procedure.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#F">F.</span> The participating physician may not bill the Department under this Program for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#F(1)">(1)</span> Completion of a form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#F(2)">(2)</span> A broken or missed appointment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#F(3)">(3)</span> A professional service rendered by mail or telephone; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#F(4)">(4)</span> A professional service provided to a patient enrolled in a Medical Assistance program other than those listed in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03#C(4)" title="">Regulation .03C(4) of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04#G">G.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.04-1" data-order="|10|14|02|.04-1|" data-ref-path="10|14|02|.04-1" class="h__section">.04-1 Physician Assistant Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A">A.</span> To be considered a participating physician assistant in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(1)">(1)</span> Be licensed to practice as a physician assistant in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(2)">(2)</span> Have a current written executed delegation agreement with a licensed supervising physician who is licensed to practice medicine in Maryland or a jurisdiction bordering on Maryland, if required by that jurisdiction;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(3)">(3)</span> Agree to accept, for each reimbursed medical procedure performed or service provided, the following reimbursement including, if applicable, a medical management fee as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(3)(a)">(a)</span> The current Medical Assistance approved rate in the State of an eligible patient who is uninsured or has insurance that does not provide coverage for a certain procedure or services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(3)(b)">(b)</span> The reimbursement rate approved by the insurer plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who has insurance, other than Medicare, that provides coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(3)(c)">(c)</span> The reimbursement rate approved by Medicare plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who is covered by Medicare only; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(3)(d)">(d)</span> For an eligible patient who has insurance that provides coverage for a reimbursed procedure or service that is less than the current Medical Assistance approved rate, the reimbursement rate approved by the insurer plus the difference between the reimbursement rate approved by the insurer, and the Medical Assistance approved rate in the State plus the payment of the deductible and patient contribution amount by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(4)">(4)</span> Agree to abide by the provisions set forth in this section by signing and sending to the Department the designated Departmental form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#A(5)">(5)</span> Agree to the medical, financial, and reporting requirements of the Program pursuant to Regulation .04A(5), (6), (7)(a)—(e), and (8)—(10) of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#B">B.</span> An eligible health care provider may be a physician assistant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C">C.</span> The reimbursed medical services include services related to breast and cervical cancer rendered to participants in accordance with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C(1)">(1)</span> The functions allowed under:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C(1)(a)">(a)</span> The Physician Assistant’s Practice Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C(1)(b)">(b)</span> COMAR 10.32.03; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C(1)(c)">(c)</span> The physician assistant’s written delegation agreement with a physician; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#C(2)">(2)</span> If out-of-State, the functions authorized in the state in which the services are provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#D">D.</span> Non-reimbursed medical procedures and services include a procedure or service not related to the diagnosis and treatment of breast and cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-1#E">E.</span> The participating physician assistant shall accept the responsibilities pursuant to Regulation .04E—G of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.04-2" data-order="|10|14|02|.04-2|" data-ref-path="10|14|02|.04-2" class="h__section">.04-2 Certified Nurse Midwife Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A">A.</span> To be considered a participating certified nurse midwife in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(1)">(1)</span> Be a certified nurse midwife in Maryland or a jurisdiction bordering on Maryland and hold all certifications as required by the Maryland Board of Nursing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(2)">(2)</span> Agree to accept, for each reimbursed medical procedure performed or service provided, the following reimbursement including, if applicable, a medical management fee as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(2)(a)">(a)</span> The current Medical Assistance approved rate in the State for an eligible patient who is uninsured or has insurance that does not provide coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(2)(b)">(b)</span> The reimbursement rate approved by the insurer plus the payment of the deductible by the Department for an eligible patient who has insurance, other than Medicare, that provides coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(2)(c)">(c)</span> The reimbursement rate approved by Medicare plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who is covered by Medicare only; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(2)(d)">(d)</span> For an eligible patient who has insurance that provides coverage for a reimbursed procedure or service that is less than the current Medical Assistance approved rate, the reimbursement rate approved by the insurer plus the difference between the reimbursement rate approved by the insurer, and the Medical Assistance approved rate in the State plus the payment of the deductible by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(3)">(3)</span> Agree to abide by the provisions set forth in this section by signing and sending to the Department the designated Departmental form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#A(4)">(4)</span> Agree to the medical, financial, and reporting requirements of the Program pursuant to Regulation .04A(5), (6), (7)(a)—(e), and (8)—(10) of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#B">B.</span> If out-of-State, the provider shall meet the regulatory requirements of the state in which the services are provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C">C.</span> The reimbursed medical procedure includes but is not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(1)">(1)</span> Colposcopically directed cervical or vaginal biopsy or both:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(2)">(2)</span> Colposcopy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(3)">(3)</span> Cyst aspiration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(4)">(4)</span> Endocervical curettage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(5)">(5)</span> Endometrial biopsy if the patient has taken Tamoxifen for the treatment of breast cancer or if cervical cancer has been documented;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(6)">(6)</span> Medically necessary services within the provider’s scope of practice as described in COMAR 10.27.05; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#C(7)">(7)</span> If out-of-State, nurse midwife services authorized in the state in which the services are provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#D">D.</span> Non-reimbursed medical procedures and services include a procedure or service not related to the diagnosis and treatment of breast and cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.04-2#E">E.</span> The participating certified nurse midwife shall accept the responsibilities pursuant to Regulation .04E—G of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.05" data-order="|10|14|02|.05|" data-ref-path="10|14|02|.05" class="h__section">.05 Nurse Practitioner Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A">A.</span> To be considered a participating nurse practitioner in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(1)">(1)</span> Be a certified nurse practitioner in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(2)">(2)</span> Have a current written attestation with a physician who is licensed to practice medicine in Maryland or a jurisdiction bordering Maryland, if required by that jurisdiction;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(3)">(3)</span> Agree to accept, for each reimbursed medical procedure performed or service provided, the following reimbursement including, if applicable, a medical management fee as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(3)(a)">(a)</span> The current Medical Assistance approved rate in the State for an eligible patient who is uninsured or has insurance that does not provide coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(3)(b)">(b)</span> The reimbursement rate approved by the insurer plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who has insurance, other than Medicare, that provides coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(3)(c)">(c)</span> The reimbursement rate approved by Medicare plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who is covered by Medicare only; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(3)(d)">(d)</span> For an eligible patient who has insurance that provides coverage for a reimbursed procedure or service that is less than the current Medical Assistance approved rate, the reimbursement rate approved by the insurer plus the difference between the reimbursement rate approved by the insurer and the Medical Assistance approved rate in the State plus the payment of the deductible by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(4)">(4)</span> Agree to abide by the provisions set forth in this section by signing and sending to the Department the designated Departmental form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#A(5)">(5)</span> Agree to the medical, financial, and reporting requirements of the Program pursuant to Regulation .04A(5)—(6), (7)(a)—(e), and (8)—(10) of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#B">B.</span> An eligible health care provider may be a certified nurse practitioner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C">C.</span> The reimbursed medical procedure includes but is not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C(1)">(1)</span> Colposcopically directed cervical or vaginal biopsy or both;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C(2)">(2)</span> Colposcopy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C(3)">(3)</span> Cyst aspiration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C(4)">(4)</span> Endocervical curettage; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#C(5)">(5)</span> Endometrial biopsy if the patient has taken Tamoxifen for the treatment of breast cancer or if cervical cancer has been documented.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#D">D.</span> Non-reimbursed medical procedures and services include a procedure or service not related to the diagnosis and treatment of breast and cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.05#E">E.</span> The participating nurse practitioner shall accept the responsibilities pursuant to Regulation .04E, F, and G of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.06" data-order="|10|14|02|.06|" data-ref-path="10|14|02|.06" class="h__section">.06 Nurse Anesthetist Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A">A.</span> To be considered a participating nurse anesthetist in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(1)">(1)</span> Be a certified nurse anesthetist in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(2)">(2)</span> Be currently collaborating with an anesthesiologist or other physician who is licensed to practice medicine in Maryland or a jurisdiction bordering Maryland in the manner prescribed by COMAR 10.27.06 or by the jurisdiction in which the service is provided;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(3)">(3)</span> Agree to accept, for each covered medical procedure performed or service provided, the following reimbursement including, if applicable, a medical management fee as described in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(3)(a)">(a)</span> The current Medical Assistance approved rate in the State for an eligible patient who is uninsured or who has insurance that does not provide coverage for a reimbursed procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(3)(b)">(b)</span> The reimbursement rate approved by the insurer plus the payment of the deductible and the patient contribution amount by the Department for an eligible patient who has insurance, other than Medicare, that provides coverage for a certain procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(3)(c)">(c)</span> The reimbursement rate approved by Medicare plus the payment of the deductible and patient contribution amount by the Department for an eligible patient who is covered by Medicare only; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(3)(d)">(d)</span> For an eligible patient who has insurance that provides reimbursement for a covered procedure or service that is less than the current Medical Assistance approved rate, the reimbursement rate approved by the insurer plus the difference between the reimbursement rate approved by the insurer and the Medical Assistance approved rate in the State plus the payment of the deductible by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(4)">(4)</span> Agree to abide by the provisions set forth in this section by signing and sending to the Department the designated Departmental form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#A(5)">(5)</span> Agree to the medical, financial, and reporting requirements of the Program pursuant to Regulation .04A(5),(6), (9), and (10) of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#B">B.</span> An eligible health care provider may be a certified nurse anesthetist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#C">C.</span> The reimbursed medical procedure is anesthesia required for the diagnosis and treatment of breast cancer or cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#D">D.</span> Non-reimbursed medical procedures and services include an anesthesia procedure or service not related to the diagnosis and treatment of breast cancer and cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.06#E">E.</span> The participating nurse anesthetist provider shall accept the responsibilities pursuant to Regulation .04E(1)—(5), F, and G of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.07" data-order="|10|14|02|.07|" data-ref-path="10|14|02|.07" class="h__section">.07 Physical Therapy Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A">A.</span> To be considered a participating physical therapist in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(1)">(1)</span> Be a physical therapist licensed to practice physical therapy in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(3)">(3)</span> Follow standard health and safety procedures to protect an eligible patient from potential hazards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(4)">(4)</span> Agree to the medical and reporting requirements of the Program pursuant to Regulation .04A(5), (9), and (10) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(5)">(5)</span> Agree to accept, as payment in full, the amount paid by the Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.07#E" title="">§E of this regulation</a> plus the amount paid by the eligible patient’s health insurer, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#A(6)">(6)</span> Agree not to bill an eligible patient an additional charge for the covered service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B">B.</span> The Program shall reimburse a participating physical therapist for a medically necessary physical therapy service ordered in writing by a participating physician when the service is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(1)">(1)</span> Provided by a physical therapist or by a physical therapist assistant under the direct supervision of a physical therapist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(2)">(2)</span> Provided in a physical therapy office or the patient's home;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(3)">(3)</span> Considered one or more of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(3)(a)">(a)</span> Diagnostic;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(3)(b)">(b)</span> Rehabilitative; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(3)(c)">(c)</span> Therapeutic;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(4)">(4)</span> Directly related to the written treatment order;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(5)">(5)</span> Of sufficient complexity and sophistication, or the condition of the patient is such that the service of a physical therapist is required;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)">(6)</span> Rendered pursuant to a written treatment order which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(a)">(a)</span> Is signed and dated by the prescribing physician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(b)">(b)</span> Specifies the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(b)(i)">(i)</span> Body part to be treated;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(b)(ii)">(ii)</span> Type of modality or treatment to be rendered;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(b)(iii)">(iii)</span> Expected result of physical therapy treatment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(b)(iv)">(iv)</span> Frequency and duration of treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(c)">(c)</span> Is kept on file by the physical therapist as a part of the permanent patient record subject to review by the Department or its designee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(6)(d)">(d)</span> Is not altered by the physical therapist unless medically indicated, whereby the physical therapist shall make a necessary change and sign the treatment order, advising the prescribing physician of the change and noting it in the patient record;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)">(7)</span> Recorded in the permanent record to include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(a)">(a)</span> The treatment order;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(b)">(b)</span> The initial evaluation by the physical therapist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(c)">(c)</span> Significant past history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(d)">(d)</span> Pertinent diagnoses and prognoses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(e)">(e)</span> Contraindications, if applicable; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(7)(f)">(f)</span> Progress notes, at least once every 2 weeks;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(8)">(8)</span> For a written treatment order for treatment exceeding 30 days and the participating physician:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(8)(a)">(a)</span> Reviews and rewrites the order monthly; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(8)(b)">(b)</span> Initials and dates a copy of the original order monthly; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#B(9)">(9)</span> For an initial physical therapy evaluation, on a one-time basis, per condition, when the requirements of this regulation are met.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#C">C.</span> The Program does not reimburse for services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#C(1)">(1)</span> Performed by a physical therapy assistant when not under the direct supervision of the physical therapist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#C(2)">(2)</span> Performed by a physical therapy aide; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#C(3)">(3)</span> Not directly related to the treatment of breast and cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#D">D.</span> The participating physical therapist is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#D(1)">(1)</span> Submitting to the Department, within 12 months of the date of service, a request for payment on the designated form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#D(2)">(2)</span> Certifying on the invoice that the treatment order is on file and was in effect at the time that services were rendered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#D(3)">(3)</span> Specifying on the invoice the type of treatment provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E">E.</span> Reimbursement Principles.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(1)">(1)</span> The Department shall reimburse the participating physical therapist:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(1)(a)">(a)</span> The current Medical Assistance approved rate in the State for a covered service performed in the provider’s office for an eligible patient who is uninsured or has insurance that does not provide coverage for the reimbursed procedure or service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(1)(b)">(b)</span> The outstanding deductible and patient contribution for a covered service performed in the provider’s office for an eligible patient who has Medicare or other insurance that provides reimbursement for a covered procedure or service; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(1)(c)">(c)</span> For covered services performed in the home of an eligible patient pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.11#F" title="">Regulation .11F of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(2)">(2)</span> The Department may not reimburse the participating physical therapist for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(2)(a)">(a)</span> Services rendered by mail or telephone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(2)(b)">(b)</span> Completion of a form or report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(2)(c)">(c)</span> A broken or missed appointment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#E(2)(d)">(d)</span> A service which is provided at no charge to the general public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#F">F.</span> The participating physical therapist shall obtain recovery pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.17" title=".17 Reimbursement.">Regulation .17 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.07#G">G.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.08" data-order="|10|14|02|.08|" data-ref-path="10|14|02|.08" class="h__section">.08 Pharmacy Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A">A.</span> To be considered a participating pharmacy in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A(1)">(1)</span> Obtain a permit from the Department pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A(3)">(3)</span> Agree to accept, as payment in full, the amount paid by the Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#E" title="">§E of this regulation</a> plus the amount paid by the eligible patient's health insurer, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A(4)">(4)</span> Agree not to bill an eligible patient for an additional charge for the reimbursed pharmacy services provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#A(5)">(5)</span> Maintain adequate prescription and administrative records for a minimum of 5 years and, upon request, allow the Department access to the records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B">B.</span> Reimbursed pharmacy services include but are not limited to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)">(1)</span> A prescription, when ordered and signed by a prescriber for an eligible patient, within the limits established by the Program which includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)">(a)</span> A legend drug, including but not limited to the following drug classifications:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(i)">(i)</span> Analgesic;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(ii)">(ii)</span> Antidepressant;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(iii)">(iii)</span> Antiemetic;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(iv)">(iv)</span> Anti-infective;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(v)">(v)</span> Antineoplastic agent;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(vi)">(vi)</span> Benzodiazepine;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(vii)">(vii)</span> Colony stimulating factor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(viii)">(viii)</span> Hormone; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(a)(ix)">(ix)</span> Individual vitamin; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(1)(b)">(b)</span> An especially formulated enteral or parenteral nutritional preparation required for a patient with a documented pathologic condition, when treatment is medically necessary and life sustaining;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(2)">(2)</span> Hypodermic needle and syringe;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(3)">(3)</span> Over-the-counter iron preparation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(4)">(4)</span> Durable medical equipment as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.10#B" title="">Regulation .10B of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#B(5)">(5)</span> A disposable medical supply as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.10#B" title="">Regulation .10B of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#C">C.</span> Non-reimbursed pharmacy services include but are not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#C(1)">(1)</span> An over-the-counter drug, excluding iron preparations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#C(2)">(2)</span> A legend drug for which federal finance participation is prohibited pursuant to 42 CFR §441.25;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#C(3)">(3)</span> An experimental drug; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#C(4)">(4)</span> A drug not directly related to the diagnosis and treatment of breast or cervical cancer or a complication of treatment for breast or cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D">D.</span> The participating pharmacy responsibilities are as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D(1)">(1)</span> Monitoring an eligible patient’s file for contraindications and toxicity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D(2)">(2)</span> Submitting a bill on the designated Departmental form for the reimbursed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D(2)(a)">(a)</span> Medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D(2)(b)">(b)</span> Durable medical equipment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#D(2)(c)">(c)</span> Disposable medical supply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#E">E.</span> The Department shall reimburse the participating pharmacy:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#E(1)">(1)</span> Pursuant to COMAR 10.09.03.07A—G, H(1)—(3), and (5)—(6); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#E(2)">(2)</span> For the deductible or patient contribution amount, or both.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#F">F.</span> The participating pharmacy shall obtain recovery pursuant to COMAR 10.09.03.08.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#G">G.</span> Periodic peer review may be performed by the Department or its designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#H">H.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#I" title="">§I of this regulation</a>, a drug manufacturer shall pay drug rebates to the Department for reimbursable pharmacy services in the same manner and amount that rebates are provided to the State for State-Only and Pharmacy Assistance recipients' purchases of drugs in accordance with §1927(c) of Title XIX of the Social Security Act (42 U.S.C. §1396r-8(c)) which is incorporated by reference.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I">I.</span> Limitations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(1)">(1)</span> The Department shall provide notice to a drug manufacturer who fails to provide adequate rebates in accordance with this chapter indicating that the manufacturer shall pay the drug rebate unless:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(1)(a)">(a)</span> The manufacturer submits a written request to the Secretary for a waiver of the rebate requirement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(1)(b)">(b)</span> The Secretary grants a waiver under <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#I(2)" title="">§I(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(2)">(2)</span> The Secretary shall grant a waiver to the requirement set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#H" title="">§H of this regulation</a> only if the Secretary determines that the drug manufacturer has demonstrated that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(2)(a)">(a)</span> The drug is a single source drug or an innovator multiple source drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(2)(b)">(b)</span> The Department has determined that the drug is essential to the health of the eligible patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(2)(c)">(c)</span> The drug has been given a rating of I-A by the Food and Drug Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(2)(d)">(d)</span> The physician has obtained the Department's authorization for use of the drug before prescribing the drug to the eligible patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#I(3)">(3)</span> No manufacturer or its designee may dispute or request repayment of any rebate paid under <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#H" title="">§H of this regulation</a> more than 3 years after the date the rebate was paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.08#J">J.</span> Except when a manufacturer has been granted a waiver to the rebate requirement under <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#I" title="">§I of this regulation</a>, the Program may not pay for a drug under this chapter if the manufacturer has not provided a rebate to the Program in accordance with <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#H" title="">§H of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.09" data-order="|10|14|02|.09|" data-ref-path="10|14|02|.09" class="h__section">.09 Hospital Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A">A.</span> To be considered a participating hospital in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A(1)">(1)</span> Be licensed as a hospital in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A(3)">(3)</span> Agree to accept, as payment in full, the amount paid by the Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.09#E" title="">§E of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A(4)">(4)</span> Agree not to bill an eligible patient for an additional charge for the reimbursed hospital services provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#A(5)">(5)</span> Maintain adequate records for a minimum of 5 years and, upon request, allow the Department access to the records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B">B.</span> The participating hospital shall receive reimbursement for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(1)">(1)</span> Medically necessary inpatient hospital service for the number of days, per admission, including preoperative days certified by the utilization control agent, which is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(1)(a)">(a)</span> Necessary for the provision of diagnostic, curative, palliative, or rehabilitative treatment for breast cancer or cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(1)(b)">(b)</span> Described in the eligible patient's medical record in sufficient detail to support the invoices submitted for services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(2)">(2)</span> Medically necessary outpatient hospital service which is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(2)(a)">(a)</span> Necessary for the provision of diagnostic, curative, palliative, or rehabilitative treatment for breast cancer or cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#B(2)(b)">(b)</span> Described in the eligible patient's medical record in sufficient detail to support the invoices submitted for services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#C">C.</span> Limitations. The limitations on coverage of some hospital inpatient and outpatient services contained in COMAR 10.09.92.05 apply to this Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D">D.</span> Preauthorization Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)">(1)</span> The following surgical procedures require preauthorization when performed on a hospital inpatient basis unless the patient is already a hospital inpatient for another condition, or an unrelated procedure is being done simultaneously which itself requires surgical hospitalization. If an emergency necessitates performing any of the listed procedures on an inpatient basis, the provider shall request and obtain post-authorization before billing. The procedures are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(a)">(a)</span> Biopsy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(b)">(b)</span> Breast biopsy if a two-stage procedure is planned for a possible malignancy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(c)">(c)</span> Colposcopy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(d)">(d)</span> Cryotherapy alone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(e)">(e)</span> Cryotherapy with biopsy or dilation and curettage, or both;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(f)">(f)</span> Dilation and curettage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(g)">(g)</span> Excision of benign lesion; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(1)(h)">(h)</span> Hysteroscopy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#D(2)">(2)</span> Authorization is required by the Program for all preoperative inpatient days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E">E.</span> The participating hospital is responsible for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(1)">(1)</span> Submitting a bill for the reimbursed services provided on the designated Departmental form as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(1)(a)">(a)</span> If an eligible patient is uninsured, or is insured but the insurance does not provide coverage for the reimbursed service, the participating hospital shall send the Department the bill for the service, with a denial from the patient’s insurance carrier, within 12 months of the date of discharge or outpatient service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(1)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating hospital shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(1)(b)(i)">(i)</span> Medicare or the other insurance for the procedure or service; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(1)(b)(ii)">(ii)</span> The Department for the outstanding deductible and patient contribution amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(2)">(2)</span> Documenting the sum collected from the eligible patient's insurer as a patient collection; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#E(3)">(3)</span> Submitting properly completed attachments with the bill as requested by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F">F.</span> Reimbursement Principles.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(1)">(1)</span> The Program shall reimburse for a room and board charge for the day of admission, and may not reimburse for a room and board charge for the day of discharge from the participating hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(2)">(2)</span> The participating hospital may not collect a total payment, including the eligible patient's insurance and the Department's payment, which exceeds the provider's rate established by the Department or its designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(3)">(3)</span> A participating hospital may not bill the Program a charge exceeding that charged the general public for a similar service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(4)">(4)</span> The Department may not reimburse the participating hospital for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(4)(a)">(a)</span> Completion of a form or report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(4)(b)">(b)</span> A broken or missed appointment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(4)(c)">(c)</span> A professional service rendered by mail or telephone; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(4)(d)">(d)</span> A service which is provided at no charge to the general public.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#F(5)">(5)</span> The Department may not make direct payment to an eligible patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G">G.</span> Reimbursement Rates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(1)">(1)</span> A participating hospital located in Maryland shall be reimbursed by the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(1)(a)">(a)</span> Pursuant to COMAR 10.09.92.07A(2)—(4) and B for an eligible patient who is uninsured or who has insurance that does not provide coverage for the reimbursed service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(1)(b)">(b)</span> Pursuant to COMAR 10.09.92.07A(8) and (9) for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(1)(c)">(c)</span> For an eligible patient who has insurance other than Medicare that provides coverage for the reimbursed service, the outstanding deductible and patient contribution amount required by the insurer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(2)">(2)</span> A participating hospital located in a state bordering Maryland shall be reimbursed by the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(2)(a)">(a)</span> Pursuant to COMAR 10.09.92.07B for an eligible patient who is uninsured or who has insurance that does not provide coverage for the reimbursed service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(2)(b)">(b)</span> Pursuant to COMAR 10.09.92.07A(8) and (9) for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(2)(c)">(c)</span> For an eligible patient who has insurance other than Medicare that provides coverage for the reimbursed services, the outstanding deductible and patient contribution amount required by the insurer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(3)">(3)</span> A participating hospital located in the District of Columbia shall be reimbursed by the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(3)(a)">(a)</span> Pursuant to COMAR 10.09.92.08A and B for an eligible patient who is uninsured or who has insurance that does not provide coverage for the reimbursed service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(3)(b)">(b)</span> Pursuant to COMAR 10.09.92.07A(8) and (9) for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#G(3)(c)">(c)</span> For an eligible patient who has insurance other than Medicare that provides coverage for the reimbursed services, the outstanding deductible, and patient contribution required by the insurer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.09#H">H.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.10" data-order="|10|14|02|.10|" data-ref-path="10|14|02|.10" class="h__section">.10 Disposable Medical Supplies and Durable Medical Equipment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A">A.</span> To be considered a participating medical supply company in the Program, the provider of disposable medical supplies and durable medical equipment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A(1)">(1)</span> To the extent required by law, be licensed and legally authorized to practice or deliver services in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A(3)">(3)</span> Agree to accept, as payment in full, the amount paid by the Department pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.10#F" title="">§F of this regulation</a> plus, if applicable, the amount paid by the eligible patient's health insurer and the patient contribution amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A(4)">(4)</span> Agree not to bill an eligible patient for an additional charge for the eligible disposable medical supplies and eligible durable medical equipment other than the patient contribution amount, excluding the deductible; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#A(5)">(5)</span> Maintain adequate records for a minimum of 6 years and, upon request, allow the Department access to the records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B">B.</span> The Department shall reimburse for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)">(1)</span> Eligible disposable medical supplies, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(a)">(a)</span> Central catheter for administration of intravenous solutions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(b)">(b)</span> Administration set for intravenous medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(c)">(c)</span> Parenteral feeding equipment, as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(c)(i)">(i)</span> Administration set;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(c)(ii)">(ii)</span> Dravon clamp;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(c)(iii)">(iii)</span> Filter; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(c)(iv)">(iv)</span> Injection cap; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(d)">(d)</span> Enteral feeding equipment, as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(d)(i)">(i)</span> Adapter;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(d)(ii)">(ii)</span> Administration set;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(d)(iii)">(iii)</span> Feeding syringe; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(1)(d)(iv)">(iv)</span> Nasogastric tube;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)">(2)</span> Eligible durable medical equipment for purchase or rental, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(a)">(a)</span> A delivery system comprised of a pump and pole assembly for an enteral or parenteral feeding;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(b)">(b)</span> An individually form-fitted arm support stocking for a recipient prescribed by the participating physician as medically necessary, not to exceed two stockings at one time or three stockings in a 12-month period for a non-institutionalized individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(c)">(c)</span> IV pole for use with parenteral administration of medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(d)">(d)</span> External ambulatory infusion pump with administrative equipment, when the usual and customary mode of therapy has been tried and shown to be unsuccessful or impractical;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(e)">(e)</span> Breast prosthesis, including surgical brassiere; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(f)">(f)</span> A wig when the following conditions are met:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(f)(i)">(i)</span> Hair loss is a direct result of the administration of chemotherapy or radiation for the treatment of breast or cervical cancer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(f)(ii)">(ii)</span> The cost does not exceed $350; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#B(2)(f)(iii)">(iii)</span> The wig is prescribed by an oncologist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#C">C.</span> The Department may not reimburse for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#C(1)">(1)</span> A disposable medical supply which is not directly related to the diagnosis and treatment of breast cancer or cervical cancer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#C(2)">(2)</span> Durable medical equipment as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#C(2)(a)">(a)</span> Head covering; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#C(2)(b)">(b)</span> An item not directly related to the diagnosis and treatment of breast cancer or cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#D">D.</span> Preauthorization is required for the disposable medical supply and durable medical equipment pursuant to COMAR 10.09.12.06A—F and H.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E">E.</span> Reimbursement Procedures. The participating medical supply company:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(1)">(1)</span> Shall submit the request for payment for the reimbursed service on the form designated by the Department within 12 months of the date of service as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(1)(a)">(a)</span> If an eligible patient is uninsured, or is insured but the insurance does not provide coverage for the reimbursed service, the participating medical supply company shall send the Department the bill for the service, with a denial from the patient’s insurance carrier; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(1)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating medical supply company shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(1)(b)(i)">(i)</span> Medicare or the other insurance for the service; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(1)(b)(ii)">(ii)</span> The Department for the outstanding deductible, patient contribution amount, and if the insurer pays less than the current Medical Assistance approved rate for the service, the difference between the insurance reimbursement rate and the Medical Assistance approved rate in the State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(2)">(2)</span> May not bill the Program a charge exceeding the usual and customary charge to the general public for a similar item; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(3)">(3)</span> Shall bill the Program the usual and customary charge for the prosthetic device and an individually form-fitted arm support stocking including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(3)(a)">(a)</span> Fitting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(3)(b)">(b)</span> Dispensing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#E(3)(c)">(c)</span> Follow-up care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F">F.</span> Reimbursement Procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(1)">(1)</span> The Department shall reimburse the participating medical supply company:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(1)(a)">(a)</span> Pursuant to COMAR 10.09.12.07F—K for an eligible patient who is uninsured or who has insurance that does not provide coverage for the reimbursed service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(1)(b)">(b)</span> Pursuant to COMAR 10.09.12.07R and S for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(1)(c)">(c)</span> The outstanding deductible and patient contribution amount required by the insurer for an eligible patient who has insurance, other than Medicare, that provides coverage for the reimbursed service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(2)">(2)</span> The Department may not reimburse for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(2)(a)">(a)</span> Completion of a form;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(2)(b)">(b)</span> A broken or missed appointment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(2)(c)">(c)</span> A professional service rendered by mail or telephone; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#F(2)(d)">(d)</span> A service rendered to the general public at no charge.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.10#G">G.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.11" data-order="|10|14|02|.11|" data-ref-path="10|14|02|.11" class="h__section">.11 Home Health Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A">A.</span> To be considered a participating home health services provider in the Program, the provider of home health services shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A(1)">(1)</span> Be a home health services provider licensed in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation and apply for participation in the Program by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A(3)">(3)</span> Comply with COMAR 10.09.04.03A, B(2),(3), C(4), and D, if offering skilled nursing care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A(4)">(4)</span> Accept, as payment in full for covered services rendered, the amount paid by the Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.11#D" title="">§D of this regulation</a> plus, if applicable, the amount paid by the eligible patient's health insurer and the patient contribution amount, and agree not to bill an eligible patient an additional charge for the covered services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#A(5)">(5)</span> Maintain the patient care, medical supply, billing, and the patient contribution amount records for a minimum of 6 years and, upon request, allow the Department access to the records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B">B.</span> The Program shall reimburse for a service listed in <a class="internal-link " href="/us/md/exec/comar/10.14.02.11#C" title="">§C of this regulation</a> when the service is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(1)">(1)</span> Provided upon the written order of the participating physician and furnished under the current plan of treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(2)">(2)</span> Rendered to an eligible patient who is certified by the participating physician as homebound;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(3)">(3)</span> Consistent with the current diagnosis and treatment of the patient condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(4)">(4)</span> In accordance with accepted standards of practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(5)">(5)</span> Required by the medical condition rather than the convenience or preference of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(6)">(6)</span> Considered under accepted standards of practice to be a specific and effective treatment for the condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(7)">(7)</span> Required on a part-time, intermittent basis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(8)">(8)</span> Rendered in the home of the eligible patient by a participating home health services provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(9)">(9)</span> Adequately described in the signed and dated progress note; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#B(10)">(10)</span> Directly related to the diagnosis and treatment of breast cancer or cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C">C.</span> The Program provides reimbursement for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C(1)">(1)</span> Skilled nursing care provided by a licensed nurse when the complexity of the service requires the judgment, knowledge, and skill of a licensed nurse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C(2)">(2)</span> Physical therapy, provided by a licensed physical therapist as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.07" title=".07 Physical Therapy Services.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C(3)">(3)</span> Occupational therapy provided by a licensed occupational therapist as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.14" title=".14 Occupational Therapy Services.">Regulation .14 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C(4)">(4)</span> Medical supplies and equipment as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.10#B" title="">Regulation .10B of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#C(5)">(5)</span> Other supplies which are used during a reimbursed home health visit as part of the treatment ordered by the participating physician.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#D">D.</span> The Program does not reimburse for services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#D(1)">(1)</span> Not directly related to the treatment of breast and cervical cancer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#D(2)">(2)</span> Pursuant to COMAR 10.09.04.05A, B, D, G, N, and P;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#D(3)">(3)</span> Rendered by Home Health Aides; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#D(4)">(4)</span> Rendered by social workers.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E">E.</span> The participating home health services provider is responsible for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(1)">(1)</span> Submitting a bill for the reimbursed service provided on the form designated by the Department within 12 months of the date of service, as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(1)(a)">(a)</span> If an eligible patient is uninsured or is insured, but the insurance does not provide coverage for a reimbursed service, the participating home health services provider shall send the Department the bill for the service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(1)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating home health services provider shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(1)(b)(i)">(i)</span> Medicare or the other insurance for the procedure or service; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(1)(b)(ii)">(ii)</span> The Department for the outstanding deductible and patient contribution amount; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#E(2)">(2)</span> Not billing the Department under this Program a charge in excess of that charged the general public for a similar service or for a service rendered at no charge to the general public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#F">F.</span> Reimbursement Rates. A non-hospital-based participating home health services provider located in Maryland, or a participating home health services provider located in a jurisdiction bordering Maryland shall be reimbursed by the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#F(1)">(1)</span> Pursuant to COMAR 10.09.04.07D for an eligible patient who is uninsured or who has insurance that does not provide coverage for the reimbursement service; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#F(2)">(2)</span> For the outstanding deductible and patient contribution amount, if applicable, for an eligible patient who is covered by Medicare or other insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.11#G">G.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.12" data-order="|10|14|02|.12|" data-ref-path="10|14|02|.12" class="h__section">.12 Medical Laboratory Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A">A.</span> To be considered a participating medical laboratory in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(1)">(1)</span> Be in compliance with the applicable license requirements for a medical laboratory providing services for Maryland residents including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(1)(a)">(a)</span> Requirements for Medicare certification;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(1)(b)">(b)</span> Compliance with the requirements pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.01" title=".01 General.">COMAR 10.10.03.01</a> if operating in Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(1)(c)">(c)</span> Requirements for the Federal Clinical Laboratory Improvement Act of 1988, 42 U.S.C. §263a;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(2)">(2)</span> Agree to accept as payment in full for the reimbursed service, the amount paid by the Program as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.12#E" title="">§E of this regulation</a> plus, if applicable, the amount paid by the eligible patient's health insurer and the patient contribution amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(3)">(3)</span> Agree not to bill an eligible patient for an additional charge for the medical laboratory services provided;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(4)">(4)</span> Abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(5)">(5)</span> Place no restriction on the eligible patient's right to select a provider; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#A(6)">(6)</span> Maintain records adequate to substantiate the ordering, performance, and reporting of laboratory procedures performed or referred for a minimum of 6 years, and, upon request, allow the Department access to the records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#B">B.</span> A reimbursed service includes but is not limited to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#B(1)">(1)</span> Preparation, analysis, and interpretation of a cervical biopsy, endometrial biopsy, vaginal biopsy, and breast biopsy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#B(2)">(2)</span> A laboratory procedure or service related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C">C.</span> A non-reimbursed service includes but is not limited to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(1)">(1)</span> A laboratory service not directly related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(2)">(2)</span> A service for which there does not exist an order signed by a participating health care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(3)">(3)</span> A procedure for which the laboratory has not been certified by Medicare;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(4)">(4)</span> A service not provided according to the laws and regulations of the jurisdiction in which the service is rendered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(5)">(5)</span> A procedure that is investigational or experimental in nature; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#C(6)">(6)</span> A service included and paid for by the Program as part of the total charge submitted by an inpatient facility or hospital outpatient department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D">D.</span> Reimbursement Procedures. The participating medical laboratory is responsible for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(1)">(1)</span> Submitting a bill for the reimbursed service provided on the form designated by the Department within 12 months of the date of service as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(1)(a)">(a)</span> If an eligible patient is uninsured or has insurance that does not provide coverage for the reimbursed service, the participating medical laboratory shall send the bill to the Department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(1)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating medical laboratory shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(1)(b)(i)">(i)</span> Medicare or the other insurance for the service; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(1)(b)(ii)">(ii)</span> The Department for the outstanding deductible and patient contribution amount; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#D(2)">(2)</span> Keeping in the records, for each invoice, a copy of the signed orders from a participating health care provider requesting the service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E">E.</span> Payment Procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(1)">(1)</span> The Department shall pay the participating medical laboratory for a reimbursed service:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(1)(a)">(a)</span> Pursuant to COMAR 10.09.09.07E for an eligible patient who is uninsured or has insurance that does not provide coverage for the reimbursed service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(1)(b)">(b)</span> Pursuant to COMAR 10.09.09.07F and G(1) and 100 percent of co-insurance for an approved procedure for an eligible patient who is covered by Medicare.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(2)">(2)</span> The Department may not reimburse for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(2)(a)">(a)</span> Completion of a form or report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(2)(b)">(b)</span> A broken or missed appointment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#E(2)(c)">(c)</span> A service which is normally provided at no charge.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.12#F">F.</span> The Program shall reimburse for claims pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.13" data-order="|10|14|02|.13|" data-ref-path="10|14|02|.13" class="h__section">.13 Freestanding Ambulatory Surgical Center Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A">A.</span> To be considered a participating freestanding ambulatory surgical center in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(1)">(1)</span> Be Medicare certified to provide ambulatory surgical services in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(2)">(2)</span> Comply with COMAR 10.09.42.02 and .03B;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(3)">(3)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated Departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(4)">(4)</span> Agree to accept, as payment in full for the reimbursed service, the amount paid by the Program as specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.13#E" title="">§E of this regulation</a> plus, if applicable, the amount paid by the eligible patient's health insurer and the patient contribution amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(5)">(5)</span> Agree not to bill an eligible patient, who is either uninsured or who is insured with Medicare only, for the reimbursed service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(6)">(6)</span> Agree not to bill an eligible patient, who has insurance coverage other than Medicare only, for an additional charge for the reimbursed service other than the patient contribution amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(7)">(7)</span> Maintain adequate records for a minimum of 6 years and, upon request, allow the Department access to the records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#A(8)">(8)</span> Agree to the medical requirements of the Program pursuant to Regulation .04A(8)—(10) of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B">B.</span> The Program shall reimburse a participating freestanding ambulatory surgical center for a service when the service:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(1)">(1)</span> Complies with COMAR 10.09.42.04; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)">(2)</span> Is directly related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion including, but not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(a)">(a)</span> Breast biopsy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(b)">(b)</span> Conization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(c)">(c)</span> Dilation and curettage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(d)">(d)</span> Laser treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(e)">(e)</span> Mastotomy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#B(2)(f)">(f)</span> Simple or partial mastectomy excluding modified radical mastectomy and radical mastectomy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#C">C.</span> The Program does not reimburse for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#C(1)">(1)</span> A service that is not directly related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#C(2)">(2)</span> A service or procedure pursuant to COMAR 10.09.42.05.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D">D.</span> A participating freestanding ambulatory surgical center shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(1)">(1)</span> Accept and perform the responsibilities pursuant to Regulation .04E(1)—(7) and (9) of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(2)">(2)</span> Submit a bill for the reimbursed service provided for an eligible patient on the form designated by the Department within 12 months of the date of service as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(2)(a)">(a)</span> If an eligible patient is uninsured or has insurance that does not provide coverage for the reimbursed service, the participating freestanding ambulatory surgical center shall send the bill to the Department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(2)(b)">(b)</span> If an eligible patient is covered by Medicare or other insurance, the participating freestanding ambulatory surgical center shall bill:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(2)(b)(i)">(i)</span> Medicare or the other insurance the composite rate for the service or procedure performed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#D(2)(b)(ii)">(ii)</span> The Department for the outstanding deductible and patient contribution amount.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#E">E.</span> The Department shall pay the participating freestanding ambulatory surgical center for a reimbursed service:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#E(1)">(1)</span> Pursuant to COMAR 10.09.42.06A, B, D, and E for an eligible patient who is uninsured or has insurance that does not provide coverage for the reimbursed service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#E(2)">(2)</span> Pursuant to COMAR 10.09.42.06F for an eligible patient who is covered by Medicare; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#E(3)">(3)</span> The outstanding deductible and patient contribution amount required by the insurer for an eligible patient who has insurance, other than Medicare, that provides coverage for the reimbursed service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.13#F">F.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.14" data-order="|10|14|02|.14|" data-ref-path="10|14|02|.14" class="h__section">.14 Occupational Therapy Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A">A.</span> To be considered a participating occupational therapist in the Program, the provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(1)">(1)</span> Be an occupational therapist licensed to practice occupational therapy in Maryland or a jurisdiction bordering Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(2)">(2)</span> Agree to abide by the provisions set forth in this regulation by signing and sending to the Department the designated departmental form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(3)">(3)</span> Follow standard health and safety procedures to protect an eligible patient from potential hazards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(4)">(4)</span> Agree to requirements of the Program set forth in Regulation .04A(5), (9), and (10) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(5)">(5)</span> Agree to accept as payment in full the amount paid by the Program under <a class="internal-link " href="/us/md/exec/comar/10.14.02.14#E" title="">§E of this regulation</a>, plus the amount paid by the eligible patient's health insurer, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#A(6)">(6)</span> Agree not to bill an eligible patient an additional charge for the service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#B">B.</span> The cost of an occupational therapist’s services are covered as set forth in COMAR 10.09.04.04B(4).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#C">C.</span> The Program does not reimburse for services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#C(1)">(1)</span> Performed by an occupational therapy assistant if not under the direct supervision of a licensed occupational therapist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#C(2)">(2)</span> Performed by an occupational therapy aide; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#C(3)">(3)</span> Not directly related to the treatment of breast or cervical cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#D">D.</span> The participating occupational therapist is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#D(1)">(1)</span> Submitting to the Department, within 12 months of the date of service, a request for payment on the designated form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#D(2)">(2)</span> Certifying on the invoice that a treatment order is on file and was in effect at the time services were rendered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#D(3)">(3)</span> Specifying on the invoice the type of treatment provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E">E.</span> Reimbursement Principles.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(1)">(1)</span> The Department shall reimburse the participating occupational therapist:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(1)(a)">(a)</span> For a covered service performed in the provider’s office the amount of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(1)(a)(i)">(i)</span> The current Medical Assistance approved rate for the State for an eligible patient who is uninsured or has insurance that does not provide coverage for the reimbursed procedure or service; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(1)(a)(ii)">(ii)</span> The outstanding deductible and patient contribution for an eligible patient who is covered by Medicare or other insurance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(1)(b)">(b)</span> For covered services performed in the home of an eligible patient under <a class="internal-link " href="/us/md/exec/comar/10.14.02.11#F" title="">Regulation .11F of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(2)">(2)</span> The Department may not reimburse the participating occupational therapist for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(2)(a)">(a)</span> Services rendered by mail or telephone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(2)(b)">(b)</span> Completion of a form or report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(2)(c)">(c)</span> A broken or missed appointment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#E(2)(d)">(d)</span> A service which is provided at no charge to the general public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#F">F.</span> The participating occupational therapist shall obtain recovery under <a class="internal-link " href="/us/md/exec/comar/10.14.02.17" title=".17 Reimbursement.">Regulation .17 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.14#G">G.</span> The Program shall reimburse for claims submitted pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.15" data-order="|10|14|02|.15|" data-ref-path="10|14|02|.15" class="h__section">.15 Medical Management Fee.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A">A.</span> A participating health care provider eligible to receive a medical management fee may be one of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(1)">(1)</span> Anesthesiologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(2)">(2)</span> Certified nurse midwife;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(3)">(3)</span> Family practitioner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(4)">(4)</span> Gynecologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(5)">(5)</span> Medical internist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(6)">(6)</span> Medical oncologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(7)">(7)</span> Nurse anesthetist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(8)">(8)</span> Nurse practitioner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(9)">(9)</span> Pathologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(10)">(10)</span> Physician assistant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(11)">(11)</span> Radiation oncologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(12)">(12)</span> Radiologist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(13)">(13)</span> Surgeon; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#A(14)">(14)</span> Participating health care provider who renders services pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.15#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B">B.</span> The Department shall reimburse a participating health care provider as outlined in <a class="internal-link " href="/us/md/exec/comar/10.14.02.15#A" title="">§A of this regulation</a> a medical management fee of $50 each time a reimbursed service:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(1)">(1)</span> Is in compliance with the medical guidelines pursuant to Regulation .04A(7)(a)—(f) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(2)">(2)</span> Involves a consult with an oncologist pursuant to Regulation .04A(7)(g) and (h) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(3)">(3)</span> Is in compliance with the medical care management guidelines pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.04#A(6)" title="">Regulation .04A(6) of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(4)">(4)</span> Is billed with the medical management fee for reporting and includes a copy of the relevant medical report including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(4)(a)">(a)</span> Radiology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(4)(b)">(b)</span> Biopsy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(4)(c)">(c)</span> Operative; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#B(4)(d)">(d)</span> Staging.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.15#C">C.</span> The Program shall reimburse for claims pursuant to this regulation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21" title=".21 Billing and Reimbursement Time Limitations.">Regulation .21 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.16" data-order="|10|14|02|.16|" data-ref-path="10|14|02|.16" class="h__section">.16 Department, Local Health Department, Hospital, and Health Care Provider Responsibilities.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A">A.</span> The Department is responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(1)">(1)</span> Developing the necessary administrative forms needed for the Program including, but not limited to, a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(1)(a)">(a)</span> Standard application form to determine eligibility of patients;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(1)(b)">(b)</span> Release of patient information form; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(1)(c)">(c)</span> Participating health care provider agreement form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)">(2)</span> Distributing the administrative forms to the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(a)">(a)</span> Freestanding ambulatory surgical center;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(b)">(b)</span> Home health services provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(c)">(c)</span> Certified nurse midwife;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(d)">(d)</span> Hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(e)">(e)</span> Occupational therapist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(f)">(f)</span> Local health department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(g)">(g)</span> Medical laboratory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(h)">(h)</span> Medical supply company;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(i)">(i)</span> Nurse anesthetist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(j)">(j)</span> Nurse practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(k)">(k)</span> Pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(l)">(l)</span> Physical therapist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(m)">(m)</span> Physician assistant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(n)">(n)</span> Physician provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(2)(o)">(o)</span> Other appropriate health care providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(3)">(3)</span> Providing upon request a list of participating health care providers to local health department coordinators and health care providers for referral of eligible patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(4)">(4)</span> Updating the list of participating health care providers not less than once a year;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(5)">(5)</span> Reviewing and reimbursing a bill submitted by a participating physician for the reimbursed medical procedure and service using the payment guidelines specified in Regulations .04E(5) and .15 of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(6)">(6)</span> Reviewing and reimbursing a bill submitted by a participating physician assistant using the payment guidelines specified in Regulations .04-1 and .15 of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(7)">(7)</span> Reviewing and reimbursing a bill submitted by a participating certified nurse midwife using the payment guidelines specified in Regulations .04-2 and .15 of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(8)">(8)</span> Reviewing and reimbursing a bill submitted by a participating nurse practitioner using the payment guidelines specified in Regulations .05 and .15 of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(9)">(9)</span> Reviewing and reimbursing a bill submitted by a participating nurse anesthetist using the payment guidelines specified in Regulations .06 and .15 of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(10)">(10)</span> Reviewing and reimbursing a bill submitted by a participating physical therapist using the payment guidelines specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.07" title=".07 Physical Therapy Services.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(11)">(11)</span> Developing a list of reimbursed medications and pharmacy services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(12)">(12)</span> Updating the medication and pharmacy service list at least annually;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(13)">(13)</span> Developing and providing information to the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(14)">(14)</span> Reviewing and paying a bill submitted by a participating pharmacy for reimbursed medication, pharmacy service, durable medical equipment, and disposable medical supplies according to <a class="internal-link " href="/us/md/exec/comar/10.14.02.08#E" title="">Regulation .08E of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(15)">(15)</span> Reviewing and paying a disposable medical supply and durable medical equipment bill and the required deductible, if applicable, according to <a class="internal-link " href="/us/md/exec/comar/10.14.02.10" title=".10 Disposable Medical Supplies and Durable Medical Equipment.">Regulation .10 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(16)">(16)</span> Receiving the application for an eligible patient from the local health department, hospital, or health care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(17)">(17)</span> Developing and issuing to an eligible patient a letter identifying the patient as a participant in the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(18)">(18)</span> Reviewing and reimbursing a bill submitted by a participating home health services provider using the payment guidelines specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.11" title=".11 Home Health Services.">Regulation .11 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(19)">(19)</span> Reviewing and reimbursing a bill submitted by a participating medical laboratory using the payment guidelines specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.12" title=".12 Medical Laboratory Services.">Regulation .12 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(20)">(20)</span> Reviewing and reimbursing a bill submitted by a participating freestanding ambulatory surgical center using the payment guidelines specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.13" title=".13 Freestanding Ambulatory Surgical Center Services.">Regulation .13 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(21)">(21)</span> Reviewing and reimbursing a bill submitted by an occupational therapist using the payment guidelines specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.14" title=".14 Occupational Therapy Services.">Regulation .14 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(22)">(22)</span> Reviewing and reimbursing in accordance with <a class="internal-link " href="/us/md/exec/comar/10.14.02.22" title=".22 Maryland Health Insurance Plan Coverage.">Regulation .22 of this chapter</a> a bill submitted by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(22)(a)">(a)</span> MHIP or an insurer under contract with MHIP; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(22)(b)">(b)</span> A participating health care provider; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(23)">(23)</span> Ensuring compliance with the applicable regulations within this chapter by performing a periodic review of the records of a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(23)(a)">(a)</span> Hospital; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#A(23)(b)">(b)</span> Participating health care provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B">B.</span> The local health department, hospital, and a health care provider who refers a patient to the Program, are responsible for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(1)">(1)</span> Identifying potentially eligible patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(2)">(2)</span> Assisting the applicant in completing the application form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(3)">(3)</span> Collecting the completed application form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(4)">(4)</span> Collecting verifying documentation from the applicant, including, but not limited to, proof of residency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(5)">(5)</span> Determining eligibility of the applicant using the general, medical, health insurance, and financial criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.03" title=".03 Patient Eligibility.">Regulation .03 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(6)">(6)</span> Assisting an eligible patient in selecting a participating health care provider and assisting in scheduling an appointment with the participating health care provider for the reimbursed medical procedure or service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(7)">(7)</span> Having an eligible patient sign a release of information form;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(8)">(8)</span> Providing an eligible patient with a copy of a temporary referral letter, identifying the patient as a participant in the Program, to be given to the participating health care provider until the card is issued to the eligible patient by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(9)">(9)</span> Sending the original application with verifying information to the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#B(10)">(10)</span> Evaluating patient progress through follow-up contact with the patient and the participating health care provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#C">C.</span> If an additional diagnostic or treatment procedure is necessary, the local health department, hospital, or health care provider who determines patient eligibility and refers an eligible patient to the Program shall repeat the procedure as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.02.16#B(6)" title="">§B(6) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.16#D">D.</span> The local health department, hospital, or other health care provider who determines patient eligibility and refers an eligible patient to the Program shall document in the patient’s medical record the result of the reimbursed diagnostic and treatment procedure performed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.17" data-order="|10|14|02|.17|" data-ref-path="10|14|02|.17" class="h__section">.17 Reimbursement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#A">A.</span> The Department shall reimburse a participating health care provider only for a medical service or procedure related to the diagnosis and treatment of breast cancer, cervical cancer, or a precancerous cervical lesion for an eligible patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#B">B.</span> The Department shall reimburse a participating health care provider a medical management fee pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.02.15" title=".15 Medical Management Fee.">Regulation .15 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#C">C.</span> The participating health care provider shall reimburse the Department for an overpayment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D">D.</span> Insurance or Other Coverage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(1)">(1)</span> If the patient has insurance or other coverage, the participating health care provider shall first seek payment from that source.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(2)">(2)</span> The provider shall submit a copy of the insurance carrier’s notice or remittance advice with the invoice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(3)">(3)</span> If the insurance carrier provides coverage for a reimbursable procedure or service, the Department shall pay the deductible and patient contribution amount.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(4)">(4)</span> If an insurance carrier rejects the claim or pays less than the amount of the allowed Medical Assistance Program rate, the provider may submit a claim to the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(5)">(5)</span> The Department shall pay the difference between what was paid by the insurance carrier and the maximum allowable Medical Assistance Program rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#D(6)">(6)</span> If payment is made by both the Department and the insurance carrier or other source for the same service, the provider shall refund to the Department within 60 days of receipt the amount paid by the Department, or the Department may recoup those funds.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.17#E">E.</span> The Department may not make a direct payment to the eligible patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.18" data-order="|10|14|02|.18|" data-ref-path="10|14|02|.18" class="h__section">.18 Liability.</h3>
                <p>Responsibility for liability for services provided, and for the availability of appropriate insurance coverage, rests with the participating health care provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.19" data-order="|10|14|02|.19|" data-ref-path="10|14|02|.19" class="h__section">.19 Termination from the Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.19#A">A.</span> If the Department determines that a participating health care provider has failed to comply with the applicable regulations of this chapter, the Department may terminate the written agreement with the provider by giving 30 days notice in writing to the participating health care provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.19#B">B.</span> The participating health care provider may terminate the provider agreement with the Department by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.19#B(1)">(1)</span> Giving 30 days notice in writing to the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.19#B(2)">(2)</span> Notifying eligible patients, for whom services have not been provided, of the provider's withdrawal from the Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.20" data-order="|10|14|02|.20|" data-ref-path="10|14|02|.20" class="h__section">.20 Appeal Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.20#A">A.</span> A provider filing an appeal of the Department’s decision to terminate the provider’s agreement with the Program shall do so according to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.20#B">B.</span> A provider shall file an appeal within 30 days of receipt of written notice of termination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.21" data-order="|10|14|02|.21|" data-ref-path="10|14|02|.21" class="h__section">.21 Billing and Reimbursement Time Limitations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#A">A.</span> The Program may not reimburse claims received for payment more than 12 months after the date of service except as specified in §§B—D of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#B">B.</span> To obtain reimbursement from the Program, a health care provider that originally submits a claim to Medicare or another health insurer shall also submit the claim to the Program within a period whereby the Program receives the claim within the latter of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#B(1)">(1)</span> 12 months after the date of service; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#B(2)">(2)</span> 6 months from the Medicare or other health insurer remittance date as shown on the explanation of benefits.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#C">C.</span> The Program shall pay a claim that is originally rejected for payment due to improper completion or incomplete information only if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#C(1)">(1)</span> The health care provider properly completes and resubmits the claim to the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#C(2)">(2)</span> The Program receives the resubmitted claim within the latter of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#C(2)(a)">(a)</span> The original 12 month period from the date of service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#C(2)(b)">(b)</span> 6 months after claim rejection.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.21#D">D.</span> When the Program initially rejects a claim for payment in error, the Program shall pay the claim if the participating health care provider resubmits the claim and the resubmitted claim is received by the Program within the same period specified in <a class="internal-link " href="/us/md/exec/comar/10.14.02.21#C" title="">§C of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.22" data-order="|10|14|02|.22|" data-ref-path="10|14|02|.22" class="h__section">.22 Maryland Health Insurance Plan Coverage.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#A">A.</span> In lieu of providing direct reimbursement to participating health care providers, the Program may pay MHIP, if available, to provide health coverage for individuals enrolled in the Program who are also eligible for MHIP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#B">B.</span> The Program may pay MHIP, if available, for health coverage for eligible patients, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#B(1)">(1)</span> MHIP premiums;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#B(2)">(2)</span> Pre-existing condition buy-downs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#B(3)">(3)</span> Any MHIP fees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#C">C.</span> The Program may not pay any amount to MHIP, if available, for an eligible patient’s spouse, children, or other family members enrolled in MHIP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D">D.</span> Fees Reimbursable to Participating Providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(1)">(1)</span> The Program may reimburse participating health care providers for a bill the provider submits to the Department for patient contribution amounts and deductibles for services directly related to the treatment of breast and cervical cancer for individuals enrolled in MHIP through the Program, if funding is available for the payment of patient contribution amounts and deductibles under this section.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(2)">(2)</span> The Program's decision regarding whether to pay for patient contribution amounts and deductibles shall be based solely on the availability of funding and may not be contingent upon any other factor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(3)">(3)</span> If MHIP does not provide coverage for a service covered by this chapter, the Program shall reimburse the participating health care provider as otherwise provided by this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(4)">(4)</span> To obtain reimbursement, the participating health care provider shall submit to the Program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(4)(a)">(a)</span> The bill for the service on the form designated by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#D(4)(b)">(b)</span> A copy of the explanation of benefits or denial from MHIP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#E">E.</span> Payment to MHIP.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#E(1)">(1)</span> The Department shall submit timely payments to MHIP for premiums, pre-existing condition buy-downs, and any MHIP fees for individuals enrolled in MHIP through the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#E(2)">(2)</span> The Department shall work with the designated MHIP staff to assure timely payments of MHIP invoices for individuals enrolled in MHIP through the Program to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#E(2)(a)">(a)</span> Preserve MHIP coverage; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.02.22#E(2)(b)">(b)</span> Resolve any existing issues related to the payment of MHIP premiums.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.02.23" data-order="|10|14|02|.23|" data-ref-path="10|14|02|.23" class="h__section">.23 Funding Availability.</h3>
                <p>Payment under this chapter is contingent on the availability of funds in accordance with State Finance and Procurement Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-234" title="">7-234</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-235" title="">7-235</a>, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.03" data-order="|10|14|03|" data-ref-path="10|14|03" class="h__chapter">Chapter 03 Breast Cancer Treatment Methods</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: November 14, 1988 (15:23 Md. R. 2658)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.03.01#B" title="">Regulation .01B</a> amended effective January 20, 1992 (19:1 Md. R. 31)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.03.03" title=".03 Requirements of Treating Physicians.">Regulation .03</a> amended effective January 20, 1992 (19:1 Md. R. 31)</p>
                  <p>——————</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.05" title="Chapter 05 Meningococcal Vaccination Requirements for Students in Institutions of Higher Education">COMAR 10.06.05</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.03" title="Chapter 03 Breast Cancer Treatment Methods">COMAR 10.14.03</a> in July, 1993</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §20-113, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.03.01" data-order="|10|14|03|.01|" data-ref-path="10|14|03|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.01#A">A.</span> The following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.01#B(1)">(1)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.01#B(2)">(2)</span> "Diagnosis" means a histopathologic finding of breast cancer in a biopsy specimen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.01#B(3)">(3)</span> "Treating physician" means an individual authorized under the Medical Practice Act to practice medicine in Maryland who, in Maryland, treats a patient for breast cancer.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.03.02" data-order="|10|14|03|.02|" data-ref-path="10|14|03|.02" class="h__section">.02 Requirements for the Maryland Department of Health.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#A">A.</span> The Department shall provide a standardized written summary in layman's language that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#A(1)">(1)</span> Lists effective methods of treating breast cancer that may be medically practicable including all types of surgical treatment and radiological, hormonal, and chemotherapeutic treatment and combinations of these treatments; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#A(2)">(2)</span> Describes the advantages, disadvantages, risks, and procedures associated with each method of treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#B">B.</span> The Department shall update the standardized written summary annually.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#C">C.</span> The Department shall provide a statement indicating acknowledgement of receipt of the standardized written summary to be signed by the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.02#D">D.</span> The Department shall distribute copies of the standardized written summary and the acknowledgement of receipt statement to all hospitals, clinics, other facilities, and physicians' offices where treatment of breast cancer is performed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.03.03" data-order="|10|14|03|.03|" data-ref-path="10|14|03|.03" class="h__section">.03 Requirements of Treating Physicians.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#A">A.</span> At any time before, but not more than 5 days after, a treating physician informs a patient of a diagnosis of breast cancer, and before treatment, the treating physician shall give the patient:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#A(1)">(1)</span> The standardized written summary provided by the Department; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#A(2)">(2)</span> An equivalent summary including the requirements under Regulation .02A written in language that the patient understands.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#B">B.</span> A treating physician may not undertake any of the treatments described in Regulation .02A(1) until a breast cancer patient has been given the written summary described in §A(1) and (2) of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#C">C.</span> A treating physician who provides a patient with the written summary required under these regulations shall have the patient sign a statement provided by the Department acknowledging receipt of the summary and shall have a copy of this signed acknowledgement placed in the patient's medical record which is used by the treating physician.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#D">D.</span> The requirements under this regulation do not apply if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#D(1)">(1)</span> Treating physician certifies in writing in the patient's medical record that one of the treatments for breast cancer described in Regulation .02A(1) occurred within 5 days of the physician informing the patient of the diagnosis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#D(2)">(2)</span> Treatment within this period of time was necessary to save the life of the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#E">E.</span> These regulations should not be interpreted to require a waiting period between diagnosis and treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.03.03#F">F.</span> This regulation is supplemental and additional to any other requirements established by other laws upon a treating physician and may not be regarded as in derogation or substitution of any requirements now existing upon a treating physician, such as the need to obtain informed consent for treatment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.04" data-order="|10|14|04|" data-ref-path="10|14|04" class="h__chapter">Chapter 04 Breast Cancer Program</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: November 10, 2003 (30:22 Md. R. 1581)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.04.04" title=".04 Eligibility — Breast and Cervical Cancer Program.">Regulation .04</a> amended effective March 16, 2015 (42:5 Md. R. 486)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §20-116, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.04.01" data-order="|10|14|04|.01|" data-ref-path="10|14|04|.01" class="h__section">.01 Purpose and Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#A">A.</span> This chapter:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#A(1)">(1)</span> Establishes the requirements for participating medical providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#A(2)">(2)</span> Sets criteria for applicant eligibility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#A(3)">(3)</span> Outlines services covered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#A(4)">(4)</span> Delineates the responsibilities of the Department and local health departments for breast cancer screening, diagnosis, and treatment services under the Breast Cancer Program created by Health-General Article, §20-116, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#B">B.</span> This chapter operates in conjunction with the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#B(1)">(1)</span> Breast and Cervical Cancer Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#B(2)">(2)</span> Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program, as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02" title="Chapter 02 Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment">COMAR 10.14.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.01#C">C.</span> This chapter addresses the purpose set forth in Health-General Article, §20-116, Annotated Code of Maryland, by providing the services funded under the Breast Cancer Program through the programs cited in <a class="internal-link " href="/us/md/exec/comar/10.14.04.01#B" title="">§B of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.02" data-order="|10|14|04|.02|" data-ref-path="10|14|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(1)">(1)</span> "Annual gross income" means the total amount of income received by the applicant and, if applicable, the applicant's spouse, each year from all sources before taxes are withheld.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(2)">(2)</span> "Applicant" means an individual who has applied to receive services under this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(3)">(3)</span> "Biennial" means once every other year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)">(4)</span> "Breast and Cervical Cancer Program" means the program that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(a)">(a)</span> Administered by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(a)(i)">(i)</span> A local health department; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(a)(ii)">(ii)</span> A private entity that contracts with the Department to render services in Baltimore City and Calvert County under the Breast and Cervical Cancer Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(b)">(b)</span> Established for the early detection of breast and cervical cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(c)">(c)</span> Funded by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(c)(i)">(i)</span> The federal Centers for Disease Control and Prevention;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(c)(ii)">(ii)</span> The Breast Cancer Program under Health-General Article, §20-116, Annotated Code of Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(4)(c)(iii)">(iii)</span> Both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(5)">(5)</span> "Breast Cancer Program" means the program created by Health-General Article, §20-116, Annotated Code of Maryland, to provide:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(5)(a)">(a)</span> At least biennial screening mammograms and clinical breast examinations to low-income, underinsured and low-income, uninsured women 40 years old through 49 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(5)(b)">(b)</span> Annual screening mammograms and clinical breast examinations to low-income, underinsured and low-income, uninsured women 50 years old or older; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(5)(c)">(c)</span> Diagnosis and treatment for individuals who are identified by the Breast Cancer Program as being in need.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(6)">(6)</span> "Clinical breast examination" means a physical examination of the breast performed by a health care professional for the purpose of detecting breast cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(7)">(7)</span> "Contract" means the written agreement between a local health department and a health care provider for the provision of breast cancer services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(8)">(8)</span> "Copayment" means the set amount of money that an individual who is enrolled in a health insurance plan is responsible for paying each time the individual receives a medical service after the deductible, if applicable, has been paid.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(9)">(9)</span> "Deductible" means a specific sum of money that an individual who is enrolled in a health insurance plan is required to pay before the individual's health insurance plan reimburses the individual or the individual's medical provider for covered medical services received.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(10)">(10)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(11)">(11)</span> "Diagnosis" means a histopathologic finding of breast cancer in a biopsy specimen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(12)">(12)</span> "Eligible individual" means an applicant who meets the requirements of <a class="internal-link " href="/us/md/exec/comar/10.14.04.03" title=".03 Overview of Funding and Delivery of Services.">Regulation .03 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(13)">(13)</span> "Enrollee" means an eligible individual who has been accepted into the Breast Cancer Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(14)">(14)</span> "Free-standing ambulatory surgical center" means a facility that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(14)(a)">(a)</span> Provides ambulatory surgical services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(14)(b)">(b)</span> Is physically separate from a hospital or hospital grounds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(14)(c)">(c)</span> Is certified by Medicare to provide ambulatory surgical services in Maryland or a jurisdiction bordering Maryland under the laws of that jurisdiction; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(14)(d)">(d)</span> Complies with COMAR 10.09.42.02 and .03B.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)">(15)</span> "Home health services provider" means a public or private agency, organization, or part of an agency or organization licensed in Maryland or a jurisdiction bordering Maryland that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(a)">(a)</span> Meets one of the following licensure requirements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(a)(i)">(i)</span> If the provider is a home health agency located in Maryland, the provider is licensed under Health-General Article, Title 19, Subtitle 4, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(a)(ii)">(ii)</span> If the provider is a home health agency located in a jurisdiction bordering Maryland, the provider is legally authorized to provide home health services under the laws of that jurisdiction;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(a)(iii)">(iii)</span> If the provider is part of a hospital or related institution located in Maryland, the provider is licensed under Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(a)(iv)">(iv)</span> If the provider is an individual who has a contractual agreement with the Department to provide skilled nursing care to eligible individuals, the individual is a nurse who is licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Subtitle 3, Annotated Code of Maryland</a>, to practice registered nursing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(b)">(b)</span> Provides nursing or physical therapy services in the home; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(15)(c)">(c)</span> Meets the requirements for participation in Medicare.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(16)">(16)</span> "Hospital" means an institution which is located:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(16)(a)">(a)</span> In Maryland, that is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(16)(a)(i)">(i)</span> Subject to the provisions of Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(16)(a)(ii)">(ii)</span> Licensed pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(16)(b)">(b)</span> In a jurisdiction bordering Maryland, that is licensed pursuant to applicable standards established by the jurisdiction in which the hospital is located.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(17)">(17)</span> "Local health department" means a governmental entity that provides public health services on behalf of a county in Maryland or Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)">(18)</span> "Mammogram" means an X-ray examination of the breast to detect breast cancer that uses equipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)">(a)</span> Specifically dedicated for mammography, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(i)">(i)</span> X-ray tubes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(ii)">(ii)</span> Filters;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(iii)">(iii)</span> Compression devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(iv)">(iv)</span> Screens;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(v)">(v)</span> Films; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(a)(vi)">(vi)</span> Cassettes; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(18)(b)">(b)</span> That is designed to deliver an average radiation exposure of less than one rad mid-breast with two views for each breast.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(19)">(19)</span> "Medical Assistance" means the program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(19)(a)">(a)</span> Provides comprehensive medical and other health-related care for eligible individuals; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(19)(b)">(b)</span> Is administered by the State under Title XIX of the Social Security Act, 42 U.S.C. §1396.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)">(20)</span> "Medical laboratory" means a laboratory that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(a)">(a)</span> Examines tissue specimens in connection with the diagnosis, treatment, or control of human disease or the assessment of human health or nutritional or medical conditions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(b)">(b)</span> Is in compliance with the applicable license requirements for a medical laboratory providing services for Maryland residents including, but not limited to the requirements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(b)(i)">(i)</span> For Medicare certification;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(b)(ii)">(ii)</span> Set forth in Health-General Article, Title 17, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(b)(iii)">(iii)</span> Set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.01" title="Chapter 01 General">COMAR 10.10.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.08" title="Chapter 08 Medical Laboratories — Sanctions">10.10.08</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(20)(b)(iv)">(iv)</span> Of the federal Clinical Laboratories Improvement Act, 42 U.S.C. §263a.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(21)">(21)</span> "Medical supply company" means a provider of disposable medical supplies or durable medical equipment that, to the extent required by law, is licensed and legally authorized to practice or deliver services in Maryland or in a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(22)">(22)</span> "Medicare" means the medical insurance program administered by the federal government under Title XVIII of the Social Security Act, 42 U.S.C. §1395.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(23)">(23)</span> "Nurse anesthetist" means a registered nurse who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(23)(a)">(a)</span> Certified as a nurse anesthetist in Maryland or a jurisdiction bordering Maryland under the laws of that jurisdiction; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(23)(b)">(b)</span> Currently collaborating with an anesthesiologist or other physician who is licensed to practice medicine:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(23)(b)(i)">(i)</span> In Maryland as prescribed by COMAR 10.27.06; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(23)(b)(ii)">(ii)</span> In a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(24)">(24)</span> "Nurse practitioner" means a registered nurse who is certified:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(24)(a)">(a)</span> By the Maryland Board of Nursing to engage in the activities specified in COMAR 10.27.07; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(24)(b)">(b)</span> As a nurse practitioner in a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(25)">(25)</span> "Participating medical provider under the Breast and Cervical Cancer Program" means a health care provider who has entered into a written agreement with a local health department or the private entity that contracts with the Department to render services in Baltimore City and Calvert County under the Breast and Cervical Cancer Program to provide breast cancer services to an enrollee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)">(26)</span> "Participating medical provider under the Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program" means any of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(a)">(a)</span> A physician who meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04#A" title="">COMAR 10.14.02.04A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(b)">(b)</span> A nurse practitioner who meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#A" title="">COMAR 10.14.02.05A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(c)">(c)</span> A nurse anesthetist who meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#A" title="">COMAR 10.14.02.06A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(d)">(d)</span> A physical therapist who meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07#A" title="">COMAR 10.14.02.07A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(e)">(e)</span> A pharmacy that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08#A" title="">COMAR 10.14.02.08A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(f)">(f)</span> A hospital that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09#A" title="">COMAR 10.14.02.09A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(g)">(g)</span> A medical supply company that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10#A" title="">COMAR 10.14.02.10A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(h)">(h)</span> A home health service provider that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.11#A" title="">COMAR 10.14.02.11A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(i)">(i)</span> A medical laboratory that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12#A" title="">COMAR 10.14.02.12A</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(26)(j)">(j)</span> A free-standing ambulatory surgical center that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.13#A" title="">COMAR 10.14.02.13A</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(27)">(27)</span> "Pharmacy" means an establishment or institution that holds a permit to provide pharmacy services under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(28)">(28)</span> "Physical therapist" means an individual who is licensed or registered to practice physical therapy:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(28)(a)">(a)</span> In Maryland under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 13, Subtitle 3, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(28)(b)">(b)</span> In a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(29)">(29)</span> "Physician" means an individual who is licensed to practice medicine:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(29)(a)">(a)</span> In Maryland under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 14, Subtitle 3, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(29)(b)">(b)</span> In a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(30)">(30)</span> "Recipient of service" means an enrollee who has received a covered service under this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(31)">(31)</span> "Registered nurse" means an individual who is licensed to practice registered nursing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(31)(a)">(a)</span> In Maryland under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Subtitle 3, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(31)(b)">(b)</span> In a jurisdiction bordering Maryland under the laws of that jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(32)">(32)</span> "Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program" means the program operated by the Department to pay for breast and cervical cancer diagnostic and treatment procedures for eligible women under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02" title="Chapter 02 Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment">COMAR 10.14.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(33)">(33)</span> "Resident" means an individual who is currently residing in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(34)">(34)</span> "Screening" means a medical test to detect cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(35)">(35)</span> "Surgical consult" means a consultation with a surgeon for advice on the recommended follow-up of the results of screening tests that are not considered normal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(36)">(36)</span> "Treatment" means the medical management and care of a patient for breast cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.02#B(37)">(37)</span> "Ultrasound" means a medical test in which high frequency sound waves are used to make an image of a specific area of the breast to determine if a breast lump is a fluid-filled cyst or a solid mass.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.03" data-order="|10|14|04|.03|" data-ref-path="10|14|04|.03" class="h__section">.03 Overview of Funding and Delivery of Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.03#A">A.</span> The Breast Cancer Program created by Health-General Article, §20-116, Annotated Code of Maryland, provides State funding for breast cancer screening, diagnosis, and treatment for eligible individuals under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.03#B">B.</span> Services funded under the Breast Cancer Program shall be delivered through two previously existing programs as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.03#B(1)">(1)</span> Breast cancer screening and diagnostic services shall be provided to an enrollee through local health departments and private entities that contract with the Department to render services in Baltimore City and Calvert County under the Breast and Cervical Cancer Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.03#B(2)">(2)</span> Breast cancer diagnostic and treatment services shall be provided to an enrollee through the Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.03#C">C.</span> An applicant is eligible for services under the Breast Cancer Program if the applicant meets the eligibility requirements of either Regulation .04 or .05 of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.04" data-order="|10|14|04|.04|" data-ref-path="10|14|04|.04" class="h__section">.04 Eligibility — Breast and Cervical Cancer Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A">A.</span> To be eligible to receive breast cancer services under this chapter through the Breast and Cervical Cancer Program, an applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(1)">(1)</span> Be a resident of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(2)">(2)</span> Be 40 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(3)">(3)</span> Meet the financial eligibility criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.14.04.04#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(4)">(4)</span> Meet the health insurance criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.14.04.04#C" title="">§C of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(5)">(5)</span> Be determined to be eligible to receive covered services by a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(5)(a)">(a)</span> Local health department or an agency or organization designated by the local health department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#A(5)(b)">(b)</span> Private entity that contracts with the Department to render services in Baltimore City or Calvert County.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B">B.</span> Financial Eligibility Criteria.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(1)">(1)</span> Financial eligibility under this chapter is based on annual gross income and family size.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(2)">(2)</span> To be financially eligible to receive breast cancer services under this chapter through the Breast and Cervical Cancer Program, an applicant may not have an annual gross income that exceeds 250 percent of the most recent federal poverty guidelines updated annually in the Federal Register by the United States Department of Health and Human Services in accordance with 42 U.S.C. §9902(2).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(3)">(3)</span> For the purposes of determining family size under the federal poverty guidelines set forth at <a class="internal-link " href="/us/md/exec/comar/10.14.04.04#B(2)" title="">§B(2) of this regulation</a>, the following individuals are family members of the applicant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(3)(a)">(a)</span> The applicant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(3)(b)">(b)</span> The applicant's spouse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(3)(c)">(c)</span> The applicant's financially dependent children; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#B(3)(d)">(d)</span> The applicant's financially dependent relatives.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#C">C.</span> To be eligible to receive breast cancer services under this chapter through the Breast and Cervical Cancer Program, an applicant shall meet one of the following health insurance criteria:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#C(1)">(1)</span> The applicant is not currently covered by health insurance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#C(2)">(2)</span> The applicant is currently covered by health insurance that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#C(2)(a)">(a)</span> Does not provide reimbursement for a service covered under this chapter; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#C(2)(b)">(b)</span> Requires the applicant to pay a co-pay, co-insurance, or a deductible that has not been met for a service covered under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#D">D.</span> An applicant may not receive breast cancer services under this chapter through the Breast and Cervical Cancer Program if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#D(1)">(1)</span> The applicant is enrolled in Medical Assistance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.04#D(2)">(2)</span> The applicant is enrolled in a health maintenance organization.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.05" data-order="|10|14|04|.05|" data-ref-path="10|14|04|.05" class="h__section">.05 Eligibility — Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program.</h3>
                <p>To be eligible to receive breast cancer services under this chapter through the Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program, an applicant shall meet the eligibility requirements specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.03" title=".03 Patient Eligibility.">COMAR 10.14.02.03</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.06" data-order="|10|14|04|.06|" data-ref-path="10|14|04|.06" class="h__section">.06 Covered Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A">A.</span> The following breast cancer services are covered for enrollees under this chapter through the Breast and Cervical Cancer Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A(1)">(1)</span> Annual clinical breast examinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A(2)">(2)</span> Mammograms that are provided:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A(2)(a)">(a)</span> Annually to enrollees 50 years old or older; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A(2)(b)">(b)</span> At least on a biennial basis to enrollees 40 years old through 49 years old; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#A(3)">(3)</span> Follow-up clinical breast examinations, mammograms, ultrasounds, and surgical consults as considered medically necessary by the participating medical provider under the Breast and Cervical Cancer Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B">B.</span> The following breast cancer services are covered for enrollees under this chapter through the Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(1)">(1)</span> A physician's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04#C" title="">COMAR 10.14.02.04C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(2)">(2)</span> A nurse practitioner's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#C" title="">COMAR 10.14.02.05C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(3)">(3)</span> A nurse anesthetist's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#C" title="">COMAR 10.14.02.06C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(4)">(4)</span> A physical therapist's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07#B" title="">COMAR 10.14.02.07B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(5)">(5)</span> A pharmacy's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08#B" title="">COMAR 10.14.02.08B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(6)">(6)</span> A hospital's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09#B" title="">COMAR 10.14.02.09B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(7)">(7)</span> A medical supply company's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10#B" title="">COMAR 10.14.02.10B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(8)">(8)</span> A home health service provider's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.11#B" title="">COMAR 10.14.02.11B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(9)">(9)</span> A medical laboratory's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12#B" title="">COMAR 10.14.02.12B</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#B(10)">(10)</span> A free-standing ambulatory surgical center's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.13#B" title="">COMAR 10.14.02.13B</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C">C.</span> The following breast cancer services are not covered for enrollees under this chapter:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(1)">(1)</span> A physician's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.04#D" title="">COMAR 10.14.02.04D</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(2)">(2)</span> A nurse practitioner's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.05#D" title="">COMAR 10.14.02.05D</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(3)">(3)</span> A nurse anesthetist's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.06#D" title="">COMAR 10.14.02.06D</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(4)">(4)</span> A physical therapist's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.07#C" title="">COMAR 10.14.02.07C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(5)">(5)</span> A pharmacy's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.08#C" title="">COMAR 10.14.02.08C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(6)">(6)</span> A hospital's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.09#C" title="">COMAR 10.14.02.09C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(7)">(7)</span> A medical supply company's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.10#C" title="">COMAR 10.14.02.10C</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(8)">(8)</span> A home health service provider's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.11#D" title="">COMAR 10.14.02.11D</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(9)">(9)</span> A medical laboratory's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.12#C" title="">COMAR 10.14.02.12C</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.06#C(10)">(10)</span> A free-standing ambulatory surgical center's services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.13#C" title="">COMAR 10.14.02.13C</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.07" data-order="|10|14|04|.07|" data-ref-path="10|14|04|.07" class="h__section">.07 Responsibilities of the Department.</h3>
                <p>The Department shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.07#A">A.</span> Award grants to local health departments and private entities in Baltimore City and Calvert County as specified by Health-General Article, §20-116, Annotated Code of Maryland, for use in providing breast cancer screening services to eligible women under the Breast and Cervical Cancer Program; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.07#B">B.</span> Reimburse a participating medical provider under the Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program for performing covered breast and cervical cancer diagnosis and treatment services on enrollees, pursuant to funding provided under Health-General Article, §20-116, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.08" data-order="|10|14|04|.08|" data-ref-path="10|14|04|.08" class="h__section">.08 Responsibilities of Local Health Departments and Private Entities.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A">A.</span> A local health department and the private entities in Baltimore City and Calvert County shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A(1)">(1)</span> Enter into written agreements with health care providers to provide breast cancer services to enrollees using the contracts developed by the Department for use in the Breast and Cervical Cancer Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A(2)">(2)</span> Reimburse a participating medical provider under the Breast and Cervical Cancer Program for performing covered services on enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A(3)">(3)</span> Determine eligibility of applicants using the criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.14.04.05" title=".05 Eligibility — Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment Program.">Regulation .05 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A(4)">(4)</span> Recruit eligible individuals; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#A(5)">(5)</span> Provide enrollees, recipients of services, and medical providers with assistance in obtaining program-related information and services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.04.08#B">B.</span> In order to assure the availability of breast cancer diagnostic and treatment services, a local health department shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.02.15#B" title="">COMAR 10.14.02.15B</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.04.09" data-order="|10|14|04|.09|" data-ref-path="10|14|04|.09" class="h__section">.09 Funding Availability.</h3>
                <p>The implementation and ongoing administration of this chapter is contingent upon the availability of funds.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.05" data-order="|10|14|05|" data-ref-path="10|14|05" class="h__chapter">Chapter 05 Maryland Cancer Fund</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.01" title=".01 Purpose and Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.16" title=".16 Payments, Terms and Conditions of Grant Awards, and Terminations.">.16</a> adopted as an emergency provision effective June 1, 2006 (33:15 Md. R. 1274); adopted permanently effective October 9, 2006 (33:20 Md. R. 1616)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.02#B" title="">Regulation .02B</a> amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.02#B" title="">Regulation .02B</a> amended as an emergency provision effective December 22, 2008 (36:2 Md. R. 97); amended permanently effective April 6, 2009 (36:7 Md. R. 524)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.02#B" title="">Regulation .02B</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.02#B" title="">Regulation .02B</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.03#A" title="">Regulation .03A</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.05#C" title="">Regulation .05C</a> amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.07" title=".07 Persons Eligible For Grants.">Regulation .07</a> amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.08" title=".08 Allowable Uses of the Funds.">Regulation .08</a> amended effective October 4, 2010 (37:20 Md. R. 1393); March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.08" title=".08 Allowable Uses of the Funds.">Regulation .08</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.08#D" title="">Regulation .08D</a>, E amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.09" title=".09 Unallowable Uses of Grant Funds.">Regulation .09</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.10#A" title="">Regulation .10A</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.11" title=".11 Application Process for Cancer Research Grants.">Regulation .11</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.12" title=".12 Application Process for Cancer Primary Prevention Grants.">Regulation .12</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.13" title=".13 Application Process for Cancer Secondary Prevention Grants.">Regulation .13</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.14" title=".14 Application Process for Cancer Treatment Grants.">Regulation .14</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.14#C" title="">Regulation .14C</a>, D amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.14#D" title="">Regulation .14D</a>, E amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.15" title=".15 Grant Application Review and Approval and Grant Extensions.">Regulation .15</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.15#B" title="">Regulation .15B</a> amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.16#C" title="">Regulation .16C</a> amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.16#C" title="">Regulation .16C</a> amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.05.16#D" title="">Regulation .16D</a> amended effective October 4, 2010 (37:20 Md. R. 1393)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §20-117; <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gtg&amp;section=2-112" title="">Tax-General Article, §2-112</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.05.01" data-order="|10|14|05|.01|" data-ref-path="10|14|05|.01" class="h__section">.01 Purpose and Scope.</h3>
                <p>This chapter:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.01#A">A.</span> Defines the Maryland Cancer Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.01#B">B.</span> Describes how contributions may be made to the Maryland Cancer Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.01#C">C.</span> Sets forth the responsibilities of the Maryland Department of Health and the Comptroller with respect to the Maryland Cancer Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.01#D">D.</span> Identifies eligible applicants; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.01#E">E.</span> Outlines the grant application process for the Maryland Cancer Fund.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.02" data-order="|10|14|05|.02|" data-ref-path="10|14|05|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(1)">(1)</span> "Annual family income" means the total amount received per year from all sources before taxes are withheld.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(2)">(2)</span> "Applicant" means a person who has applied to receive a grant under the Maryland Cancer Fund.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(3)">(3)</span> "Applied research" means research that is undertaken to determine:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(3)(a)">(a)</span> Possible uses for the findings of basic research; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(3)(b)">(b)</span> New ways of achieving some specific objective.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(4)">(4)</span> "Authorized representative" means an individual or organization that has received permission from an individual diagnosed with cancer to perform certain tasks on the individual's behalf.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(5)">(5)</span> "Basic research" means experimental or theoretical work undertaken to acquire new knowledge or understanding of cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(6)">(6)</span> "Case management" means the coordination of services by a health care professional for an individual for cancer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(6)(a)">(a)</span> Screening;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(6)(b)">(b)</span> Diagnosis; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(6)(c)">(c)</span> Treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(7)">(7)</span> "Capital expenditures" means money spent to add or expand property, equipment, and assets that will benefit an organization in the long term.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(8)">(8)</span> "Center for Cancer Prevention and Control (CCPC)" means a unit of the Maryland Department of Health within the Prevention and Health Promotion Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(9)">(9)</span> "Clinical research" means research:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(9)(a)">(a)</span> Conducted primarily on patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(9)(b)">(b)</span> Designed to answer questions about the etiology, prevention, early detection, diagnosis, or treatment of cancer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(10)">(10)</span> "Community-based participatory research" means a collaborative, partnership approach to research that equitably involves community members, organizational representatives, and researchers in all aspects of the research process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(11)">(11)</span> "Comptroller" means the Comptroller of the Treasury.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(12)">(12)</span> "Coinsurance" means the percent of allowable charges for a medical service that an individual with health insurance is responsible for paying.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(13)">(13)</span> "Copayment (copay)" means the set amount of money that an individual with health insurance is responsible for paying each time the individual receives a medical service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(14)">(14)</span> "County" means a county of this State or Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(15)">(15)</span> "Current Procedure Terminology (CPT)" means the uniform descriptive terms and identifying codes for reporting medical services and procedures performed by physicians.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(16)">(16)</span> "Deductible" means the amount of money that an individual with health insurance is required to pay before the individual's health insurance starts coverage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(17)">(17)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(18)">(18)</span> "Diagnosis" means a histopathologic finding of cancer in a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(18)(a)">(a)</span> Biopsy; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(18)(b)">(b)</span> Surgical specimen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)">(19)</span> Educational Institution.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(a)">(a)</span> "Educational institution" means an organization whose primary mission is to educate individuals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)">(b)</span> "Educational institution" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(i)">(i)</span> Private and public elementary schools;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(ii)">(ii)</span> Middle schools;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(iii)">(iii)</span> High schools;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(iv)">(iv)</span> Colleges;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(v)">(v)</span> Universities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(vi)">(vi)</span> Graduate schools; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(19)(b)(vii)">(vii)</span> Research institutions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)">(20)</span> "Family" means the unit comprised of all of the following that apply:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(a)">(a)</span> For a financially independent adult 18 years old or older diagnosed with cancer, the adult diagnosed with cancer or the adult diagnosed with cancer and one or more of the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(a)(i)">(i)</span> Spouse;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(a)(ii)">(ii)</span> Financially dependent child; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(a)(iii)">(iii)</span> Financially dependent relative; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(b)">(b)</span> For a financially dependent child, the child and one or more of the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(b)(i)">(i)</span> Parent, foster parent, or guardian;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(b)(ii)">(ii)</span> Sibling living in the household; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(20)(b)(iii)">(iii)</span> Half brother or half sister living in the household.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(21)">(21)</span> “Federal poverty level” means the poverty guidelines, as amended, which are updated periodically in the Federal Register by the U.S. Department of Health and Human Services and which are incorporated by reference by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.01" title=".01 Incorporation by Reference.">COMAR 10.11.03.01</a>–1.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(22)">(22)</span> "Fund" means the Maryland Cancer Fund.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)">(23)</span> Grant.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(a)">(a)</span> "Grant" means financial assistance from the State to support an applicant's activities related to cancer:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(a)(i)">(i)</span> Research;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(a)(ii)">(ii)</span> Primary prevention;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(a)(iii)">(iii)</span> Secondary prevention; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(a)(iv)">(iv)</span> Treatment.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(23)(b)">(b)</span> "Grant" does not mean a contract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(24)">(24)</span> "Governmental entity" means a federal, State, or local governmental organization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(25)">(25)</span> "Health Services Cost Review Commission (HSCRC)" means the independent organization within the Department that is responsible for reviewing and approving rates for hospitals pursuant to Health-General Article, Title 19, Subtitle 2, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(26)">(26)</span> "Hospital" means an institution that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(26)(a)">(a)</span> Operates within the jurisdiction of Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(26)(b)">(b)</span> Is licensed pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a> or other applicable standards established by the jurisdiction in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(27)">(27)</span> "Laboratory" means a licensed or certified facility operated for the examination of material derived from the human body for the purpose of obtaining information for the diagnosis, treatment, and management of a disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(28)">(28)</span> "Local health department" means a governmental entity in a county in Maryland that provides public health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(29)">(29)</span> "Major medical equipment" means equipment that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(29)(a)">(a)</span> Costs in excess of $500; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(29)(b)">(b)</span> Is used for the provision of medical or health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(30)">(30)</span> "Maryland Comprehensive Cancer Control Plan" means the most recent edition of the cancer plan developed by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(31)">(31)</span> "Maryland Health Insurance Plan (MHIP)" means a State-administered program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(31)(a)">(a)</span> Is operated by a unit within the Maryland Insurance Administration under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gin/gin.pdf" title="">Insurance Article, Title 14, Subtitle 5, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(31)(b)">(b)</span> Provides health insurance coverage to medically uninsurable Maryland residents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(32)">(32)</span> "Medical Assistance" means the program administered by the State under Title XIX of the Social Security Act, 42 U.S.C. §§1396 — 1396v, which provides comprehensive medical and other health-related care for eligible categorically and medically needy persons.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(33)">(33)</span> "Medicare" means the medical insurance program administered by the federal government under Title XVIII of the Social Security Act, 42 U.S.C. §§1395 — 1395hhh.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(34)">(34)</span> “Patient contribution amount” means the amount of money required by an individual’s health insurance policy to be paid by the individual for a given medical procedure or service received, excluding the deductible.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(35)">(35)</span> "Physician" means an individual who is licensed to practice medicine in the jurisdiction in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(36)">(36)</span> "Premium" means the amount of money than an individual pays in regular installments to a health insurer for a health insurance policy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)">(37)</span> Primary Prevention.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(a)">(a)</span> "Primary prevention" means activities to prevent or reduce the development of cancer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(b)">(b)</span> "Primary prevention" includes interventions such as:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(b)(i)">(i)</span> Tobacco use prevention and cessation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(b)(ii)">(ii)</span> Protection from ultraviolet light;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(b)(iii)">(iii)</span> Proper nutrition and physical activity; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(37)(b)(iv)">(iv)</span> Reduction of exposure to environmental and occupational carcinogens.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(38)">(38)</span> Research.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(38)(a)">(a)</span> "Research" means activities to develop or advance the understanding of cancer or the techniques or modalities effective in the prevention, cure, screening, diagnosis, or treatment of cancer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(38)(b)">(b)</span> "Research" includes basic, clinical, applied, translational, and community-based participatory research.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(39)">(39)</span> "Secondary prevention" means activities to detect and diagnose cancer in its early stages, when the chances of treatment and control are the greatest.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(40)">(40)</span> "Secretary" means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(41)">(41)</span> "Translational research" means using or applying new discoveries to benefit patient care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)">(42)</span> "Treatment" means the medical management and care of a patient that is provided for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)">(a)</span> Obtaining a cancer diagnosis, determining the full extent of the cancer spread, or treating the cancer, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(i)">(i)</span> Surgery;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(ii)">(ii)</span> Chemotherapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(iii)">(iii)</span> Radiation therapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(iv)">(iv)</span> Hormonal therapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(v)">(v)</span> Biopsy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(vi)">(vi)</span> Imaging procedures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(vii)">(vii)</span> Laboratory testing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(viii)">(viii)</span> Home health services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(a)(ix)">(ix)</span> Medical supplies or medical equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(b)">(b)</span> Treating medical complications resulting from cancer screening or treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(c)">(c)</span> Treating other co-morbid conditions in order to treat cancer; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(42)(d)">(d)</span> Providing palliative or end-of-life care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(43)">(43)</span> "Uninsured" means that an individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(43)(a)">(a)</span> Does not have any health insurance; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.02#B(43)(b)">(b)</span> Has health insurance that does not cover the cancer prevention, screening, diagnosis, or treatment services provided under the Fund.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.03" data-order="|10|14|05|.03|" data-ref-path="10|14|05|.03" class="h__section">.03 Maryland Cancer Fund.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#A">A.</span> The Maryland Cancer Fund is a nonlapsing, special fund created by Health-General Article, §20-117, Annotated Code of Maryland, for cancer research, prevention, and treatment, which is generated from:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#A(1)">(1)</span> Contributions from the income tax checkoff system under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gtg&amp;section=2-112" title="">Tax-General Article, §2-112, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#A(2)">(2)</span> Any other donations to the Fund.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#B">B.</span> The Department may only expend funds:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#B(1)">(1)</span> In accordance with an appropriation approved by the General Assembly in the annual State budget; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#B(2)">(2)</span> Through an approved budget amendment under State Finance and Procurement Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-209" title="">7-209</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-210" title="">7-210</a>, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#C">C.</span> The Department may only make grant awards under the Fund for cancer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#C(1)">(1)</span> Research;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#C(2)">(2)</span> Primary prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#C(3)">(3)</span> Secondary prevention; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#C(4)">(4)</span> Treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#D">D.</span> Any unspent portions of the Fund shall remain in the Fund and may not revert to the General Fund of the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#E">E.</span> Money expended from the Fund is supplemental to, and is not intended to take the place of, funding that would otherwise be appropriated to the Department for cancer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#E(1)">(1)</span> Research;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#E(2)">(2)</span> Primary prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#E(3)">(3)</span> Secondary prevention; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.03#E(4)">(4)</span> Treatment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.04" data-order="|10|14|05|.04|" data-ref-path="10|14|05|.04" class="h__section">.04 Contributions to the Maryland Cancer Fund.</h3>
                <p>An individual or each spouse in the case of a joint income tax return may contribute an amount to the Fund by:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.04#A">A.</span> Deducting the amount of the contribution from any refund due under a tax return; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.04#B">B.</span> Adding the amount of the contribution to the income tax to be paid with a tax return.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.05" data-order="|10|14|05|.05|" data-ref-path="10|14|05|.05" class="h__section">.05 Responsibilities of the Department.</h3>
                <p>The Department:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#A">A.</span> Shall administer the Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#B">B.</span> May not spend more than 5 percent of the proceeds received from the Comptroller for the Fund to promote further donations to the Fund; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#C">C.</span> Shall provide a grant in each fiscal year to persons to conduct one or more of the following cancer-related activities:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#C(1)">(1)</span> Research;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#C(2)">(2)</span> Primary prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#C(3)">(3)</span> Secondary prevention; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.05#C(4)">(4)</span> Treatment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.06" data-order="|10|14|05|.06|" data-ref-path="10|14|05|.06" class="h__section">.06 Responsibilities of the Comptroller.</h3>
                <p>The Comptroller shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A">A.</span> Include in the individual income tax return form:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(1)">(1)</span> A checkoff designated as the Maryland Cancer Fund contribution; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(2)">(2)</span> A description that the Fund may only be used for cancer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(2)(a)">(a)</span> Research;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(2)(b)">(b)</span> Primary prevention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(2)(c)">(c)</span> Secondary prevention; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#A(2)(d)">(d)</span> Treatment;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#B">B.</span> Collect the checkoff contributions and other donations and account to the Treasurer for the money collected;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#C">C.</span> Distribute the amount necessary to administer the checkoff system to an administrative cost account;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#D">D.</span> After the distribution under <a class="internal-link " href="/us/md/exec/comar/10.14.05.06#C" title="">§C of this regulation</a>, distribute the remainder of the money to the Fund; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#E">E.</span> Notify the Department annually of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#E(1)">(1)</span> The gross amount of donations to the Fund through the income tax checkoff system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#E(2)">(2)</span> The gross amount of other donations to the Fund; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.06#E(3)">(3)</span> The costs of administration of the income tax checkoff system by the Comptroller.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.07" data-order="|10|14|05|.07|" data-ref-path="10|14|05|.07" class="h__section">.07 Persons Eligible For Grants.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A">A.</span> Subject to any limitations imposed under <a class="internal-link " href="/us/md/exec/comar/10.14.05.07#B" title="">§B of this regulation</a>, the following persons are eligible to receive a grant from the Department for cancer research, primary prevention, secondary prevention, or treatment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(1)">(1)</span> Physicians;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(2)">(2)</span> Hospitals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(3)">(3)</span> Laboratories;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(4)">(4)</span> Educational institutions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(5)">(5)</span> Local health departments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(6)">(6)</span> Governmental entities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#A(7)">(7)</span> Another person or organization with expertise in cancer research, primary prevention, secondary prevention, or treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#B">B.</span> The Department may limit the persons eligible to receive a grant in <a class="internal-link " href="/us/md/exec/comar/10.14.05.07#A" title="">§A of this regulation</a> based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#B(1)">(1)</span> Availability of funds; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#B(2)">(2)</span> The Department's ability to account for and monitor the grant funding.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#C">C.</span> In order to be eligible to receive a grant, an applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#C(1)">(1)</span> May be a nonprofit or for-profit entity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#C(2)">(2)</span> Shall have an office located in Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.07#C(3)">(3)</span> May only propose work that will serve or benefit one or more Maryland residents.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.08" data-order="|10|14|05|.08|" data-ref-path="10|14|05|.08" class="h__section">.08 Allowable Uses of the Funds.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A">A.</span> A grantee that is funded to conduct cancer research by the Fund may use the grant funds:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A(1)">(1)</span> For basic, clinical, translational, applied, or community-based participatory research;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A(2)">(2)</span> To support:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A(2)(a)">(a)</span> The individuals engaged in the research; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A(2)(b)">(b)</span> The individual's support staff; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#A(3)">(3)</span> To purchase office supplies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B">B.</span> A grantee that is funded to conduct cancer primary prevention or secondary prevention by the Fund may use the grant funds for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(1)">(1)</span> Education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(2)">(2)</span> Outreach;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(3)">(3)</span> Policy changes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(4)">(4)</span> Provider interventions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(5)">(5)</span> Clinical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(6)">(6)</span> Case management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(7)">(7)</span> Quality assurance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(8)">(8)</span> Data collection; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#B(9)">(9)</span> Partnership development.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#C">C.</span> If a grantee is funded to conduct cancer secondary prevention services, the Fund shall provide to the grantee reimbursement for a clinical service at a rate not higher than the rate that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#C(1)">(1)</span> Medicare pays for the clinical service in the region; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#C(2)">(2)</span> The HSCRC has approved for the clinical service, if the clinical service is provided by a HSCRC-regulated facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#D">D.</span> If a grantee is funded to conduct cancer secondary prevention or treatment, the grantee shall only provide clinical services to individuals who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#D(1)">(1)</span> Are Maryland residents; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#D(2)">(2)</span> Have an annual family income that is not more than 250 percent of the federal poverty guidelines.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E">E.</span> If a grantee is funded to conduct cancer treatment, a grantee may use the grant funds:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(1)">(1)</span> For grants awarded before January 1, 2014 to provide MHIP reimbursement, to pay up to a maximum of $15,000 for direct costs per individual per year for the premium, deductible, coinsurance, and copay of the MHIP costs and for services not covered under MHIP; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(2)">(2)</span> To pay up to a specified amount, as determined by the Department, for direct costs per individual per year for the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(2)(a)">(a)</span> Deductible and patient contribution amount for the reimbursed medical procedure or service for insured individuals; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(2)(b)">(b)</span> Medical procedure or service not covered under their health insurance policy for individuals who meet the eligibility criteria of <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#D" title="">§D of this regulation</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(3)">(3)</span> To pay up to a maximum of $20,000 for direct costs per individual per year for the cancer treatment costs under the individual’s treatment plan:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(3)(a)">(a)</span> Who meet the eligibility criteria in <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#D" title="">§D of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#E(3)(b)">(b)</span> At a rate not to exceed the rate that Medical Assistance pays for clinical services or the rate that the HSCRC has approved for the clinical services, if treatment is provided by a HSCRC-regulated facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F">F.</span> If a grantee is funded to pay for cancer treatment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(1)">(1)</span> Under <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#E(1)" title="">§E(1) of this regulation</a>, the grantee shall only pay or direct the Department to pay MHIP the following for services directly related to the treatment of cancer for the individual diagnosed with cancer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(1)(a)">(a)</span> Premiums;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(1)(b)">(b)</span> Deductibles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(1)(c)">(c)</span> Coinsurance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(1)(d)">(d)</span> Copays;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(2)">(2)</span> Under <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#E(2)" title="">§E(2) of this regulation</a>, the grantee shall only pay or direct the Department to pay the deductible and patient contribution amount for the reimbursed medical procedure or service that the individual is required to pay for the services directly related to the diagnosis and treatment of cancer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#F(3)">(3)</span> May not pay any amount for the individual’s spouse, children, or other family members’ health insurance costs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#G">G.</span> For the purpose of §F(1) and (2) of this regulation, the Department shall pay the health insurance costs out of the funds that are set aside for the grantee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.08#H">H.</span> In addition to the direct costs allowed under <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#E" title="">§E of this regulation</a>, the Fund shall also pay a maximum of 7 percent of the indirect costs to local health department grantees or non-local health department grantees.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.09" data-order="|10|14|05|.09|" data-ref-path="10|14|05|.09" class="h__section">.09 Unallowable Uses of Grant Funds.</h3>
                <p>A grantee may not use grant funds from the Fund to pay for:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#A">A.</span> Major medical equipment purchases;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#B">B.</span> Renovations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#C">C.</span> Capital expenditures; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#D">D.</span> Cancer prevention or cancer treatment that would be provided by an individual's existing health insurance, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#D(1)">(1)</span> Medical Assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#D(2)">(2)</span> Medicare; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.09#D(3)">(3)</span> Private health insurance.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.10" data-order="|10|14|05|.10|" data-ref-path="10|14|05|.10" class="h__section">.10 Grant Application.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#A">A.</span> A person may obtain an application packet from the CCPC for a cancer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#A(1)">(1)</span> Research grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#A(2)">(2)</span> Primary prevention grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#A(3)">(3)</span> Secondary prevention grant; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#A(4)">(4)</span> Treatment grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#B">B.</span> An applicant may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#B(1)">(1)</span> Apply for one or more grants in any fiscal year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.10#B(2)">(2)</span> Combine multiple requests for cancer research, primary prevention, or secondary prevention grants within a single application, provided that the information required for separate grant applications is included in the combined application.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.11" data-order="|10|14|05|.11|" data-ref-path="10|14|05|.11" class="h__section">.11 Application Process for Cancer Research Grants.</h3>
                <p>An applicant for a cancer research grant shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#A">A.</span> Submit a completed application to the CCPC by the due date listed in the application packet; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B">B.</span> Include in the application packet the following information as specified in the Department’s application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)">(1)</span> An executive summary stating:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)(a)">(a)</span> How the grant funds will be used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)(b)">(b)</span> What institutions and other persons will be involved in the research;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)(c)">(c)</span> Whether basic, clinical, applied, translational, or community-based research is being proposed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)(d)">(d)</span> Whether the proposed research is included in a recommendation of the Maryland Comprehensive Cancer Control Plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(1)(e)">(e)</span> How the grant money is expected to further the knowledge of cancer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(2)">(2)</span> A statement of the need for the cancer research, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(2)(a)">(a)</span> Previous literature in the area; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(2)(b)">(b)</span> Any work that the applicant has done in the research area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(3)">(3)</span> A proposed cancer research plan describing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(3)(a)">(a)</span> How the grant funds will be used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(3)(b)">(b)</span> Who will be involved in the research;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(3)(c)">(c)</span> What the anticipated results of the research with the grant funds will be; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(3)(d)">(d)</span> What goals, objectives, and activities will be pursued with the grant funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(4)">(4)</span> A brief professional resume or curriculum vitae of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(4)(a)">(a)</span> The principal investigator; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(4)(b)">(b)</span> Other key staff;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(5)">(5)</span> A description of how the proposed research will help to eliminate disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(6)">(6)</span> A list of the institutional review boards to which the research will be submitted for review and approval before the research is initiated, including the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(6)(a)">(a)</span> Department's Institutional Review Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(6)(b)">(b)</span> Applicant's relevant institutional review board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(7)">(7)</span> A timeline showing the expected start date and completion date for each activity to be conducted under the grant, including application to and approval from the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(7)(a)">(a)</span> Department's Institutional Review Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(7)(b)">(b)</span> Applicant's relevant institutional review board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(8)">(8)</span> An organizational chart showing where the work under the research grant is located within the applicant's organization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(9)">(9)</span> A statement that the grant funds will not be used to supplant any existing funding for this cancer research and, if an applicant receives funding for a similar cancer research activity, a listing of the funding:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(9)(a)">(a)</span> Source;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(9)(b)">(b)</span> Amount; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(9)(c)">(c)</span> Period for the activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(10)">(10)</span> A line item budget for the cancer research grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.11#B(11)">(11)</span> A written budget justification for each line item request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.12" data-order="|10|14|05|.12|" data-ref-path="10|14|05|.12" class="h__section">.12 Application Process for Cancer Primary Prevention Grants.</h3>
                <p>An applicant for a cancer primary prevention grant shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#A">A.</span> Submit a completed application to the CCPC by the due date listed in the application packet; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B">B.</span> Include in the application packet the following information, as specified in the Department's application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)">(1)</span> An executive summary describing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(a)">(a)</span> How the grant funds will be used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(b)">(b)</span> What persons will be involved in the grant activities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(c)">(c)</span> What cancer primary prevention activities will be conducted;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(d)">(d)</span> Whether the primary prevention activities are included in a recommendation in the Maryland Comprehensive Cancer Control Plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(e)">(e)</span> What population groups will be served and in what jurisdiction groups will be served;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(f)">(f)</span> What types of services will be offered, including education and policy initiatives:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(g)">(g)</span> What the eligibility for services will be; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(1)(h)">(h)</span> What outcome is expected as a result of the funding;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(2)">(2)</span> A statement of the need for the cancer primary prevention intervention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(3)">(3)</span> A description of previous literature in the area documenting the effectiveness of the cancer primary prevention intervention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)">(4)</span> A proposed cancer primary prevention plan describing the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(a)">(a)</span> Estimated number of persons to be served;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(b)">(b)</span> Goals, objectives, and activities to be conducted with the grant funds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(c)">(c)</span> Evaluation measures for each activity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(d)">(d)</span> How the grant funds will be used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(e)">(e)</span> Who will be involved in the plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(4)(f)">(f)</span> What the expected results of the activity with the grant funds are;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(5)">(5)</span> A description of how the primary prevention plan will address the goal of eliminating disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(6)">(6)</span> A list of key staff to be involved in the project, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(6)(a)">(a)</span> If existing staff will be used in the project, a description of the experience of the key staff in carrying out similar cancer primary prevention activities; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(6)(b)">(b)</span> If new staff will be hired for the grant, a job description of the staff that will be responsible for carrying out the project;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(7)">(7)</span> A description of the previous experience of the applicant's organization in implementing similar cancer primary prevention activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(8)">(8)</span> A timeline showing the expected start date and completion date for each activity to be conducted under the grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(9)">(9)</span> An organizational chart showing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(9)(a)">(a)</span> Where the activities under the cancer primary prevention grant falls within the applicant's organizational structure; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(9)(b)">(b)</span> The relationship of the applicant with other organizations involved in the project;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(10)">(10)</span> A statement that the grant funds will not be used to supplant any existing funding for this cancer primary prevention activity and, if an applicant receives funding for a similar cancer primary prevention activity a list of the funding:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(10)(a)">(a)</span> Source;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(10)(b)">(b)</span> Amount; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(10)(c)">(c)</span> Period for the activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(11)">(11)</span> A line item budget for the cancer primary prevention grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.12#B(12)">(12)</span> A written budget justification for each line item requested.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.13" data-order="|10|14|05|.13|" data-ref-path="10|14|05|.13" class="h__section">.13 Application Process for Cancer Secondary Prevention Grants.</h3>
                <p>An applicant for a cancer secondary prevention grant shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#A">A.</span> Submit a completed application to the CCPC by the due date stated in the application packet; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B">B.</span> Include in the application packet the following information, as specified in the Department's application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)">(1)</span> An executive summary describing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(a)">(a)</span> How the grant funds will be used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(b)">(b)</span> What persons will be involved in the application;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(c)">(c)</span> What cancer secondary prevention activities will be conducted;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(d)">(d)</span> Whether the proposed activities are included in a recommendation in the Maryland Comprehensive Cancer Control Plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(e)">(e)</span> What population groups will be served and in what jurisdiction groups will be served;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)">(f)</span> What services will be offered, such as:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(i)">(i)</span> Outreach;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(ii)">(ii)</span> Screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(iii)">(iii)</span> Case management;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(iv)">(iv)</span> Quality assurance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(v)">(v)</span> Data collection; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(f)(vi)">(vi)</span> Partnership building;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(g)">(g)</span> What the eligibility for services will be; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(1)(h)">(h)</span> What outcome is expected as a result of the grant funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(2)">(2)</span> A description of previous literature in the area documenting the effectiveness of the cancer secondary prevention activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(3)">(3)</span> A description and justification of the need for the cancer secondary prevention activity in the population group to be served;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)">(4)</span> A description of the population to be served including, at a minimum, a description of the following for the individuals to be served:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(a)">(a)</span> Age;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(b)">(b)</span> Race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(c)">(c)</span> Gender;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(d)">(d)</span> Residency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(e)">(e)</span> Educational level;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(f)">(f)</span> Income level; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(4)(g)">(g)</span> Health insurance requirements of persons to be served;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(5)">(5)</span> A description of the screening guidelines to be used for clinical services and the eligibility guidelines for these services, including age, symptoms, and, if appropriate, risk factors;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(6)">(6)</span> A description of the reimbursement levels to be used for clinical services provided with grant funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)">(7)</span> A proposed cancer secondary prevention plan describing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)(a)">(a)</span> The estimated number of individuals to be served;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)(b)">(b)</span> The goals, objectives, and activities to be conducted with the grant funds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)(c)">(c)</span> Evaluation measures for each activity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)(d)">(d)</span> Who will be involved in the plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(7)(e)">(e)</span> What the expected results of the funded activity are;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(8)">(8)</span> A description of how the proposed cancer secondary prevention activities will address the goal of eliminating disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(9)">(9)</span> A list of key staff to be involved in the project, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(9)(a)">(a)</span> If existing staff will be used in the project, a description of the experience of the key staff in carrying out similar cancer secondary prevention activities; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(9)(b)">(b)</span> If new staff will be hired for this activity, a job description of the staff responsible for carrying out the project;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(10)">(10)</span> A description of the previous experience of the applicant's organization in implementing similar cancer secondary prevention activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(11)">(11)</span> A timeline showing the expected start date and completion date for each activity to be conducted with the grant funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(12)">(12)</span> An organizational chart showing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(12)(a)">(a)</span> Where the cancer secondary prevention grant activities fall within the applicant's organizational structure; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(12)(b)">(b)</span> The relationship of the applicant with other organizations involved in the project;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(13)">(13)</span> A statement that the grant funds will not be used to supplant any existing funding for this cancer secondary prevention activity and, if an applicant receives funding for a similar cancer secondary prevention activity, a list of the funding:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(13)(a)">(a)</span> Source;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(13)(b)">(b)</span> Amount; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(13)(c)">(c)</span> Period for the activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(14)">(14)</span> A line item budget for the cancer secondary prevention grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.13#B(15)">(15)</span> A written budget justification for each line item requested.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.14" data-order="|10|14|05|.14|" data-ref-path="10|14|05|.14" class="h__section">.14 Application Process for Cancer Treatment Grants.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#A">A.</span> An applicant for a cancer treatment grant shall submit a completed application to the CCPC.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#B">B.</span> Cancer treatment grants are open and continuous throughout the year to the extent that funding is available.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C">C.</span> An applicant seeking a cancer treatment grant to pay for cancer treatment costs shall include in the Department's application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)">(1)</span> A completed cancer treatment grant application for each individual for whom grant funds are being requested, including the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(a)">(a)</span> Name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(b)">(b)</span> Phone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(c)">(c)</span> Mailing address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(d)">(d)</span> County; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(e)">(e)</span> Signature of the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(e)(i)">(i)</span> Individual diagnosed with cancer if the individual is an adult; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(1)(e)(ii)">(ii)</span> Parent or guardian if the individual diagnosed with cancer is younger than 18 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)">(2)</span> A letter written by the individual’s physician on the physician’s letterhead:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(a)">(a)</span> Confirming:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(a)(i)">(i)</span> That the individual has been diagnosed with or treated for cancer or the individual has a finding suggestive of cancer and needs to obtain a cancer diagnosis; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(a)(ii)">(ii)</span> The dates of diagnosis or treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(b)">(b)</span> Containing the physician's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(b)(i)">(i)</span> Full name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(b)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(b)(iii)">(iii)</span> Specialty; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(2)(b)(iv)">(iv)</span> Medical license number;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)">(3)</span> Proof of current Maryland residency for at least 6 months before the application date for each individual for whom grant funds are being requested in one of the following forms:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(a)">(a)</span> Maryland driver’s license or State identification card;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(b)">(b)</span> Lease or rental agreement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(c)">(c)</span> Property tax bill;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(d)">(d)</span> Motor vehicle registration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(e)">(e)</span> Pay check or stub with name and home address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(f)">(f)</span> Utility bill;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(g)">(g)</span> Voter registration card; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(3)(h)">(h)</span> W-2 statement issued not more than 12 months ago;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)">(4)</span> Proof of annual family income for each individual for whom grant funds are being requested, including a copy of at least one of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(a)">(a)</span> Most recent:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(a)(i)">(i)</span> Income tax return; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(a)(ii)">(ii)</span> W-2 form;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(b)">(b)</span> Pay stubs for two:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(b)(i)">(i)</span> Consecutive pays; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(b)(ii)">(ii)</span> Pays in the same month;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(c)">(c)</span> Social security entitlement letter; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(4)(d)">(d)</span> Notarized letter from the individual stating that the individual is not working and does not have any income;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(5)">(5)</span> Documentation of the eligibility of the individual for grant funds, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(5)(a)">(a)</span> The family size of the individual for whom the applicant is applying; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(5)(b)">(b)</span> The family’s annual household income;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(6)">(6)</span> Certification that the applicant will:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(6)(a)">(a)</span> Keep financial records, as described in <a class="internal-link " href="/us/md/exec/comar/10.14.05.16#B" title="">Regulation .16B of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(6)(b)">(b)</span> Send demographic and fiscal information on each individual covered to the CCPC at the end of the grant period; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(6)(c)">(c)</span> Act as the authorized representative of the individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(7)">(7)</span> Attestation that grant funds will not be used to supplant any existing funding for this cancer treatment activity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(8)">(8)</span> If the applicant currently receives funding for a similar cancer treatment activity, a list of the funding:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(8)(a)">(a)</span> Source;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(8)(b)">(b)</span> Amount; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#C(8)(c)">(c)</span> Period for the activity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D">D.</span> An applicant seeking a cancer treatment grant to pay for deductibles and patient contribution costs through their health insurance policy under <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#E(2)" title="">Regulation .08E(2) of this chapter</a> shall include in the Department’s application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)">(1)</span> A completed and signed Maryland Cancer Fund — Cancer Treatment Grant application that;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(a)">(a)</span> Certifies that the applicant shall pay:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(a)(i)">(i)</span> The deductible and patient contribution amount; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(a)(ii)">(ii)</span> Costs for services not covered under the individual’s health insurance policy for a time period not to exceed 1 year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(b)">(b)</span> Includes a treatment plan for a total request not to exceed a specified amount, as determined by the Department, per individual per year, including the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(b)(i)">(i)</span> Deductible and patient contribution amount; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(1)(b)(ii)">(ii)</span> Costs for services not covered under the individual’s health insurance policy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#D(2)">(2)</span> Documentation of the individual’s health insurance policy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E">E.</span> An applicant seeking a cancer treatment grant to pay directly for cancer treatment costs under <a class="internal-link " href="/us/md/exec/comar/10.14.05.08#E(3)" title="">Regulation .08E(3) of this chapter</a> shall include in the Department’s application packet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(1)">(1)</span> A completed Maryland Cancer Fund — Cancer Treatment Grant application; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(2)">(2)</span> A signed document that certifies that the applicant shall pay directly for cancer treatment costs for the individual for a time period not to exceed 1 year; and certifies that the applicant shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(2)(a)">(a)</span> Reimburse the provider in an amount not greater than the Medical Assistance rate for the medical procedure or the HSCRC-regulated rate for the medical procedure performed, if the medical procedure is performed in a HSCRC-regulated facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(2)(b)">(b)</span> Accept the Medical Assistance rate as payment in full for the cancer treatment procedures performed, if the applicant is a medical provider; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(3)">(3)</span> Includes a treatment plan for a total request not to exceed $20,000 per individual, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(3)(a)">(a)</span> The planned cancer treatment procedures; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.14#E(3)(b)">(b)</span> The Medical Assistance or HSCRC-regulated rate for each procedure.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.15" data-order="|10|14|05|.15|" data-ref-path="10|14|05|.15" class="h__section">.15 Grant Application Review and Approval and Grant Extensions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A">A.</span> Each fiscal year the CCPC shall determine:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(1)">(1)</span> The amount of money available for grants under the Maryland Cancer Fund;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(2)">(2)</span> The allocation of funding for cancer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(2)(i)">(i)</span> Research;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(2)(ii)">(ii)</span> Primary prevention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(2)(iii)">(iii)</span> Secondary prevention; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(2)(iv)">(iv)</span> Treatment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#A(3)">(3)</span> The maximum grant award amount for each type of grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#B">B.</span> Each year the Department shall consider for award, funding for one or more of the following types of grant applications for cancer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#B(1)">(1)</span> Research;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#B(2)">(2)</span> Primary prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#B(3)">(3)</span> Secondary prevention; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#B(4)">(4)</span> Treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#C">C.</span> The CCPC shall develop one or more evaluation committees or shall contract with one or more external consultants with expertise in cancer research and prevention to review the cancer research and primary prevention and secondary prevention grant applications that are submitted for funding under the Maryland Cancer Fund.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#D">D.</span> Due to the need for timeliness in the cancer treatment grants, the CCPC shall review each application for cancer treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E">E.</span> The evaluation committee or external consultants shall review:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)">(1)</span> Cancer research grant applications based on:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(a)">(a)</span> Scientific need;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(b)">(b)</span> The degree to which the cancer research plan will achieve the goals and objectives set forth in the plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(c)">(c)</span> The inclusion of a plan for Institutional Review Board approval;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(d)">(d)</span> The feasibility of the timeline in delivering goals and objectives of the plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(e)">(e)</span> The experience and expertise of the principal investigator;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(f)">(f)</span> The degree to which a grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(g)">(g)</span> Whether the research is recommended in the Maryland Comprehensive Cancer Plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(h)">(h)</span> The lack of other resources or funding for the proposed research; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(1)(i)">(i)</span> The amount of the funding requested;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)">(2)</span> Cancer primary prevention grant applications based on:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(a)">(a)</span> The need for the cancer primary prevention activity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(b)">(b)</span> The previously documented effectiveness of the primary prevention intervention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(c)">(c)</span> The degree to which the cancer primary prevention plan will achieve the goals and objectives set forth in the plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(d)">(d)</span> The degree to which a grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(e)">(e)</span> The experience of the applicant in cancer primary prevention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(f)">(f)</span> Whether the primary prevention intervention is recommended in the Maryland Comprehensive Cancer Control Plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(g)">(g)</span> The lack of other resources or funding for the proposal; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(2)(h)">(h)</span> The amount of funding requested; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)">(3)</span> Cancer secondary prevention grant applications based on:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(a)">(a)</span> The previously documented effectiveness of the secondary prevention intervention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(b)">(b)</span> The need for the cancer secondary prevention intervention in the population group to be served;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(c)">(c)</span> The degree to which the cancer secondary prevention plan will achieve the goals and objectives of the plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(d)">(d)</span> The feasibility of the timeline in delivering the goals and objectives of the plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(e)">(e)</span> The extent to which medical guidelines for screening and diagnosis are being followed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(f)">(f)</span> The percent of the budget allocated to clinical services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(g)">(g)</span> The degree to which the grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(h)">(h)</span> The experience of the applicant in cancer secondary prevention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(i)">(i)</span> Whether the secondary prevention intervention is recommended in the Maryland Comprehensive Cancer Control Plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(j)">(j)</span> The lack of other resources or funding for the proposal; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#E(3)(k)">(k)</span> The amount requested.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#F">F.</span> After reviewing each cancer research, primary prevention, and secondary prevention grant application, the evaluation committee or external consultant shall make a recommendation to the CCPC about whether to award grant funds to each applicant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#G">G.</span> The CCPC shall review each cancer treatment application based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#G(1)">(1)</span> Completeness;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#G(2)">(2)</span> Availability of funds; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#G(3)">(3)</span> Whether the application meets the relevant application process requirements set forth in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#H">H.</span> The Director of the CCPC shall recommend an application to the Secretary for approval based upon:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#H(1)">(1)</span> The evaluation committee's or external consultant's recommendations for awarding the cancer research, primary prevention, secondary prevention, and treatment grants for each application; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#H(2)">(2)</span> The availability of funds.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I">I.</span> The Secretary shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(1)">(1)</span> Consider the grant recommendations of the CCPC for the cancer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(1)(a)">(a)</span> Research;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(1)(b)">(b)</span> Primary prevention;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(1)(c)">(c)</span> Secondary prevention; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(1)(d)">(d)</span> Treatment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#I(2)">(2)</span> Make the final determination on which grant applications to approve.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#J">J.</span> A grant period expires 1 year from the date of award of the grant, unless extended as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.05.16" title=".16 Payments, Terms and Conditions of Grant Awards, and Terminations.">Regulation .16 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#K">K.</span> A person awarded a grant under this chapter may apply for a no-cost extension of the grant period for the award before the expiration of the grant period, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.05.15#J" title="">§J of this regulation</a>, by submitting a written request for an extension to the CCPC.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#L">L.</span> In evaluating whether to grant an extension of the grant period, the CCPC:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#L(1)">(1)</span> Shall assess whether progress has been made on the grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#L(2)">(2)</span> If progress has been made based on the reports submitted pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.05.16#C" title="">Regulation .16C of this chapter</a>, may recommend to the Secretary that an extension be granted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#M">M.</span> The Secretary may approve an extension for up to 1 year based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#M(1)">(1)</span> The recommendation of the CCPC; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.15#M(2)">(2)</span> Whether progress has been shown on the grant pursuant to <a class="internal-link " href="/us/md/exec/comar/10.14.05.16#C" title="">Regulation .16C of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.05.16" data-order="|10|14|05|.16|" data-ref-path="10|14|05|.16" class="h__section">.16 Payments, Terms and Conditions of Grant Awards, and Terminations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#A">A.</span> Payments Under the Grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#A(1)">(1)</span> The Department may not make more than monthly payments during the grant period to a person awarded a grant under this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#A(2)">(2)</span> Before the first payment under the grant, at the request of the person awarded the grant under this chapter, the Department may approve an advanced payment for the grant based on financial need, if a request for advanced payment was specified in the grant application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#A(3)">(3)</span> If a financial or progress report required in §B or C of this regulation is overdue, the Department may withhold payment until the report is submitted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B">B.</span> Financial Reports and Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(1)">(1)</span> A person awarded a grant shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(1)(a)">(a)</span> Establish a separate account to track expenditures under the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(1)(b)">(b)</span> Maintain accurate records, including documentation of each transaction pertaining to the grant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(1)(c)">(c)</span> Submit to the Department monthly invoices for payment and an annual financial expenditure report containing the signature of the financial officer of the entity affiliated with the grant award.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(2)">(2)</span> The Department may audit the accounts referenced in <a class="internal-link " href="/us/md/exec/comar/10.14.05.16#B(1)" title="">§B(1) of this regulation</a> at any time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(3)">(3)</span> A person awarded a grant under this chapter shall submit to the Department within 90 days after the date the grant period ends:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(3)(a)">(a)</span> A final financial expenditure report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(3)(b)">(b)</span> A refund of any unexpended funds.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(4)">(4)</span> A person awarded a grant under this chapter shall retain all records pertaining to a grant award for 3 years from the date the final financial expenditure report is submitted under <a class="internal-link " href="/us/md/exec/comar/10.14.05.16#B(3)" title="">§B(3) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#B(5)">(5)</span> In the case of an audit or litigation, the Department may extend the time period under §B(3) or (4) of this regulation until the completion of the audit or litigation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C">C.</span> Progress Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(1)">(1)</span> A grantee shall submit to the CCPC three copies of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(1)(a)">(a)</span> An interim report describing the progress of the grant:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(1)(a)(i)">(i)</span> 6 months after the date of award of the grant; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(1)(a)(ii)">(ii)</span> Every 6 months until the end of the grant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(1)(b)">(b)</span> A comprehensive final report, not later than 60 days after the date the grant period ends, that provides a summary of all of the activity conducted under the grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)">(2)</span> A grantee receiving a cancer research grant shall include the following information in the comprehensive final report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)(a)">(a)</span> Hypothesis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)(b)">(b)</span> Methods;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)(c)">(c)</span> Results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)(d)">(d)</span> Discussion of results and limitations of the research; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(2)(e)">(e)</span> Conclusion.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)">(3)</span> A grantee receiving a cancer primary prevention or secondary prevention grant shall include the following information in the comprehensive final report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(a)">(a)</span> Number of individuals served, by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(a)(i)">(i)</span> Type of service;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(a)(ii)">(ii)</span> Age;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(a)(iii)">(iii)</span> Race; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(a)(iv)">(iv)</span> Gender;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(b)">(b)</span> Number of individuals with abnormal screening results, by type of cancer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(c)">(c)</span> Number of cancers diagnosed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(3)(d)">(d)</span> Other outcome measures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)">(4)</span> A grantee receiving a cancer treatment grant shall include the following information in the comprehensive final report for each individual receiving funds for cancer treatment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(a)">(a)</span> Type of cancer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(b)">(b)</span> Stage of cancer at diagnosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(c)">(c)</span> Age;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(d)">(d)</span> Race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(e)">(e)</span> Gender;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(f)">(f)</span> County; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(4)(g)">(g)</span> Amount of funds expended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#C(5)">(5)</span> The Department shall keep research results confidential as required by Health-General Article, §§4-101 — 4-103, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#D">D.</span> Publications.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#D(1)">(1)</span> A person who publishes results from activities supported by a grant approved by the Secretary under this chapter shall include in the publication the following acknowledgement: "Supported in part with funds from the Maryland Cancer Fund of the Maryland Department of Health."</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#D(2)">(2)</span> A person awarded a grant under this chapter shall provide the Department with three copies of any published article pertaining to the activities conducted under the grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#E">E.</span> Ownership of Equipment. A person awarded a grant under this chapter:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#E(1)">(1)</span> Shall ensure that equipment purchased under a grant under this chapter is used for the sole purpose of the grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#E(2)">(2)</span> Shall keep an inventory of all equipment purchased; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#E(3)">(3)</span> May not transfer the equipment to another entity without the written permission of the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F">F.</span> Termination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)">(1)</span> The Secretary may terminate a grant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(a)">(a)</span> If a grantee fails to comply with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(a)(i)">(i)</span> The requirements of this chapter; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(a)(ii)">(ii)</span> State, federal, and municipal laws applicable to the performance of research under the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(b)">(b)</span> If a grantee fails to carry out the purposes for which the grant was awarded;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(c)">(c)</span> In compliance with a court order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(1)(d)">(d)</span> At the request of the grantee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(2)">(2)</span> The Department and the State are not responsible for any expenses incurred by a grantee after cancellation of a grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#F(3)">(3)</span> The grantee shall return all unexpended funds to the Department within 60 days of termination of a grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#G">G.</span> Compliance with Existing Laws. A person awarded a grant under this chapter shall ensure that an activity conducted in the performance of the grant is in compliance with all State, federal, and local laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#H">H.</span> Liability.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#H(1)">(1)</span> A person awarded a grant under this chapter is solely responsible for the person's actions pertaining to research conducted under a grant award.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#H(2)">(2)</span> The State and the Department are not liable for any claims, losses, liabilities, expenses, or damages arising from research conducted under a grant awarded under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.05.16#I">I.</span> Grant Agreements. A person awarded a grant under this chapter shall enter into a grant agreement with the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.06" data-order="|10|14|06|" data-ref-path="10|14|06" class="h__chapter">Chapter 06 Cigarette Restitution Fund Program</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: January 15, 2007 (34:1 Md. R. 32)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.01" title=".01 Scope.">Regulation .01</a> amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.02#B" title="">Regulation .02B</a> amended effective February 27, 2017 (44:4 Md. R. 254); March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.03" title=".03 Responsibilities of the Department.">Regulation .03</a> amended effective February 27, 2017 (44:4 Md. R. 254)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.03#A" title="">Regulation .03A</a> amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.04#B" title="">Regulation .04B</a> amended effective February 27, 2017 (44:4 Md. R. 254); March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.05" title=".05 Criteria for Eligibility for Cancer Treatment Services.">Regulation .05</a> repealed and new Regulation .05 adopted effective February 27, 2017 (44:4 Md. R. 254)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.06.06" title=".06 Criteria for Eligibility for Tobacco Treatment Products.">Regulation .06</a> repealed and new Regulation .06 adopted effective February 27, 2017 (44:4 Md. R. 254)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §§13-1001—13-1014 and 13-1101—13-1119, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.06.01" data-order="|10|14|06|.01|" data-ref-path="10|14|06|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes the financial eligibility criteria for an uninsured or underinsured individual to receive cancer treatment services and tobacco treatment products under the Cigarette Restitution Fund Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.02" data-order="|10|14|06|.02|" data-ref-path="10|14|06|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(1)">(1)</span> "Applicant" means an individual who has applied to receive cancer treatment services or tobacco treatment products under this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(2)">(2)</span> "Cancer Prevention, Education, Screening, and Treatment Program" means the program created by Health-General Article, §§13-1101—13-1119, Annotated Code of Maryland, to provide cancer prevention, education, screening, and treatment services in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)">(3)</span> "Cancer treatment service" means a medical service, medical supply, or medical equipment provided to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)">(a)</span> Treat cancer, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(i)">(i)</span> Surgery;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(ii)">(ii)</span> Chemotherapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(iii)">(iii)</span> Radiation therapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(iv)">(iv)</span> Hormonal therapy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(v)">(v)</span> Home health services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(a)(vi)">(vi)</span> Medical supplies and medical equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(b)">(b)</span> Treat medical complications resulting from cancer screening or treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(c)">(c)</span> Treat other comorbid conditions in order to treat cancer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(3)(d)">(d)</span> Serve the needs of cancer patients for palliative or end-of-life care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(4)">(4)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(5)">(5)</span> "Federal poverty level" means the amount of household income by family size that a family needs for basic necessities as determined by the federal poverty guidelines, as amended, which are updated annually in the Federal Register by the U.S. Department of Health and Human Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(6)">(6)</span> “Gross annual household income” means the total income of the applicant and any member of the applicant’s household received each year from all sources before taxes are withheld or deductions are taken.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(7)">(7)</span> "Local health department" means a governmental entity in a county in Maryland that provides public health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(8)">(8)</span> “Maryland Children’s Health Insurance Program” means the program administered by Medical Assistance to provide health insurance coverage to eligible children younger than 19 years old in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(9)">(9)</span> "Medical Assistance" means the program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(9)(a)">(a)</span> Provides comprehensive medical and other health-related care for eligible individuals; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(9)(b)">(b)</span> Is administered by the State under Title XIX of the Social Security Act, 42 U.S.C. §§1396—1396v.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(10)">(10)</span> "Medicare" means the medical insurance program administered by the federal government under Title XVIII of the Social Security Act, 42 U.S.C. §1395 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(11)">(11)</span> “Statewide academic health center” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(11)(a)">(a)</span> The University of Maryland Medical Group;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(11)(b)">(b)</span> The Johns Hopkins Institutions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(11)(c)">(c)</span> The organization designated by the Department as stipulated by Health-General Article, §13-1115, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(11)(d)">(d)</span> One or more of the organizations in §B(11)(a)—(c) of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(12)">(12)</span> "Tobacco product" means cigarettes, cigars, pipe tobacco, smokeless tobacco, and any other product containing tobacco in any form.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(13)">(13)</span> “Tobacco treatment product” means all Food and Drug Administration-approved tobacco cessation medications, including both prescription and over-the-counter medications, that assist individuals to stop using tobacco products.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(14)">(14)</span> "Tobacco Use Prevention and Cessation Program" means the program created by Health-General Article, §§13-1001—13-1014, Annotated Code of Maryland, to provide tobacco use prevention and cessation services in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)">(15)</span> “Underinsured” individual means an applicant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(a)">(a)</span> Who has private medical insurance, Medical Assistance, Medicare, or Maryland Children’s Health Insurance Program coverage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(b)">(b)</span> For whom the appropriate treatment is not adequately covered due to out-of-pocket costs including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(b)(i)">(i)</span> Copayments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(b)(ii)">(ii)</span> Coinsurance; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(b)(iii)">(iii)</span> Deductibles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(15)(c)">(c)</span> Who the Department determines does not have the financial means to pay for appropriate treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(16)">(16)</span> "Uninsured" individual means an applicant who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(16)(a)">(a)</span> Either:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(16)(a)(i)">(i)</span> Does not have private medical insurance, Medical Assistance, Medicare, or Maryland Children's Health Insurance Program coverage; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(16)(a)(ii)">(ii)</span> Has private medical insurance, Medical Assistance, Medicare, or Maryland Children's Health Insurance Program coverage that does not provide insurance coverage for medically necessary services for a cancer treatment service or tobacco treatment product; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(16)(b)">(b)</span> Does not have the financial means to pay for a cancer treatment service or tobacco treatment product as defined by the criteria established in this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.02#B(17)">(17)</span> "University of Maryland Medical Group (UMMG)" means the University of Maryland Medical Systems Corporation, the University of Maryland Medical School, and the University of Maryland, Baltimore.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.03" data-order="|10|14|06|.03|" data-ref-path="10|14|06|.03" class="h__section">.03 Responsibilities of the Department.</h3>
                <p>The Department shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.03#A">A.</span> Establish guidelines for defining financial eligibility of an:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.03#A(1)">(1)</span> Uninsured or underinsured individual for the purpose of receiving cancer treatment services under the Cancer Prevention, Education, Screening and Treatment Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.03#A(2)">(2)</span> Uninsured individual for the purpose of receiving tobacco treatment products under the Tobacco Use Prevention and Cessation Program; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.03#B">B.</span> Review the written documentation submitted by a local health department or Statewide academic health center to assure that the criteria listed in Regulations .05 and .06 of this chapter are followed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.04" data-order="|10|14|06|.04|" data-ref-path="10|14|06|.04" class="h__section">.04 Responsibilities of Local Health Departments and Statewide Academic Health Centers.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#A">A.</span> If a local health department or a Statewide academic health center decides that grant funds under the Cigarette Restitution Fund Program will not be used to pay for cancer treatment services or tobacco treatment products:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#A(1)">(1)</span> This chapter does not apply; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#A(2)">(2)</span> A local health department or a Statewide academic health center has no further responsibilities with respect to this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#B">B.</span> If a local health department or a Statewide academic health center decides that grant funds under the Cigarette Restitution Fund Program will be used to pay for cancer treatment services or tobacco treatment products:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#B(1)">(1)</span> This chapter applies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#B(2)">(2)</span> A local health department or a Statewide academic health center shall adhere to the financial guidelines established by the Department for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#B(2)(a)">(a)</span> Cancer treatment services as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.06.05" title=".05 Criteria for Eligibility for Cancer Treatment Services.">Regulation .05 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.04#B(2)(b)">(b)</span> Tobacco treatment products as set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.06.06" title=".06 Criteria for Eligibility for Tobacco Treatment Products.">Regulation .06 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.05" data-order="|10|14|06|.05|" data-ref-path="10|14|06|.05" class="h__section">.05 Criteria for Eligibility for Cancer Treatment Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A">A.</span> A local health department or a Statewide academic health center shall use the following financial eligibility criteria for cancer treatment services under the Cancer Prevention, Education, Screening and Treatment Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(1)">(1)</span> The basis for determining financial eligibility shall be the gross annual household income;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(2)">(2)</span> An applicant with a gross annual household income above 250 percent of the federal poverty level is not eligible to receive cancer treatment services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)">(3)</span> Written documentation required for determination of the gross annual household income shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(a)">(a)</span> The household’s most recent federal income tax return; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(b)">(b)</span> If a household income tax return was not filed, the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(b)(i)">(i)</span> The most recent W-2 statement;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(b)(ii)">(ii)</span> Pay stubs from two consecutive pays;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(b)(iii)">(iii)</span> A Social Security entitlement letter; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(3)(b)(iv)">(iv)</span> A notarized letter from the applicant stating that the applicant is not working and does not have any income;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(4)">(4)</span> The household income level for determining financial eligibility shall be based on the size of the family unit including the applicant and may include the following individuals as verified by the most recent tax return:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(4)(a)">(a)</span> The applicant’s spouse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(4)(b)">(b)</span> Any financially dependent children; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(4)(c)">(c)</span> Any financially dependent relative; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(5)">(5)</span> The type of written documentation that an applicant shall provide in order to document the size of the family unit includes the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(5)(a)">(a)</span> The most recent income tax return;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(5)(b)">(b)</span> A divorce decree, if applicable; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#A(5)(c)">(c)</span> If a household income tax return was not filed, written documentation shall include the names, ages, and relationship to the applicant of individuals supported by the gross annual household income.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.06.05#B">B.</span> A local health department or a Statewide academic health center may establish requirements for eligibility of cancer treatment services in addition to those cited in <a class="internal-link " href="/us/md/exec/comar/10.14.06.05#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.06" data-order="|10|14|06|.06|" data-ref-path="10|14|06|.06" class="h__section">.06 Criteria for Eligibility for Tobacco Treatment Products.</h3>
                <p>A local health department shall make tobacco treatment products available free of charge to an individual participating in the Cigarette Restitution Fund Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.06.07" data-order="|10|14|06|.07|" data-ref-path="10|14|06|.07" class="h__section">.07 Funding Availability.</h3>
                <p>Payment under this chapter is contingent on the availability of funds in accordance with State Finance and Procurement Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-234" title="">7-234</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-235" title="">7-235</a>, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.07" data-order="|10|14|07|" data-ref-path="10|14|07" class="h__chapter">Chapter 07 Cord Blood Transplant Center Support Fund</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: April 28, 2014 (41:8 Md. R. 472)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §§13-3001 — 13-3004, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.07.01" data-order="|10|14|07|.01|" data-ref-path="10|14|07|.01" class="h__section">.01 Purpose and Scope.</h3>
                <p>This chapter:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.01#A">A.</span> Defines the Cord Blood Transplant Program and Cord Blood Transplant Center Support Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.01#B">B.</span> Describes how funds may be allocated to the Cord Blood Transplant Center Support Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.01#C">C.</span> Sets forth the responsibilities of the Maryland Department of Health and the Comptroller with respect to the Cord Blood Transplant Program and Cord Blood Transplant Center Support Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.01#D">D.</span> Outlines the grant application process for the Cord Blood Transplant Center Support Fund; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.01#E">E.</span> Outlines grantee reporting requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.02" data-order="|10|14|07|.02|" data-ref-path="10|14|07|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(1)">(1)</span> "Comptroller" means the Comptroller of the Treasury.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(2)">(2)</span> “Cord Blood Transplant Center” means a medical facility that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(2)(a)">(a)</span> Uses cells obtained from a human umbilical cord or placenta to treat pediatric or adult patients afflicted with a disease or injury; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(2)(b)">(b)</span> Is a member of the National Marrow Donor Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(3)">(3)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(4)">(4)</span> "Fund" means the Cord Blood Transplant Center Support Fund.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(5)">(5)</span> Grant.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(5)(a)">(a)</span> "Grant" means financial assistance from the State to support an applicant's activities related to cord blood transplantation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(5)(b)">(b)</span> "Grant" does not mean a contract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(6)">(6)</span> “Program” means the Cord Blood Transplant Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(7)">(7)</span> “Qualified medical institution” means a medical institution that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(7)(a)">(a)</span> Is accredited by the Joint Commission on Accreditation of Health Care Organizations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(7)(b)">(b)</span> Is located in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(7)(c)">(c)</span> Has an established hematologic malignancies research program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(7)(d)">(d)</span> Meets all requirements established in the request for proposals issued by the Cord Blood Transplant Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.02#B(8)">(8)</span> "Secretary" means the Secretary of Health.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.03" data-order="|10|14|07|.03|" data-ref-path="10|14|07|.03" class="h__section">.03 Cord Blood Transplant Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.03#A">A.</span> There is a Cord Blood Transplant Program in the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.03#B">B.</span> The purpose of the Program is to provide funding to qualified medical institutions to establish or maintain a cord blood transplant center.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.03#C">C.</span> The Program administers the Fund to provide grants, subject to the limitations of the State budget, to qualified medical institutions to establish or maintain a cord blood transplant center.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.04" data-order="|10|14|07|.04|" data-ref-path="10|14|07|.04" class="h__section">.04 Cord Blood Transplant Center Support Fund.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#A">A.</span> The purpose of the Fund is to promote economic development by supporting cord blood transplant centers at qualified medical institutions with a goal of being recognized as a regional center of excellence in the area of cord blood transplantation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#B">B.</span> The Fund is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#B(1)">(1)</span> A nonlapsing, special fund pursuant to Health-General Article, §13-3001, Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#B(2)">(2)</span> Not subject to the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-302" title="">State Finance and Procurement Article, §7-302, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#C">C.</span> The Fund consists of any:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#C(1)">(1)</span> Money appropriated in the State budget to the Fund; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#C(2)">(2)</span> Other money from any other source accepted for the benefit of the Fund.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#D">D.</span> The Department may only expend funds in accordance with an appropriation approved by the General Assembly in the annual State budget.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#E">E.</span> The Department may only make grant awards under the Fund for the establishment of or support for a cord blood transplant center at a qualified medical institution.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.04#F">F.</span> Any unspent portions of the Fund shall remain in the Fund and may not revert or be credited to the general fund of the State, nor any other special fund of the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.05" data-order="|10|14|07|.05|" data-ref-path="10|14|07|.05" class="h__section">.05 Responsibilities of the Department.</h3>
                <p>The Department shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#A">A.</span> Administer the Program and perform related administration activities, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#A(1)">(1)</span> Develop and release an annual request for proposals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#A(2)">(2)</span> Convene an expert panel to review applications and select grantees; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#A(3)">(3)</span> Ensure that grantees remain in compliance with request for proposals requirements;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#B">B.</span> Administer the Fund;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#C">C.</span> Provide a grant or grants in each fiscal year, in accordance with the State budget, to qualified medical institutions; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.05#D">D.</span> Maintain records of grantee activities supported by the Fund.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.06" data-order="|10|14|07|.06|" data-ref-path="10|14|07|.06" class="h__section">.06 Allowable Use of the Fund.</h3>
                <p>A grantee may use awarded funds to establish or maintain a cord blood transplant center, which includes support of:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.06#A">A.</span> Individuals engaged in the establishment or maintenance of a cord blood transplant center; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.06#B">B.</span> Equipment necessary for the establishment or maintenance of a cord blood transplant center.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.07" data-order="|10|14|07|.07|" data-ref-path="10|14|07|.07" class="h__section">.07 Unallowable Use of the Fund.</h3>
                <p>A grantee may not use awarded funds to pay for activities not provided for in the approved grant application.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.08" data-order="|10|14|07|.08|" data-ref-path="10|14|07|.08" class="h__section">.08 Application Process for Cord Blood Transplant Center Grants.</h3>
                <p>An applicant for a cord blood transplant center grant shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#A">A.</span> Submit a completed application to the Department by the due date listed in the annual request for proposals; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B">B.</span> Include in the application packet the following information as specified in the annual request for proposals:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(1)">(1)</span> Executive summary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(2)">(2)</span> Statement of the need for funding;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(3)">(3)</span> Proposed work plan for the grant period;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(4)">(4)</span> Brief professional resume or curriculum vitae of key staff involved in the grant activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(5)">(5)</span> Description of how the requested funding will further the institution’s goal of being recognized as a cord blood transplantation regional center of excellence;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(6)">(6)</span> Timeline detailing the expected start and completion dates for each activity to be conducted under the grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(7)">(7)</span> Organizational chart indicating where the work under the grant will be located within the institution;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(8)">(8)</span> Statement that the grant money will not be used to supplant any existing funding;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(9)">(9)</span> Line item budget for the grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.08#B(10)">(10)</span> Written budget justification.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.09" data-order="|10|14|07|.09|" data-ref-path="10|14|07|.09" class="h__section">.09 Grant Application Review, Selection of Grantees, and Grant Extensions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#A">A.</span> The Department shall determine the amount of money available for grants under the Cord Blood Transplant Center Support Fund annually.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#B">B.</span> Each year the Program shall consider awarding a grant to at least one qualified medical institution.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#C">C.</span> The Program shall convene a grant evaluation committee to review the grant applications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#D">D.</span> Members of the evaluation committee may include one or more external individuals with expertise in cord blood transplantation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#E">E.</span> The evaluation committee shall review grant applications based on criteria stated in the Request for Proposals.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#F">F.</span> The Program shall recommend a grant application to the Secretary for approval based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#F(1)">(1)</span> The evaluation committee's recommendations for awarding the grants; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#F(2)">(2)</span> The availability of funds.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#G">G.</span> The Secretary shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#G(1)">(1)</span> Consider the grant award recommendations of the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#G(2)">(2)</span> Make the final determination on which grant applications to approve.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.09#H">H.</span> A grant period expires 1 year from the date of award of the grant.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.07.10" data-order="|10|14|07|.10|" data-ref-path="10|14|07|.10" class="h__section">.10 Payments, Terms and Conditions of Grant Awards, and Terminations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#A">A.</span> Payments Under the Grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#A(1)">(1)</span> The Department may not make more than quarterly payments during the grant period to a grantee awarded a grant under this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#A(2)">(2)</span> Before the first payment under the grant, at the request of the grantee in their submitted grant application, the Department may approve an advanced payment for the grant based on financial need.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#A(3)">(3)</span> If a financial or progress report required in §B or C of this regulation is overdue, the Department may withhold payment until the report is submitted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B">B.</span> Financial Reports and Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(1)">(1)</span> A grantee shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(1)(a)">(a)</span> Establish a separate account to track expenditures under the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(1)(b)">(b)</span> Maintain accurate records, including documentation of each transaction pertaining to the grant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(1)(c)">(c)</span> Submit to the Department quarterly invoices for payment and an annual financial expenditure report containing the signature of the financial officer of the entity affiliated with the grant award.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(2)">(2)</span> The Department may audit the accounts referenced in <a class="internal-link " href="/us/md/exec/comar/10.14.07.10#B(1)" title="">§B(1) of this regulation</a> at any time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(3)">(3)</span> Within 90 days after the date the grant period ends, a grantee shall submit to the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(3)(a)">(a)</span> A final financial expenditure report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(3)(b)">(b)</span> A refund of any unexpended funds.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(4)">(4)</span> A grantee shall retain all records pertaining to a grant award for 3 years from the date the final financial expenditure report is submitted under <a class="internal-link " href="/us/md/exec/comar/10.14.07.10#B(3)" title="">§B(3) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#B(5)">(5)</span> In the case of an audit or litigation, the Department may extend the time period under §B(3) or (4) of this regulation until the completion of the audit or litigation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C">C.</span> Progress Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(1)">(1)</span> A grantee shall submit to the Program one electronic copy of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(1)(a)">(a)</span> An interim report describing the progress of the grant:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(1)(a)(i)">(i)</span> 6 months after the date of award of the grant; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(1)(a)(ii)">(ii)</span> Every 6 months until the end of the grant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(1)(b)">(b)</span> Not later than 60 days after the date the grant period ends, a comprehensive final report, that provides a summary of all of the activity conducted under the grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#C(2)">(2)</span> The Department shall keep research results confidential as required by Health-General Article, §§4-101 — 4-103, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#D">D.</span> Publications.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#D(1)">(1)</span> A grantee who publishes results from activities supported by a grant approved by the Secretary under this chapter shall include in the publication the following acknowledgement: "Supported in part with funds from the Cord Blood Transplant Center Support Fund of the Maryland Department of Health."</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#D(2)">(2)</span> A grantee shall provide the Department with one electronic copy of any published article pertaining to the activities conducted under the grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#E">E.</span> Ownership of Equipment. A grantee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#E(1)">(1)</span> Shall ensure that equipment purchased under a grant under this chapter is used for the sole purpose of the grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#E(2)">(2)</span> Shall keep an inventory of all equipment purchased; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#E(3)">(3)</span> May not transfer the equipment to another entity without the written permission of the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F">F.</span> Termination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)">(1)</span> The Secretary may terminate a grant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(a)">(a)</span> If a grantee fails to comply with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(a)(i)">(i)</span> The requirements of this chapter; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(a)(ii)">(ii)</span> State, federal, and municipal laws applicable to the performance of research under the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(b)">(b)</span> If a grantee fails to carry out the purposes for which the grant was awarded;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(c)">(c)</span> In compliance with a court order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(1)(d)">(d)</span> At the request of the grantee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(2)">(2)</span> The Department and the State are not responsible for any expenses incurred by a grantee after cancellation of a grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#F(3)">(3)</span> The grantee shall return all unexpended funds to the Department within 60 days of termination of a grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#G">G.</span> Compliance with Existing Laws. A grantee shall ensure that an activity conducted in the performance of the grant is in compliance with all State, federal, and local laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#H">H.</span> Liability.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#H(1)">(1)</span> A grantee is solely responsible for the institution's actions relating to the grant-making process or pertaining to activities conducted under a grant award.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#H(2)">(2)</span> The State and the Department are not liable for any claims, losses, liabilities, expenses, or damages arising from activities relating to the grant-making process or conducted under a grant awarded under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.07.10#I">I.</span> Grant Agreements. A grantee shall enter into a grant agreement with the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.08" data-order="|10|14|08|" data-ref-path="10|14|08" class="h__chapter">Chapter 08 Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program</h2>
                <section class="line-group annotations">
                  <h4>Administrative History</h4>
                  <p>Effective date: November 13, 2023 (50:22 Md. R. 975)</p>
                  <h4>Authority</h4>
                  <p>Health-General Article, §§13-4001—13-4007, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.14.08.01" data-order="|10|14|08|.01|" data-ref-path="10|14|08|.01" class="h__section">.01 Purpose and Scope.</h3>
                <p>This chapter sets forth the:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.01#A">A.</span> Responsibilities of the Maryland Department of Health for the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program established by Health-General Article, §§13-4001—13-4007, Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.01#B">B.</span> Responsibilities of a grantee that receives funds under the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.01#C">C.</span> Application process for a grant under the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.01#D">D.</span> Reporting requirements for the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.02" data-order="|10|14|08|.02|" data-ref-path="10|14|08|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(1)">(1)</span> “Applicant” means an entity that applies to receive a grant under the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)">(2)</span> Cancer Screening Test.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(a)">(a)</span> “Cancer screening test” means a test that is designed to find cancer in an individual who does not present cancer signs or symptoms.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(b)">(b)</span> “Cancer screening test” includes, but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(b)(i)">(i)</span> A laboratory test;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(b)(ii)">(ii)</span> An imaging procedure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(b)(iii)">(iii)</span> A medical procedure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(2)(b)(iv)">(iv)</span> A genetic test.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(3)">(3)</span> “Cost effectiveness” means a comparison between cost and expected health outcomes of a cancer test or intervention.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(4)">(4)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(5)">(5)</span> “Grant” means funds distributed to a grantee under the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(6)">(6)</span> “Grantee” means a local fire department, volunteer fire department, or volunteer fire company approved to receive funds under the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(7)">(7)</span> “Health care provider” means a doctor of medicine or osteopathy, dentist, nurse practitioner, or physician assistant who is authorized to practice by the state in which the individual practices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(8)">(8)</span> “Local fire department” means a fire department operating in a Maryland county or Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(9)">(9)</span> “Program” means the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(10)">(10)</span> “Qualifications” means the education, experience, skills, and licensing of an individual associated with a Program grant application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(11)">(11)</span> “Volunteer fire company” means a volunteer fire company operating in a Maryland county or Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.02#B(12)">(12)</span> “Volunteer fire department” means a volunteer fire department operating in a Maryland county or Baltimore City.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.03" data-order="|10|14|08|.03|" data-ref-path="10|14|08|.03" class="h__section">.03 Responsibilities of the Department.</h3>
                <p>The Department shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.03#A">A.</span> Administer the Program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.03#B">B.</span> Provide one or more grants to local fire departments, volunteer fire companies, or volunteer fire departments to procure innovative cancer screening tests according to Health-General Article, §13-4003(a), Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.03#C">C.</span> Develop and distribute an application for Program grants each fiscal year if funding is available;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.03#D">D.</span> Maintain a record of information submitted by a grantee to the Department; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.03#E">E.</span> Monitor the activities of a grantee to ensure compliance with the requirements of the Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.04" data-order="|10|14|08|.04|" data-ref-path="10|14|08|.04" class="h__section">.04 Entities Eligible for Grants.</h3>
                <p>The following entities are eligible to apply for and receive a grant from the Department under the Program:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.04#A">A.</span> A local fire department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.04#B">B.</span> A volunteer fire company;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.04#C">C.</span> A volunteer fire department; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.04#D">D.</span> If authorized by a local fire department, volunteer fire company, or volunteer fire department, a county.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.05" data-order="|10|14|08|.05|" data-ref-path="10|14|08|.05" class="h__section">.05 Use of Grant Funds.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.05#A">A.</span> A grantee may use awarded funds to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.05#A(1)">(1)</span> Procure and administer innovative cancer screening tests that are not otherwise conducted during routine physical examinations or covered by insurance to professional firefighters employed by a local fire department and volunteer firefighters who serve in a volunteer fire company or department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.05#A(2)">(2)</span> Pay for activities directly associated with the grant that are approved by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.05#B">B.</span> A grantee may not use awarded funds to pay for an activity that is not included in the approved grant application.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.06" data-order="|10|14|08|.06|" data-ref-path="10|14|08|.06" class="h__section">.06 Application for Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program Grants.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A">A.</span> An applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(1)">(1)</span> Shall submit a completed application to the Department by the due date listed in the request for applications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)">(2)</span> Shall include in the application all required information listed in the request for applications, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(a)">(a)</span> The names and qualifications of the health care providers that will advise the applicant on the selection and administration of cancer screening tests;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(b)">(b)</span> The number of firefighters to be screened;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(c)">(c)</span> The selection criteria the applicant used to identify firefighters at the highest cancer risk based on the latest scientific and medical research; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)">(d)</span> A description of each test to be procured by the applicant, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(i)">(i)</span> The claimed accuracy and reliability of the test;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(ii)">(ii)</span> The scientific and clinical evidence supporting the claimed accuracy and reliability of the test;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(iii)">(iii)</span> Whether the test employs innovative or novel technologies, such as DNA sequencing, genomics, proteomics, metabolomics, machine learning, artificial intelligence, big data analytics, or other state-of-the-art technology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(iv)">(iv)</span> Whether the test has the ability to simultaneously screen for two or more cancer types for which firefighters have a higher incidence or death rate;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(v)">(v)</span> The cost of the test; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(2)(d)(vi)">(vi)</span> Whether the test is developed, manufactured, or commercialized by a business entity located in the State; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#A(3)">(3)</span> May voluntarily withdraw an application at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.06#B">B.</span> The county in which a volunteer fire company or department is located shall assist a volunteer fire company or a volunteer fire department in submitting an application.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.07" data-order="|10|14|08|.07|" data-ref-path="10|14|08|.07" class="h__section">.07 Application Review, Selection of Grantees, and Grant Period.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A">A.</span> The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A(1)">(1)</span> Determine the amount of money available for grants under the Program in each fiscal year;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A(2)">(2)</span> Develop a weighting formula to rate each application received by the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A(3)">(3)</span> Make available the weighting formula on the Program website and include the weighting formula in the request for applications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A(4)">(4)</span> Request additional information or changes to the application if necessary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#A(5)">(5)</span> Reject an application that does not meet the application requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B">B.</span> The Department shall review and prioritize applications based on the quality of the application received and the degree to which the tests listed on the application meet the following criteria:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B(1)">(1)</span> The scientific and clinical evidence supporting the claimed accuracy and reliability of test;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B(2)">(2)</span> Whether the test employs innovative or novel technologies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B(3)">(3)</span> The ability of the test to simultaneously screen for two or more cancer types;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B(4)">(4)</span> The cost effectiveness of the test; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#B(5)">(5)</span> Whether the test is developed, manufactured, or commercialized by a business entity located in the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#C">C.</span> The Department may review an application in consultation with one or more experts in cancer screening.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#D">D.</span> If the Department receives applications for grant funds totaling more than the amount of funds appropriated for the Program, the Department shall award the funds on a pro rata basis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.07#E">E.</span> Funds shall be awarded under the Program for a maximum of 1 year..</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.14.08.08" data-order="|10|14|08|.08|" data-ref-path="10|14|08|.08" class="h__section">.08 Payments, Terms and Conditions of Grant Awards, and Terminations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#A">A.</span> Payments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#A(1)">(1)</span> The Department may approve an advance payment based on financial need.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#A(2)">(2)</span> If a financial or progress report required by §B or C of this regulation is overdue, the Department may withhold payment of funds to a grantee until the financial or progress report is submitted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B">B.</span> Financial Reports and Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)">(1)</span> A grantee shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(a)">(a)</span> Establish a separate account to track expenditures under the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(b)">(b)</span> Maintain accurate records, including documentation of each transaction associated with the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(c)">(c)</span> Submit invoices for payment of grant funds to the Department within the deadline specified by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(d)">(d)</span> Submit a final report listing grant expenditures signed by the financial officer or designee of the grantee within the deadline specified by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(e)">(e)</span> Submit a final invoice for any unbilled expenditures within the deadline specified by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(1)(f)">(f)</span> Submit a refund of any unexpended funds within the deadline specified by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(2)">(2)</span> The Department may audit the accounts referenced in <a class="internal-link " href="/us/md/exec/comar/10.14.08.08#B(1)" title="">§B(1) of this regulation</a> at any time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(3)">(3)</span> A grantee shall retain all records pertaining to a grant for 3 years from the date the final report is submitted under <a class="internal-link " href="/us/md/exec/comar/10.14.08.08#B(1)" title="">§B(1) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#B(4)">(4)</span> In the case of an audit or litigation, the Department may extend the time period under §B(1) or (3) of this regulation until the completion of the audit or litigation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C">C.</span> Progress Reports. A grantee shall submit to the Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(1)">(1)</span> Interim reports describing the progress of the grant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(2)">(2)</span> A comprehensive final report that provides a summary of all activities conducted under the grant no later than the deadline specified by the Department, including the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(2)(a)">(a)</span> Number of individuals screened;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(2)(b)">(b)</span> Tests used;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(2)(c)">(c)</span> Cost of the tests; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#C(2)(d)">(d)</span> Cancers detected by the tests.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#D">D.</span> Publications.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#D(1)">(1)</span> A grantee who publishes results from activities supported by a grant approved under this chapter shall include in the publication the following acknowledgement: “Supported in part with funds from the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program of the Maryland Department of Health.”</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#D(2)">(2)</span> A grantee shall provide the Department with one electronic copy of any published article associated with an activity conducted under a grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#E">E.</span> Ownership of Cancer Screening Tests. A grantee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#E(1)">(1)</span> Shall ensure that a cancer screening test purchased under a Program grant is used for the sole purpose of the grant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#E(2)">(2)</span> Shall keep an inventory of cancer screening tests purchased; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#E(3)">(3)</span> May not transfer a cancer screening test to another entity without written permission from the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F">F.</span> Termination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)">(1)</span> The Department may terminate a grant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(a)">(a)</span> If a grantee fails to comply with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(a)(i)">(i)</span> The requirements of this chapter; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(a)(ii)">(ii)</span> State, federal, and municipal laws applicable to the grant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(b)">(b)</span> If a grantee fails to carry out the purposes for which the grant was awarded;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(c)">(c)</span> In compliance with a court order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(1)(d)">(d)</span> At the request of the grantee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(2)">(2)</span> The Department may not be held responsible for any expenses incurred by a grantee after cancellation of a grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#F(3)">(3)</span> The grantee shall return all unexpended funds to the Department within 30 days of termination of a grant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G">G.</span> Liability.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(1)">(1)</span> A grantee shall be solely responsible for its actions related to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(1)(a)">(a)</span> Program application process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(1)(b)">(b)</span> Activities conducted under a grant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(2)">(2)</span> The Department may not be held liable for any claims, losses, liabilities, expenses, or damages arising from activities related to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(2)(a)">(a)</span> Program application process; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.08.08#G(2)(b)">(b)</span> Activities conducted under a grant.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.13" aria-label="Subtitle 13 DRUGS">
                <div class="h__ui">Previous</div>
                <span>Subtitle 13 DRUGS</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.15" aria-label="Subtitle 15 FOOD">
                <div class="h__ui">Next</div>
                <span>Subtitle 15 FOOD</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
